syndrome	score	normalized_score
DRAVET SYNDROME	2.9482029999999995	100.0
CHILDHOOD ABSENCE EPILEPSY	2.5207408499999997	85.50092547901214
AURICULOCONDYLAR SYNDROME	2.333878554	79.16274944432254
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	2.333333	79.1442448162491
TOWNES-BROCKS SYNDROME 1; TBS1	1.713722434	58.12769453121105
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	1.6684777039999998	56.59304003150394
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	1.645175719	55.802660773359236
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	1.5640232699999999	53.05005354108927
CORNELIA DE LANGE SYNDROME 1	1.509313349	51.194349541059424
OROFACIODIGITAL SYNDROME TYPE 4	1.350545554	45.80910995613261
MYOCLONIC-ASTASTIC EPILEPSY	1.3442351540000002	45.59506770734581
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	1.31295385	44.53403819207837
PALLISTER-HALL SYNDROME	1.280121434	43.42039656020973
LENNOX-GASTAUT SYNDROME	1.2670541100000001	42.97716642985576
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	1.255422489	42.5826338620509
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	40.48886728627574
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	1.164156114	39.486972708460044
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1521162600000001	39.07859329903675
ALLAN-HERNDON-DUDLEY SYNDROME	1.1321738899999998	38.40216871090627
MYOPATHIC EHLERS-DANLOS SYNDROME	1.1292528	38.3030883558561
EARLOBE CREASE	1.125	38.15883777338264
TRISOMY 8P	1.103323199	37.42358307755607
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	1.1014010799999998	37.358386786798604
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	1.081343814	36.6780650450461
HYPEREKPLEXIA-EPILEPSY SYNDROME	1.0686936999999999	36.24898624687649
SLC35A2-CDG	1.052819604	35.71055330993151
BENIGN OCCIPITAL EPILEPSY	1.027027	34.835694828341204
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	1.022863704	34.694480129082024
ROLANDIC EPILEPSY	1.021574	34.65073470178275
JOUBERT SYNDROME 1	1.016462574	34.4773604124275
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	1.0151217989999999	34.43188270956919
RETT SYNDROME; RTT	1.010342529	34.2697748085868
ATONIC-ASTATIC SYNDROME OF FOERSTER	1.00689655	34.15289076091437
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	1.001086973	33.95583591089217
ATAXIA, SENSORY, AUTOSOMAL DOMINANT	1.0	33.91896690967346
EARRING HOLES, NATURAL	1.0	33.91896690967346
CRYPTOTIA, FAMILIAL	1.0	33.91896690967346
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	33.91896690967346
HAIRY EARS	1.0	33.91896690967346
HEREDITARY ANGIOEDEMA TYPE 1	1.0	33.91896690967346
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	1.0	33.91896690967346
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	33.91896690967346
RELAPSING POLYCHONDRITIS	1.0	33.91896690967346
MYOCLONIC EPILEPSY OF LAFORA	0.93788904	31.812227312705403
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.92074085	31.230578423534617
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.9172414	31.111880694782556
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.8999999999999999	30.527070218706108
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.8876050639999999	30.106646794674592
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.842211884	28.566957024329742
LAFORA DISEASE	0.78884221	26.75671281794368
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	26.138535914928525
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.75940841	25.758348729717735
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.750931904	25.470834403194086
PROGRESSIVE SUPRANUCLEAR PALSY-PURE AKINESIA WITH GAIT FREEZING SYNDROME	0.74700873	25.337764394107193
EARLY MYOCLONIC ENCEPHALOPATHY	0.719145614	24.3926762845028
CONGENITAL CONTRACTURAL ARACHNODACTYLY	0.7	23.743276836771418
XQ12-Q13.3 DUPLICATION SYNDROME	0.68797398	23.335366662336348
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.6844867539999999	23.217083559035796
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.683184133	23.17290000044095
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.67494477	22.89342931948716
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.673464634	22.843224635481345
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.672369074	22.806064372093786
MACROSTOMIA-PREAURICULAR TAGS-EXTERNAL OPHTHALMOPLEGIA SYNDROME	0.666667	22.612655912771277
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.6467644000000001	21.937580281954812
SPINOCEREBELLAR ATAXIA TYPE 10	0.62473414	21.190336622003308
BILATERAL POLYMICROGYRIA	0.6240021039999999	21.165506717142613
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.61220798	20.76546221545803
CENTRALOPATHIC EPILEPSY	0.6047009000000001	20.510829817349762
TRISOMY 18	0.602176874	20.4252174629766
ADNP SYNDROME	0.598979939	20.316780730499225
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.5967572	20.241387719909383
SCALP-EAR-NIPPLE SYNDROME	0.5847309500000001	19.833469744111927
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.5840166	19.8092397301
SCALP-EAR-NIPPLE SYNDROME; SENS	0.5796563499999999	19.661344554632095
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.57496951	19.50237178376116
PERIORAL MYOCLONIA WITH ABSENCES	0.5657097099999999	19.188288933970966
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.550630819	18.676828529107397
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.5428161300000001	18.411762351507008
BRACHYDACTYLY TYPE A2	0.537037	18.215740232270306
OTOONYCHOPERONEAL SYNDROME	0.5353489699999999	18.158483998557767
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	18.090104378836877
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.52753378	17.893400827554956
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	17.876211373504475
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.5259578189999999	17.83994585854502
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.521519964	17.68941840165009
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.516670419	17.524926845268123
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.515625	17.48946731280038
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.5140044939999999	17.434501423409447
PETERS-PLUS SYNDROME; PTRPLS	0.5128741330000001	17.396160746054466
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.512368214	17.37900049623449
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.507846503	17.22562873045038
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	17.19834929955638
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.506888193	17.193123845271174
PETERS PLUS SYNDROME	0.506868234	17.192446856610623
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.50512821	17.133427040132585
DISTAL MYOTILINOPATHY	0.50492611	17.126572016920143
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.5027027	17.051156246703503
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	0.50235294	17.039292748837177
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.501086973	16.996352456055437
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.500545554	16.97798808291017
MEDULLOBLASTOMA	0.500545554	16.97798808291017
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.500541419	16.977847827982
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.500541419	16.977847827982
PAROXYSMAL HEMICRANIA	0.5	16.95948345483673
CREST SYNDROME	0.5	16.95948345483673
PYKNOACHONDROGENESIS	0.5	16.95948345483673
113450 BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME	0.5	16.95948345483673
INHALATIONAL ANTHRAX	0.5	16.95948345483673
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	16.95948345483673
BRACHYDACTYLY TYPE C	0.5	16.95948345483673
BRACHYDACTYLY, TYPE D	0.5	16.95948345483673
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	16.95948345483673
GASTROSCHISISABDOMINAL WALL DEFECTS, INCLUDED	0.5	16.95948345483673
HIRSCHSPRUNG DISEASE WITH TYPE D BRACHYDACTYLY	0.5	16.95948345483673
MADELUNG DEFORMITY	0.5	16.95948345483673
POLAND SYNDROME	0.48888859999999995	16.58259624591658
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.48631315	16.495239642589066
EPILEPSY, JUVENILE ABSENCE	0.48251765999999996	16.366500542873066
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.47424667	16.085957106752826
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.44171742	14.982598552406333
MYOCLONIC EPILEPSY OF INFANCY	0.438861914	14.88574273888196
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.438861914	14.88574273888196
PSEUDOAMINOPTERIN SYNDROME	0.43367648400000003	14.70985831029953
CZEIZEL-LOSONCI SYNDROME	0.43333299999999997	14.698207687869527
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.41217954	13.980704178104428
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.40699812	13.804955764579308
BECKWITH-WIEDEMANN SYNDROME	0.4061966	13.777769034221865
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.40208787000000007	13.638405157311084
NEUROFACIODIGITORENAL SYNDROME	0.40031169999999994	13.578159305855126
DISTAL MONOSOMY 12Q	0.394864554	13.393397740928966
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.3883056	13.170924797240897
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.383358539	13.003125598881763
DEAFNESS-EAR MALFORMATION-FACIAL PALSY SYNDROME	0.380952	12.921498282173923
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.37778141899999995	12.813955450150482
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.36420503000000004	12.35345836090663
ACITRETIN/ETRETINATE EMBRYOPATHY	0.35752487	12.126874234915306
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	12.126629679163885
SPINOCEREBELLAR ATAXIA TYPE 42	0.35743284000000003	12.123752672390609
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.3500228329999999	11.872412890157156
GLOMUVENOUS MALFORMATION	0.35	11.871638418385709
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.34948424299999997	11.854144473769276
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.346615073	11.75682519148105
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.346069519	11.73832056340761
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.345372854	11.714690406325483
NON-DISTAL MONOSOMY 20Q	0.34408357900000003	11.670959530263014
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.342711979	11.624436275249705
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.34166633	11.588968941419573
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	11.545176841621831
FRAXE INTELLECTUAL DISABILITY	0.34017264999999997	11.53830485892593
MARTSOLF SYNDROME	0.33947207	11.514541909088353
FG SYNDROME 2; FGS2	0.33879748	11.491660513200754
PRIMROSE SYNDROME; PRIMS	0.33872228	11.489109806889147
KEUTEL SYNDROME; KTLS	0.337458649	11.44624874881411
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.335509874	11.38014831407471
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.334419973	11.34317999812089
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.33395510400000006	11.32741212189256
COG4-CDG	0.333878554	11.324815624975622
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.333874419	11.32467537004745
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.333874419	11.32467537004745
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	11.306310996902184
%173800 POLAND SYNDROME;;POLAND SYNDACTYLY;;POLAND ANOMALY;;POLAND SEQUENCEPECTORALIS MUSCLE, ABSENCE OF, INCLUDED	0.333333	11.306310996902184
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	11.306310996902184
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.333333	11.306310996902184
%607004 BRACHYDACTYLY, TYPE A1, B; BDA1B	0.333333	11.306310996902184
PLACENTAL INSUFFICIENCY	0.333333	11.306310996902184
BRACHYDACTYLY, TYPE A6	0.333333	11.306310996902184
THUMB STIFFNESS-BRACHYDACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.333333	11.306310996902184
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.327464519	11.107258184053135
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.32742392	11.105881107915568
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.3269231	11.088893810907868
RING CHROMOSOME 7 SYNDROME	0.32036969	10.866608913972344
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.31529217000000004	10.69438468110914
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.31314179999999997	10.621446352235584
JUVENILE MYOCLONIC EPILEPSY	0.3123459	10.594450246472176
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.30897985	10.480277307905869
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.30157222	10.229018151056763
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	10.219154311965628
SCHINZEL-GIEDION SYNDROME	0.29864470000000004	10.129719697049358
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.298125454	10.112107409157376
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.29551881399999996	10.023692873251944
CHROMOSOME 1P36 DELETION SYNDROME	0.29456647299999994	9.991390450386218
SAETHRE-CHOTZEN SYNDROME	0.294161199	9.977643974990869
ABLEPHARON-MACROSTOMIA SYNDROME	0.2911642	9.875988865081545
OTOONYCHOPERONEAL SYNDROME	0.28061503	9.518171916927026
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.274006144	9.29400533138322
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.269751594	9.14969539071767
ZIMMERMANN-LABAND SYNDROME	0.269013469	9.124658953267467
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.26891508399999997	9.121321835708057
FOCAL FACIAL DERMAL DYSPLASIA TYPE II	0.2659091	9.019361963881051
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.26196832000000003	8.88569477746275
LANDAU-KLEFFNER SYNDROME	0.259858903	8.814145532041044
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.259541069	8.803364931112275
8Q24.3 MICRODELETION SYNDROME	0.257848933	8.745969426121608
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.25693326	8.714910743934528
20Q13.33 MICRODELETION SYNDROME	0.25668048899999996	8.7063370127498
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.25564457999999995	8.671200049657369
123560 CRYPTOMICROTIA-BRACHYDACTYLY SYNDROME	0.25531915	8.660161800255954
HYPEREKPLEXIA 1; HKPX1	0.2542735	8.624694432506853
LAING EARLY-ONSET DISTAL MYOPATHY	0.25344828	8.596703822633653
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25196464	8.546380286567786
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.25157535000000003	8.53317597193952
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.25157535000000003	8.53317597193952
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.251086973	8.516610728637072
EAR-PATELLA-SHORT STATURE SYNDROME	0.250545554	8.498246355491805
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.250541419	8.498106100563632
CRYPTOMICROTIA-BRACHYDACTYLY-EXCESS FINGERTIP ARCH SYNDROME	0.25	8.479741727418364
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.25	8.479741727418364
VACTERL WITH HYDROCEPHALUS	0.25	8.479741727418364
HYPERPARATHYROIDISM 2	0.25	8.479741727418364
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.25	8.479741727418364
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.25	8.479741727418364
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.25	8.479741727418364
DYSTONIA 6, TORSION	0.25	8.479741727418364
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.24496114400000002	8.308828937491755
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.243045154	8.243840536082491
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.23972188400000002	8.13111865092058
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.23932652000000001	8.117708312487304
KOOLEN-DE VRIES SYNDROME; KDVS	0.23895792300000002	8.105205883041299
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.234614804	7.957891773395525
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.23387798000000004	7.932899464521272
8Q22.1 MICRODELETION SYNDROME	0.231921994	7.866554440111486
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.22901783000000003	7.768048197495222
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.226086973	7.668636555895237
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915	7.663283362780652
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.225545554	7.650272182749969
BRANCHIOOCULOFACIAL SYNDROME	0.224379069	7.6107062166343376
PIERPONT SYNDROME	0.223189613	7.570361097929826
CODAS SYNDROME	0.222744554	7.555265156435972
DISTAL 17P13.1 MICRODELETION SYNDROME	0.22135945	7.508283859693517
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.220987194	7.495657320747588
DOWN SYNDROME	0.22033085000000002	7.473394810330227
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.21929903900000003	7.43839684716419
CLASSICAL EHLERS-DANLOS SYNDROME	0.21898046	7.427590976605073
AURICULOOSTEODYSPLASIA	0.21787023	7.389933121972946
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.21740343000000004	7.3740997482195105
COHEN-GIBSON SYNDROME; COGIS	0.217252574	7.368982868547384
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.216853483	7.355446114124437
WARBURG MICRO SYNDROME 2; WARBM2	0.21619997000000002	7.333279628302394
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.21507888900000002	7.295253718960332
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.214545704	7.277168634588596
8P INVERTED DUPLICATION/DELETION SYNDROME	0.213497699	7.241621387672424
INTELLECTUAL DISABILITY, WOLFF TYPE	0.213497699	7.241621387672424
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.21237721	7.203615558358771
FGFR2-RELATED BENT BONE DYSPLASIA	0.21175792000000002	7.18260988134128
DEND SYNDROME	0.209883219	7.119021960156748
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.2098612	7.1182750984243635
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.208107573	7.058793882239453
SHELDON-HALL SYNDROME	0.20742912	7.035781457382686
BRANCHIOSKELETOGENITAL SYNDROME	0.20662026900000002	7.00834606707883
KAGAMI-OGATA SYNDROME	0.206406123	7.001082455990989
NEONATAL MARFAN SYNDROME	0.20612263	6.9914666663048655
RENPENNING SYNDROME	0.20575696899999998	6.979063822945706
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.205467529	6.969246317163372
FAMILIAL LAMBDOID SYNOSTOSIS	0.20546448	6.969142898233264
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.20540101	6.966990061403506
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.20505564	6.955275467801913
SECONDARY NON-TRAUMATIC AVASCULAR NECROSIS	0.20492611000000002	6.950881944018104
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.204129784	6.923871388774791
MOMO SYNDROME	0.203977789	6.9187158753993545
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.20376969	6.911657372304418
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.20368050000000001	6.9086321396457455
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.20344828	6.900755477149981
CODAS SYNDROME	0.203439913	6.900471677153846
XQ25 MICRODUPLICATION SYNDROME	0.20271829300000002	6.875995072252489
DISTAL TRISOMY 6P	0.20218238400000002	6.857817592614893
RING CHROMOSOME 8 SYNDROME	0.20163132	6.83912607103378
1P21.3 MICRODELETION SYNDROME	0.20054555400000001	6.802298010008132
BECKWITH-WIEDEMANN SYNDROME	0.2	6.783793381934693
FAMILIAL CERVICAL ARTERY DISSECTION	0.2	6.783793381934693
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	6.783793381934693
RADIATION PROCTITIS	0.2	6.783793381934693
MYOFIBROMATOSIS, INFANTILE, 1; IMF1	0.2	6.783793381934693
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.2	6.783793381934693
EAR PITS, POSTERIOR HELICAL	0.2	6.783793381934693
MUCKLE-WELLS SYNDROME	0.19444430000000001	6.5953497774746195
TOWNES-BROCKS SYNDROME	0.19050465	6.461720919488924
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.18830818400000002	6.387219061916702
20Q11.2 MICRODUPLICATION SYNDROME	0.188182873	6.3829686422542835
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.18796611400000002	6.375616400905909
BRANCHIOGENIC DEAFNESS SYNDROME	0.1851855	6.281300846651335
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.184140403	6.245852236090935
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.18347613999999998	6.223321121374614
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.18296851	6.206102836202257
MOWAT-WILSON SYNDROME; MOWS	0.18263544899999998	6.1948057511643535
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.18213795400000002	6.177931234721627
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.179201484	6.078329205960378
PHOCOMELIA-ECTRODACTYLY-DEAFNESS-SINUS ARRHYTHMIA SYNDROME	0.17793815	6.0354782218185115
UNILATERAL POLYMICROGYRIA	0.17776205	6.029505091745719
3MC SYNDROME	0.17750715	6.020859147080443
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.177243819	6.011927231605152
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.1769231	6.001048774456849
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.176753623	5.995300289701897
MONOSOMY 9Q22.3	0.175463843	5.951552284561139
PFAPA SYNDROME	0.17543893000000002	5.950707261338519
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.17465101400000002	5.9239819646069165
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.173769243	5.894073203236006
CEREBROOCULONASAL SYNDROME	0.17188255	5.830078525800293
ROIFMAN SYNDROME; RFMN	0.171066784	5.802408585840257
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.17086195	5.795460828172281
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.17027323	5.775492053973218
MICROTRIPLICATION 11Q24.1	0.1693697	5.744845249801321
AREDYLD SYNDROME	0.16871618000000002	5.722678526546511
BRACHYDACTYLY, TYPE E	0.16871618000000002	5.722678526546511
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.16799087399999998	5.698076896333123
TARP SYNDROME	0.167382213	5.677431744014914
GRANULOMATOSIS WITH POLYANGIITIS	0.167208419	5.671536831079814
BRACHYDACTYLY, TYPE B1	0.166667	5.653172457934547
268650 RUDIGER SYNDROME	0.166667	5.653172457934547
PITYRIASIS RUBRA PILARIS	0.166667	5.653172457934547
PEMPHIGUS VULGARIS	0.166667	5.653172457934547
AURICULOOSTEODYSPLASIA	0.166667	5.653172457934547
106990 ANONYCHIA-ONYCHODYSTROPHY WITH BRACHYDACTYLY TYPE B AND ECTRODACTYLY	0.166667	5.653172457934547
EXOSTOSES-ANETODERMIA-BRACHYDACTYLY TYPE E SYNDROME	0.166667	5.653172457934547
HOLT-ORAM SYNDROME	0.166667	5.653172457934547
BRACHYDACTYLY TYPE B2	0.166667	5.653172457934547
BRACHYDACTYLY TYPE E	0.166667	5.653172457934547
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.166667	5.653172457934547
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	5.653172457934547
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.166667	5.653172457934547
BRACHYDACTYLY TYPE B	0.166667	5.653172457934547
PATENT DUCTUS ARTERIOSUS-BICUSPID AORTIC VALVE-HAND ANOMALIES SYNDROME	0.166667	5.653172457934547
COLOBOMA OF MACULA-BRACHYDACTYLY TYPE B SYNDROME	0.166667	5.653172457934547
SPONDYLOPERIPHERAL DYSPLASIA-SHORT ULNA SYNDROME	0.166667	5.653172457934547
EXOSTOSES WITH ANETODERMIA AND BRACHYDACTYLY, TYPE E	0.166667	5.653172457934547
120400 COLOBOMA OF MACULA WITH TYPE B BRACHYDACTYLY;;APICAL DYSTROPHY;;SORSBY SYNDROME	0.166667	5.653172457934547
49,XYYYY SYNDROME	0.1666667	5.653162282244473
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 24	0.1666667	5.653162282244473
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.16594129999999999	5.628557463648195
JUVENILE ABSENCE EPILEPSY	0.16503685	5.597879454026742
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.16323018399999997	5.5365992097559085
ATYPICAL RETT SYNDROME	0.162472419	5.510896603795602
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.410268560204302
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.410268560204302
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.1594828	5.40949181586207
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.1594828	5.40949181586207
608028 THAI SYMPHALANGISM SYNDROME	0.15922215	5.400650837137063
MOWAT-WILSON SYNDROME	0.157510249	5.342584923765427
EPILEPSY, IDIOPATHIC GENERALIZED	0.15622691	5.299055390690533
DISTAL MONOSOMY 9P	0.155828444	5.285539835621904
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.15489685399999997	5.25394126523852
TEEBI-SHALTOUT SYNDROME; TBSH	0.15466734000000001	5.246156387467214
CHARGE SYNDROME	0.1536391	5.211279548932011
FEBRILE CONVULSIONS, FAMILIAL, 9	0.153624	5.210767372531675
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15266181399999998	5.178131017436724
GLYCINE ENCEPHALOPATHY	0.15211625999999998	5.159626389363284
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.151813604	5.14936061051427
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.14891950999999998	5.051195931894785
TUBEROUS SCLEROSIS COMPLEX	0.1484533	5.035382570331827
OLIVER SYNDROME	0.14795135	5.018356944891517
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.147513204	5.003495485215911
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.147513204	5.003495485215911
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.147406763	4.999885116459078
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.145058844	4.920246129591484
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.144158203	4.889697317314989
PHACE SYNDROME	0.14394397299999998	4.8824308570339285
ALG11-CDG	0.14394397299999998	4.8824308570339285
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.143244119	4.8586925323663275
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.14285699999999998	4.8455618558152205
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	4.8455618558152205
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	4.8455618558152205
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.14285699999999998	4.8455618558152205
GANGLIONEUROMA	0.14285699999999998	4.8455618558152205
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.141153799	4.7877910374556985
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.140625	4.76985472167283
16P12.1P12.3 TRIPLICATION SYNDROME	0.140118	4.752657805449625
C SYNDROME	0.139121479	4.718856842625831
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.13790635899999998	4.677641227554548
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.137708673	4.670935922662043
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.13756670399999998	4.666120480848843
ATYPICAL JUVENILE PARKINSONISM	0.13756617899999998	4.666102673391215
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.13703700000000002	4.648153468400922
CHRISTIANSON SYNDROME	0.13649015	4.629604881346367
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.13553973	4.597367616816075
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.13549420399999998	4.595823421928545
ZECHI-CEIDE SYNDROME	0.134640944	4.566881724223197
CONGENITAL MYASTHENIC SYNDROME	0.13398594900000002	4.544664970492196
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.13398594900000002	4.544664970492196
TEMTAMY SYNDROME; TEMTYS	0.132643903	4.499144156626937
WHITE-SUTTON SYNDROME; WHSUS	0.13140643400000002	4.4571704865641895
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.13133251399999998	4.454663196530226
EHLERS-DANLOS SYNDROME, TYPE I	0.13090481999999998	4.440156257896759
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.13081887	4.437240922690874
22Q11.2 MICRODUPLICATION SYNDROME	0.12952334299999999	4.393297985247284
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.129397449	4.389027790827159
LAURENCE-MOON SYNDROME	0.1286805	4.364709621420236
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.128380094	4.354520160246768
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.127506059	4.324873796003872
HEART-HAND SYNDROME TYPE 2	0.12704918	4.309376932321148
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.12704918	4.309376932321148
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.12680505	4.301096294929488
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.126057584	4.275743020409382
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.125541419	4.258235236854451
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.125541419	4.258235236854451
FAMILIAL AVASCULAR NECROSIS OF FEMORAL HEAD	0.125	4.239870863709182
PARKINSON DISEASE, LATE-ONSET; PD	0.125	4.239870863709182
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.125	4.239870863709182
PERRY SYNDROME	0.125	4.239870863709182
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.125	4.239870863709182
SECKEL SYNDROME	0.12497225000000001	4.238929612377439
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.1238095	4.199490333603216
TRISOMY XQ28	0.12359801	4.192316811291489
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.12318382900000002	4.178268219657875
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.12275444399999999	4.163703924051363
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.12240386899999998	4.151812782227005
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.12096990299999999	4.103174136923408
MENTAL RETARDATION, X-LINKED 21	0.12058098899999999	4.089982575826698
GALLOWAY-MOWAT SYNDROME	0.12045510299999998	4.085712652758308
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.119768013	4.062407269784341
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.118300879	4.0126436001862835
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.007636177020375
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.11810906400000001	4.006137433548505
20P13 MICRODELETION SYNDROME	0.116629819	3.955962971342205
BAZEX-DUPRÉ-CHRISTOL SYNDROME	0.11469522999999998	3.890343711067386
AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE	0.11469522999999998	3.890343711067386
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.113955543	3.8652542921908712
XIA-GIBBS SYNDROME	0.113461604	3.8485003915944733
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.11340077400000001	3.8464371008373583
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.11316017999999999	3.8382764009126915
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.11274232	3.824103021399816
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 63	0.1121951	3.805541884327505
SPASTIC PARAPLEGIA 61, AUTOSOMAL RECESSIVE; SPG61	0.11182266	3.7929091042916663
MAST CELL SARCOMA	0.11111099999999999	3.768770332300727
TETRAPLOIDY	0.11111099999999999	3.768770332300727
STEINERT MYOTONIC DYSTROPHY	0.11111099999999999	3.768770332300727
ULNAR-MAMMARY SYNDROME	0.11111099999999999	3.768770332300727
TARP SYNDROME; TARPS	0.11053204400000001	3.749132742894571
14Q12 MICRODELETION SYNDROME	0.11028266900000001	3.740674200521471
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.11	3.7310863600640802
SAGLIKER SYNDROME	0.10961538000000001	3.7180404470112824
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.10907568300000002	3.699734482327032
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.10899505400000001	3.696999629944072
SPINOCEREBELLAR ATAXIA TYPE 29	0.108777964	3.689636161417651
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 30	0.10833333	3.674554635484735
FAMILIAL REACTIVE PERFORATING COLLAGENOSIS	0.10793651000000001	3.6610949110356388
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.107394603	3.642713985434518
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.107320054	3.640185360370369
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.10721061000000001	3.6364731329559064
NAGER SYNDROME	0.1071242	3.633542195025242
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10675886400000001	3.6211503753303296
MATERNAL PHENYLKETONURIA	0.10673211300000002	3.6202430090465287
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.10657480000000003	3.6149071146050678
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.10615581300000002	3.600695508416484
MICROTIA	0.10531915	3.5723167638049356
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 61	0.10492611	3.5589852530507575
TRISOMY 13	0.10464842900000002	3.5495666004003126
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.104129784	3.5319746978074447
AICARDI SYNDROME; AIC	0.1036867	3.516945746273239
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.10361188900000001	3.51440823443976
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.10358423	3.5134700697340047
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.103177523	3.499674988459072
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.10310420000000001	3.4971879480483548
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.10270270000000001	3.483569482834121
PARKINSON DISEASE 15, AUTOSOMAL RECESSIVE EARLY-ONSET	0.10270270000000001	3.483569482834121
WEYERS ACROFACIAL DYSOSTOSIS	0.10204918	3.4614027595793107
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.10196464000000001	3.4585352501167668
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.10163132000000001	3.447229380066435
NON-DISTAL TRISOMY 13Q	0.10084030000000001	3.4203987988615445
CONGENITAL TRACHEAL STENOSIS	0.10057470000000002	3.411389921250336
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.100541419	3.4102610641126145
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.100541419	3.4102610641126145
LIPOID PROTEINOSIS	0.100541419	3.4102610641126145
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.10023615000000001	3.3999066550030657
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.1	3.3918966909673465
ELLIS VAN CREVELD SYNDROME	0.1	3.3918966909673465
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 5	0.1	3.3918966909673465
METAPHYSEAL ANADYSPLASIA	0.1	3.3918966909673465
ACUTE MYELOMONOCYTIC LEUKEMIA	0.1	3.3918966909673465
LICHEN PLANUS PEMPHIGOIDES	0.1	3.3918966909673465
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.1	3.3918966909673465
KAPOSI SARCOMA	0.1	3.3918966909673465
LEISHMANIASIS	0.1	3.3918966909673465
OROMANDIBULAR-LIMB HYPOGENESIS SYNDROME	0.1	3.3918966909673465
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.1	3.3918966909673465
JUVENILE XANTHOGRANULOMA	0.1	3.3918966909673465
AA AMYLOIDOSIS	0.1	3.3918966909673465
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.099348799	3.3698086257967996
WITTEVEEN-KOLK SYNDROME	0.09905529300000002	3.359853205495009
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.098953104	3.3563870601854764
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.098393854	3.3374178779412413
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.3281917832659422
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.3281917832659422
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.3281917832659422
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.3281917832659422
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.3281917832659422
49,XXXYY SYNDROME	0.09789426000000001	3.3204721655869704
ADENYLOSUCCINATE SYNTHETASE-LIKE 1-RELATED DISTAL MYOPATHY	0.09752158	3.307831244999073
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.09728178	3.2996974767341336
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.09682066000000002	3.284056762712745
ROBERTS SYNDROME; RBS	0.09672797000000001	3.2809128136698873
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.09595502900000001	3.2546954534677575
TETRASOMY 9P	0.09483284300000003	3.2166320636672596
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.09361180000000001	3.17521554655497
ROBERTS SYNDROME	0.09350383400000001	3.1715534513736
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.09325970400000001	3.163272813981942
3P25.3 MICRODELETION SYNDROME	0.09257182	3.1399404993482474
MONOSOMY 13Q34	0.09252355400000002	3.1383033664913857
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.09248751000000001	3.1370807912480934
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.09199607300000001	3.120411755906904
CHARGE SYNDROME	0.091811704	3.114158149896734
AICARDI SYNDROME	0.09146958999999998	3.1025539964513973
UNVERRICHT-LUNDBORG DISEASE	0.0909091	3.0835427546881955
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.09063464000000002	3.074233355030167
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.09051070400000001	3.0700295739472496
PSEUDOMYXOMA PERITONEI	0.09047619999999999	3.0688592339129976
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.090167594	3.058391637210871
MEIER-GORLIN SYNDROME 5; MGORS5	0.08993019	3.0503391387906467
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.08982882300000002	3.0469008748719144
17Q23.1Q23.2 MICRODELETION SYNDROME	0.08979252999999998	3.0456698538058604
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.08962860300000002	3.04010961931726
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.08928740400000001	3.028536501726646
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.08925271000000001	3.027359717088682
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.08881885000000002	3.012643634105251
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.08868102	3.00796858289609
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.08867000000000001	3.007594795880746
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.08867000000000001	3.007594795880746
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.08790998	2.981815702650055
22Q11.2 DELETION SYNDROME	0.08719101300000001	2.9574290847679086
ACROOTOOCULAR SYNDROME	0.08676967000000002	2.9431375654932865
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.08645022000000001	2.9323021515139907
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.086236449	2.925051260038743
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.08622765900000001	2.9247531123196073
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.086158213	2.9223975757435974
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.08587826000000001	2.912901859200334
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.08528754	2.8928652470674514
TRICHOHEPATOENTERIC SYNDROME 1	0.0840473	2.8507975875473983
WILLIAMS-BEUREN SYNDROME; WBS	0.08388099	2.8451565241606502
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.08346845400000001	2.8311637292276015
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.08333330000000001	2.8265794451738917
POSTORGASMIC ILLNESS SYNDROME	0.08333330000000001	2.8265794451738917
ALKAPTONURIA	0.08333330000000001	2.8265794451738917
OROMANDIBULAR DYSTONIA	0.08333330000000001	2.8265794451738917
HEMOLYTIC ANEMIA, LETHAL CONGENITAL NONSPHEROCYTIC, WITH GENITAL AND OTHER ABNORMALITIES	0.08333330000000001	2.8265794451738917
POLYDACTYLY, PREAXIAL IV; PPD4	0.08333330000000001	2.8265794451738917
SCLEROSTEOSIS	0.08333330000000001	2.8265794451738917
DIPROSOPUS	0.08333330000000001	2.8265794451738917
ERMINE PHENOTYPE	0.08333330000000001	2.8265794451738917
SYNDACTYLY-POLYDACTYLY-EARLOBE SYNDROME	0.08333330000000001	2.8265794451738917
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.082877923	2.811133527779465
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.082769773	2.807465191508184
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2W	0.0822917	2.7912494492407753
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 62	0.08223111	2.789194299035718
SPASTIC PARAPLEGIA 62, AUTOSOMAL RECESSIVE	0.08223111	2.789194299035718
FRIEDREICH ATAXIA	0.08222186000000001	2.7888805485918042
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.082141554	2.7861566520351557
PAPILLARY TUMOR OF THE PINEAL REGION	0.08184921	2.7762406455729143
PINEOCYTOMA	0.08184921	2.7762406455729143
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.08161245	2.76820999096738
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.081596	2.7676520239617157
3MC SYNDROME 2	0.080952174	2.745814111172128
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.0807113	2.7376439139367275
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.080673794	2.736371749163813
NORMAL PRESSURE HYDROCEPHALUS	0.0803924	2.7268271553892323
LOCKED-IN SYNDROME	0.08020053	2.7203191232082737
3MC SYNDROME 3	0.07936511000000002	2.6919825398725945
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.0791926	2.6861311788910065
PRIMARY PROGRESSIVE FREEZING GAIT	0.07910191	2.683055067781968
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.07852351	2.663436337321413
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.07785055399999999	2.640610365025746
N SYNDROME	0.07746865400000001	2.627656711562943
PEDIATRIC-ONSET GRAVES DISEASE	0.07746865400000001	2.627656711562943
ETHYLMALONIC ENCEPHALOPATHY	0.07746451900000001	2.6275164566347713
DDOST-CDG	0.07746451900000001	2.6275164566347713
NEUROFIBROMATOSIS TYPE 1	0.07746451900000001	2.6275164566347713
7Q11.23 MICRODUPLICATION SYNDROME	0.077365189	2.6241472856516332
OKAMOTO SYNDROME	0.07698323400000001	2.611191766645649
DERMATOMYOSITIS	0.07692310000000001	2.609152083489503
CONGENITAL ENTEROVIRUS INFECTION	0.07692310000000001	2.609152083489503
ACQUIRED HYPERTRICHOSIS LANUGINOSA	0.07692310000000001	2.609152083489503
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	2.609152083489503
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.07692310000000001	2.609152083489503
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.07692310000000001	2.609152083489503
CLASSIC MYCOSIS FUNGOIDES	0.07692310000000001	2.609152083489503
DERMOODONTODYSPLASIA	0.07692310000000001	2.609152083489503
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.609152083489503
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.07689308	2.608133836102874
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.076616449	2.5987507983676843
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.588325837806963
NOONAN SYNDROME 7; NS7	0.07567976900000001	2.5669795804427316
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.0754241	2.5583075520919016
URBAN-ROGERS-MEYER SYNDROME	0.07502633	2.544815604624241
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.07489701900000001	2.5404295090941846
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.07462507	2.5312052799620655
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.07442027300000001	2.524258777295865
COHEN SYNDROME	0.07435666299999999	2.5221011918107403
MIYOSHI MYOPATHY	0.07404541	2.5115438116032047
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.07394574999999999	2.5081634473609857
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.07394574999999999	2.5081634473609857
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.07394574999999999	2.5081634473609857
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.07378154	2.502593613804749
DYSFERLIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R2	0.07356325	2.495189442518036
MYOPATHY AND DIABETES MELLITUS	0.07356325	2.495189442518036
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.073394869	2.4894781329508184
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.07251557300000001	2.4596533210230103
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.07251557300000001	2.4596533210230103
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.07251557300000001	2.4596533210230103
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.07251557300000001	2.4596533210230103
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.072426573	2.4566345329680486
CRANIOECTODERMAL DYSPLASIA 1	0.07231184	2.4527429081376018
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07197415400000001	2.441288947877742
RABIES	0.07197001900000001	2.4411486929495707
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.07197001900000001	2.4411486929495707
VASCULAR EHLERS-DANLOS SYNDROME	0.07194529399999999	2.440310046492728
WALDENSTRÖM MACROGLOBULINEMIA	0.07142860000000001	2.4227843198043018
STEVENS-JOHNSON SYNDROME	0.07142860000000001	2.4227843198043018
TOXIC EPIDERMAL NECROLYSIS	0.07142860000000001	2.4227843198043018
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.07142860000000001	2.4227843198043018
SIX2-RELATED FRONTONASAL DYSPLASIA	0.07142860000000001	2.4227843198043018
ESOPHAGEAL ATRESIA	0.07142860000000001	2.4227843198043018
3MC SYNDROME 1	0.07142860000000001	2.4227843198043018
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.07133404	2.419576942293323
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.07110015	2.4116436351228194
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.070386854	2.387449371702017
JACOBSEN SYNDROME	0.070235983	2.3823319832453875
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.07019710000000001	2.3810131120550393
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.07019710000000001	2.3810131120550393
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.07019710000000001	2.3810131120550393
2Q23.1 MICRODUPLICATION SYNDROME	0.07008199400000001	2.3771088354499343
PHAVER SYNDROME	0.06957387000000001	2.359873794307923
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.069565194	2.3595795133510142
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0694877	2.3569509969293163
SPONDYLO-OCULAR SYNDROME	0.0694118	2.354376547340872
HOLMES-GANG SYNDROME	0.06909417400000001	2.3436030015572205
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.06902777	2.34135064647855
EPISODIC ATAXIA TYPE 1	0.06901964	2.3410748852775742
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.06895234900000001	2.338792444075256
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.06871588	2.3307716598890917
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.06871588	2.3307716598890917
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.06863134	2.3279041504265483
YOU-HOOVER-FONG SYNDROME; YHFS	0.06851795399999999	2.324058214444528
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.068270473	2.3156639145947553
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.068177764	2.3125193210915262
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.068132949	2.310999242589469
TRISOMY 20P	0.06779684	2.2995987725404254
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.0677507	2.2980337514072136
KLEEFSTRA SYNDROME	0.06759917300000001	2.292894112108292
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.06749318	2.2892989390486345
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.06734	2.2841032316974106
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.067208119	2.2796299644223956
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067208119	2.2796299644223956
PEHO SYNDROME	0.06707321399999999	2.275054126191446
RING CHROMOSOME 10 SYNDROME	0.067056209	2.2744773341591475
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.2612655912771276
TYROSINEMIA, TYPE I; TYRSN1	0.0666667	2.2612655912771276
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.2612655912771276
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.2612655912771276
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.0666667	2.2612655912771276
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.2612655912771276
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE; SEMDSH	0.0666667	2.2612655912771276
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.2612655912771276
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.2612655912771276
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.2612655912771276
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.2612655912771276
SPASTIC PARAPLEGIA 24, AUTOSOMAL RECESSIVE	0.0666667	2.2612655912771276
DESMOID TUMOR	0.0666667	2.2612655912771276
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.06653733399999999	2.25687763020389
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.06609733000000001	2.241953149087767
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.06583433400000001	2.2330325964663906
SMITH-MAGENIS SYNDROME; SMS	0.06532929300000001	2.2159021274993624
BECKER MUSCULAR DYSTROPHY	0.06504991	2.2064257447672366
MENTAL RETARDATION, X-LINKED 98; MRX98	0.064903763	2.201468589510289
CRYPTOCOCCOSIS	0.06486894900000001	2.2002877345962952
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.1984510564571034
FG SYNDROME TYPE 1	0.064568243	2.1900880977327546
PERLMAN SYNDROME	0.064564384	2.1899572044394504
DESMOSTEROLOSIS	0.06439297	2.1841430186455955
ANGELMAN SYNDROME	0.064329413	2.1819872308657176
KLHL9-RELATED EARLY-ONSET DISTAL MYOPATHY	0.06402941000000001	2.171811439035915
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.06283113	2.1311670193673913
ACROCRANIOFACIAL DYSOSTOSIS	0.06256898	2.1222751621920204
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.062373160000000004	2.115633150091768
WILLIAMS SYNDROME	0.06234121	2.114549439099004
AARSKOG-SCOTT SYNDROME	0.061731544	2.093870198219051
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.061666143	2.0916518638641914
DOORS SYNDROME	0.06152097399999999	2.086727881356881
AMISH INFANTILE EPILEPSY SYNDROME	0.061147400000000005	2.074056637212567
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.06109522999999999	2.072287084708889
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.06088126	2.0650294433592262
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.060869104	2.0646171243974725
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.06070201	2.0589494685406673
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.05952815	2.0191333500440782
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.059499109999999994	2.018148343245021
HYPERTELORISM, TEEBI TYPE	0.058779000000000005	1.9937229559836962
VELOCARDIOFACIAL SYNDROME	0.058742869999999996	1.9924974637092494
7P22.1 MICRODUPLICATION SYNDROME	0.058454094000000005	1.982702480120942
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.058111183000000004	1.971071293258979
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.05790854	1.9641978520475019
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.057803063999999994	1.960620215093737
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.057777909999999995	1.959767017400091
NORRIE DISEASE	0.05774132900000001	1.9585262276715687
17Q21.31 MICRODUPLICATION SYNDROME	0.057732474000000006	1.9582258752195836
CHIME SYNDROME	0.057728339000000004	1.958085620291412
YUNIS-VARON SYNDROME	0.057407410000000006	1.9472000401600575
AGNATHIA-OTOCEPHALY COMPLEX	0.057360650000000006	1.945613989267361
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0573294	1.9445540215514336
ALPHA-MANNOSIDOSIS	0.057316824	1.9441274566235776
HUMERORADIAL SYNOSTOSISHUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME	0.05728379	1.9430069774706835
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.05728379	1.9430069774706835
SIMPSON-GOLABI-BEHMEL SYNDROME	0.056942483	1.9314301966316436
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.056869403000000006	1.9289513985298847
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.056757249	1.9251472507150968
OGDEN SYNDROME	0.05659143400000001	1.9195229772169697
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0565438	1.917907281147194
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.056485419	1.9159270579400405
MICROHYDRANENCEPHALY; MHAC	0.05646882	1.9153640370083067
MONOSOMY 13Q14	0.05631795	1.9102466824706443
ATELOSTEOGENESIS TYPE II	0.0563121	1.9100482565142227
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.056218954	1.9068888404224542
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.05621583	1.9067828775698286
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.056097019000000005	1.9027529311923235
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.05572271	1.8900567566073303
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.055605723999999995	1.8860887123444352
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	1.8843885580470547
GITELMAN SYNDROME	0.055555600000000004	1.8843885580470547
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.055555600000000004	1.8843885580470547
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	1.8843885580470547
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	1.8843885580470547
WILDERVANCK SYNDROME	0.055555600000000004	1.8843885580470547
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	1.8843885580470547
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	1.8843885580470547
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	1.8843885580470547
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	1.8843885580470547
CROSSED POLYSYNDACTYLY	0.055555600000000004	1.8843885580470547
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	1.8843885580470547
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	1.8843885580470547
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	1.8843885580470547
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	1.8843885580470547
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.055471664	1.8815415356405245
PURE MITOCHONDRIAL MYOPATHY	0.05544662	1.8806920690332387
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.054872623999999995	1.8612227177029534
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.05468078	1.854715567415134
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.054595194	1.851812578713203
SIFRIM-HITZ-WEISS SYNDROME	0.05458702	1.8515353250776831
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.054524842999999996	1.8494263454721402
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.05426292	1.8405421879022583
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.05416457	1.8372062575066919
3Q27.3 MICRODELETION SYNDROME	0.05415799	1.836983070704426
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.054135264	1.836212228262437
TRICHOTHIODYSTROPHY	0.054080064	1.8343399012890227
HOLOPROSENCEPHALY	0.053892502999999994	1.8279780259364775
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.053721054000000004	1.822162652978781
SLC39A8-CDG	0.05356896900000001	1.8170040868963238
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.053478300000000006	1.8139286880855903
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.053441419000000004	1.8126777226669948
MONOSOMY 18P	0.053423134	1.812057514357051
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.053292754000000005	1.807635159451368
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.05320941900000001	1.8048085223439505
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.05280410900000001	1.791060825865791
%601356 LETHAL SHORT-LIMB SKELETAL DYSPLASIA, AL GAZALI TYPE	0.0526316	1.7852094988031697
HUMEROFEMORAL HYPOPLASIA WITH RADIOTIBIAL RAY DEFICIENCY; HHRRD	0.0526316	1.7852094988031697
PENILE AGENESIS	0.0526316	1.7852094988031697
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.05260885900000001	1.7844381475766768
CARDIOFACIOCUTANEOUS SYNDROME	0.052239054	1.7718947440186448
SILVER-RUSSELL SYNDROME; SRS	0.051868253999999996	1.7593175910885377
DIASTROPHIC DWARFISM	0.0518518	1.7587594884070061
20P12.3 MICRODELETION SYNDROME	0.051807133000000005	1.757244429912052
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.051678879999999996	1.7528942206489855
PERIVENTRICULAR NODULAR HETEROTOPIA	0.0515873	1.7497879216593977
PITT-HOPKINS SYNDROME	0.051423513000000004	1.7442324358261632
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.7360106817610597
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.050919583000000004	1.7271396508313712
LISSENCEPHALY, X-LINKED, 2	0.05083609900000001	1.724307959797884
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.050795713	1.72293810840027
GIANT AXONAL NEUROPATHY	0.050444939999999994	1.7110402506204627
HISTIDINEMIA	0.05043863	1.710826221939263
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.050292604000000005	1.705873170877311
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.05025664900000001	1.704653614422074
BREASTS AND/OR NIPPLES, APLASIA OR HYPOPLASIA OF, 2; BNAH2	0.05	1.6959483454836732
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.049920694	1.6932583678939344
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.049726704	1.6866784275031268
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.049412340000000006	1.6760155253895344
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.04940498	1.6757658817930792
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076853999999996	1.6646361868568753
PYRIDOXINE-DEPENDENT EPILEPSY	0.048970853999999994	1.66104077636445
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.048899293	1.658613501173427
MEHMO SYNDROME	0.04865772900000001	1.650419899850859
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.048606510000000006	1.648682604284712
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 25; LGMDR25	0.04840441	1.6418275810722673
DESMINOPATHY	0.04840441	1.6418275810722673
OCULOPHARYNGODISTAL MYOPATHY	0.04840441	1.6418275810722673
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.048388443999999996	1.6412860308465869
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.04835373900000001	1.6401088730999873
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.04835373900000001	1.6401088730999873
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.048330040000000005	1.6393050275031948
XP22.13P22.2 DUPLICATION SYNDROME	0.048286669	1.6378339279893552
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.048264879999999996	1.6370948676193602
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.04804403	1.6296038637773589
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.048007129	1.6283522199794251
CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY	0.04774224	1.6193674587536886
ANOPHTHALMIA PLUS SYNDROME	0.047619	1.6151872852717404
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.04761567900000001	1.6150746403826337
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.04757592	1.6137260561772715
DISTAL MYOPATHY WITH POSTERIOR LEG AND ANTERIOR HAND INVOLVEMENT	0.04753696	1.6124045732264707
ACROCEPHALOPOLYDACTYLY	0.04746115	1.6098331763450484
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.047402563999999994	1.6078459997496783
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.047402563999999994	1.6078459997496783
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0473363	1.6055983933263758
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.04731683	1.6049379910406443
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.04723343000000001	1.6021091492003778
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.04721557	1.6015033564513708
OCULODENTODIGITAL DYSPLASIA; ODDD	0.047146249	1.5991520597462254
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.046918213	1.5914173142080112
CHILDHOOD-ONSET AUTOSOMAL RECESSIVE SLOWLY PROGRESSIVE SPINOCEREBELLAR ATAXIA	0.04685701	1.5893413716762381
DUPLICATION/INVERSION 15Q11	0.046824869000000005	1.5882511821607947
WOLF-HIRSCHHORN SYNDROME	0.046767933000000005	1.5863199718608254
16P13.11 MICRODELETION SYNDROME	0.046763204	1.5861595690663095
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.04674574	1.585567208228199
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.04670776	1.5842789658649696
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.046659059999999995	1.5826271121764686
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.046376794	1.5730529410627425
JUVENILE PRIMARY LATERAL SCLEROSIS	0.04635260000000001	1.5722323055773302
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.046340780000000005	1.5718313833884576
NEURONAL CEROID LIPOFUSCINOSIS	0.046244349	1.5685605434903906
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.046103003999999996	1.563766267112543
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.04601606900000001	1.5608175217242508
FRYNS SYNDROME; FRNS	0.045984359	1.5597419512835449
HUNTINGTON DISEASE	0.04570293	1.5501961703451224
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.045662519	1.5488254709733356
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.045382349	1.5393223940142524
MOHR-TRANEBJAERG SYNDROME	0.045358050000000004	1.5384981970373144
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.04528335000000001	1.5359644502091618
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.045158184000000004	1.5317189487969456
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.045083863999999994	1.5291980911762184
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.045032824	1.5274668671051488
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.5238268870902039
MEHMO SYNDROME; MEHMO	0.044836343	1.520802434567769
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.044653293999999996	1.51459360159392
DIENCEPHALIC SYNDROME	0.04461426	1.5132696086395683
ZELLWEGER SYNDROME	0.04452457900000001	1.5102277217681421
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.044444410000000004	1.5075084721099603
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.044431554	1.5070724098713693
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.044316049999999996	1.5031546335174344
DE BARSY SYNDROME	0.044291424	1.502319345038317
PGM3-CDG	0.04425729899999999	1.501161860292524
OCULODENTODIGITAL DYSPLASIA	0.044201799	1.4992793576290373
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.044192229000000006	1.4989547531157121
OCULO-PALATO-CEREBRAL SYNDROME	0.044129784	1.496836683227037
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.044081028999999994	1.4951829639953558
COG1-CDG	0.04404964	1.4941182815430283
AICARDI-GOUTIERES SYNDROME 6	0.044023854	1.4932436470622956
ENDOCARDIAL FIBROELASTOSIS	0.044019719000000006	1.4931033921341244
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.044019719000000006	1.4931033921341244
6P22 MICRODELETION SYNDROME	0.043959319999999996	1.4910547204517466
NOONAN SYNDROME	0.04385423	1.487490176219209
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.043850780000000006	1.487373155783371
HAMAMY SYNDROME; HMMS	0.04363133999999999	1.4799299776847117
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.043589710000000004	1.4785179310922623
SWEENEY-COX SYNDROME; SWCOS	0.043589244000000006	1.4785021248536825
AMYOTROPHIC LATERAL SCLEROSIS 19; ALS19	0.043478300000000004	1.4747390189888556
BLEPHAROPTOSIS-MYOPIA-ECTOPIA LENTIS SYNDROME	0.043478300000000004	1.4747390189888556
LAMELLAR ICHTHYOSIS	0.043478300000000004	1.4747390189888556
DNAJB6-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY D1	0.043478300000000004	1.4747390189888556
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.043443123	1.473545851489874
OSGOOD-SCHLATTER DISEASE	0.04338761	1.4716629078798174
X-LINKED DYSTONIA-PARKINSONISM	0.04338761	1.4716629078798174
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.043303629	1.468814359119776
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.043268413	1.4676198687810849
PROGRESSIVE SUPRANUCLEAR PALSY	0.04281613	1.452278896670277
LISSENCEPHALY 2; LIS2	0.042790883999999994	1.4514225784316752
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.042756550000000004	1.4502580046217988
ALG13-CDG	0.0426748	1.4474851290769328
WEST SYNDROME	0.0426748	1.4474851290769328
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.04256882	1.4438903969638457
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.042525434	1.4424187886655027
HUNTINGTON DISEASE-LIKE 3	0.042472318999999994	1.4406171827380951
COG2-CDG	0.04221225399999999	1.4317960466087307
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.042208118999999995	1.4316557916805595
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.042208118999999995	1.4316557916805595
SARCOSINEMIA	0.04219884399999999	1.431341193262472
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.04216521	1.4302003627294324
SHPRINTZEN OMPHALOCELE SYNDROME	0.042057460000000005	1.4265455940449152
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.041904994	1.4213741048360649
AUTOIMMUNE HEMOLYTIC ANEMIA-AUTOIMMUNE THROMBOCYTOPENIA-PRIMARY IMMUNODEFICIENCY SYNDROME	0.041666699999999994	1.4132914185352907
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.041666699999999994	1.4132914185352907
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.041666699999999994	1.4132914185352907
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.041589882999999994	1.4106858652541905
ISOLATED CEREBELLAR AGENESIS	0.041571448999999996	1.4100606030181777
MERRF	0.041517359999999996	1.4082259600170004
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.041474173	1.4067611015930725
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.04144528	1.4057810808821511
RICHIERI COSTA-DA SILVA SYNDROME	0.04137935	1.4035448033937965
15Q13.3 MICRODELETION SYNDROME	0.041349853000000006	1.402544295626862
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2P; CMT2P	0.041266000000000004	1.399700088494585
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.041222629999999996	1.3982290228997123
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.04120541	1.3976449382895277
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.041188763	1.3970802892473826
MASA SYNDROME	0.041164200000000005	1.3962471376631802
PARKINSONIAN-PYRAMIDAL SYNDROME	0.041164200000000005	1.3962471376631802
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.04107905	1.3933589376308213
TOWNES-BROCKS SYNDROME 2; TBS2	0.04107905	1.3933589376308213
QAZI-MARKOUIZOS SYNDROME	0.041044329000000004	1.392181237180751
LESCH-NYHAN SYNDROME	0.041030029999999995	1.3916962298729092
HSD10 DISEASE, ATYPICAL TYPE	0.041030029999999995	1.3916962298729092
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.040989269999999994	1.3903136927816706
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.040928619000000006	1.3882564735196326
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.040928619000000006	1.3882564735196326
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.04090805300000001	1.3875588960461682
SPINOCEREBELLAR ATAXIA TYPE 11	0.04064041	1.3784807219855624
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.040545554	1.3752633044603784
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.04053880000000001	1.3750342157578705
MAL DE MELEDA	0.04051068	1.3740804144083705
GERODERMA OSTEODYSPLASTICA	0.040484054	1.3731772879954334
SHORT RIB-POLYDACTYLY SYNDROME	0.040389549999999996	1.3699718099466014
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.04030501	1.3671043004840577
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.040266550000000005	1.3657997770167118
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.040206929	1.3637774942905903
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.04018249	1.3629485486582846
9P13 MICRODELETION SYNDROME	0.04012756	1.3610853798059364
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.040113833	1.3606197741471673
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.0399385	1.3546726599219934
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.03974616	1.348148685826587
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.039741823999999995	1.3480016131860661
BRACHYDACTYLY TYPE A4	0.0397397	1.3479295693003503
WAISMAN SYNDROME; WSMN	0.039548473	1.3414433470151141
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.03940891	1.3367095142362995
CHAR SYNDROME	0.039387604	1.335986836727322
MONOSOMY 9P	0.039254293	1.3314650653296265
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.039177794	1.3288702982800034
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.039120539999999995	1.326928301748557
DUBOWITZ SYNDROME	0.039098199	1.326170518108828
CLEIDOCRANIAL DYSPLASIA; CCD	0.03908618	1.3257628460455406
OTOFACIOCERVICAL SYNDROME	0.039006064	1.3230453940926052
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.039002919000000004	1.3229387189416744
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.038978482999999994	1.3221098750662692
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.03874215	1.3140937038596057
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.03874215	1.3140937038596057
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 3	0.038632240000000005	1.3103656702065636
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.038603953999999996	1.309406238308556
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.038595194	1.3091091081584274
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.038550633	1.3075976450739657
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.3066027000176041
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	1.3045743457964059
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.0384615	1.3045743457964059
X-LINKED SPASTIC PARAPLEGIA TYPE 34	0.0384615	1.3045743457964059
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	1.3045743457964059
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	1.3045743457964059
DELTA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R6	0.0384615	1.3045743457964059
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	1.3045743457964059
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.0384615	1.3045743457964059
CYCLIC NEUTROPENIA	0.0384615	1.3045743457964059
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	1.3045743457964059
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.0384615	1.3045743457964059
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	1.3045743457964059
SPASTIC PARAPLEGIA 16, X-LINKED	0.0384615	1.3045743457964059
LIP, MEDIAN NODULE OF UPPER	0.0384615	1.3045743457964059
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.0384615	1.3045743457964059
BAZEX SYNDROME; BZX	0.0384615	1.3045743457964059
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	1.3045743457964059
LIP, HAMARTOMATOUS	0.0384615	1.3045743457964059
PSEUDOXANTHOMA ELASTICUM; PXE	0.0384615	1.3045743457964059
BLEPHAROCHALASIS AND DOUBLE LIP	0.0384615	1.3045743457964059
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	1.3045743457964059
MOSAIC TRISOMY 8	0.038460509999999996	1.304540766019165
TEMPLE-BARAITSER SYNDROME	0.038439229	1.3038189364843604
BARDET-BIEDL SYNDROME 1; BBS1	0.038309034	1.2994028565875555
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.038263999	1.2978753159127783
RETT SYNDROME	0.038210349	1.2960555633380741
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.038207	1.2959419687178937
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.038109669	1.2926406017496084
DISTAL TRISOMY 5Q	0.03808761	1.2918923832585478
BAKER-GORDON SYNDROME; BAGOS	0.038032024	1.2900069635639067
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.037936774	1.2867761819657604
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.284961042370556
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.037708754	1.2790419791310166
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.037582554	1.2747614055070158
JAWAD SYNDROME	0.037582554	1.2747614055070158
ISOTRETINOIN-LIKE SYNDROME	0.03757725	1.274581499306527
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.037521044	1.272675049852402
FLYNN-AIRD SYNDROME	0.037472419	1.2710257400864189
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.037422679	1.269338610672332
BRAIN-LUNG-THYROID SYNDROME	0.037381293999999995	1.2679348742267749
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.037113294	1.2588445910949824
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.2562567774335758
CLEIDORHIZOMELIC SYNDROME	0.037037	1.2562567774335758
BRACHYDACTYLY, TYPE A1, D	0.037037	1.2562567774335758
BRACHYDACTYLY, TYPE A4	0.037037	1.2562567774335758
MYOCLONUS AND ATAXIA	0.037037	1.2562567774335758
ANGEL-SHAPED PHALANGO-EPIPHYSEAL DYSPLASIA	0.037037	1.2562567774335758
BRACHYDACTYLY, TYPE A2; BDA2	0.037037	1.2562567774335758
BRACHYDACTYLY-SYNDACTYLY, ZHAO TYPE	0.037037	1.2562567774335758
CANAVAN DISEASE	0.037037	1.2562567774335758
MCLEOD SYNDROME; MCLDS	0.037037	1.2562567774335758
METAPHYSEAL DYSPLASIA WITH MAXILLARY HYPOPLASIA AND BRACHYDACTYLY	0.037037	1.2562567774335758
BRACHYDACTYLY, TYPE A3	0.037037	1.2562567774335758
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.037037	1.2562567774335758
SYNPOLYDACTYLY 1	0.037037	1.2562567774335758
CLEIDORHIZOMELIC SYNDROME	0.037037	1.2562567774335758
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.036931	1.2526613669411504
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.036917530000000004	1.2522044784568773
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2O; CMT2O	0.03683574	1.249430246153335
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.036801273	1.2482611611208594
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.036801273	1.2482611611208594
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.03678013	1.247544012403488
HAREL-YOON SYNDROME; HAYOS	0.036653203999999995	1.2432388136095107
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.036388	1.2342433679091978
PITT-HOPKINS SYNDROME	0.036157179	1.22641415804814
THUMBS, CONGENITAL CLASPED	0.0361093	1.2247901518314719
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.036090284	1.2241451487567174
PHELAN-MCDERMID SYNDROME	0.036045812999999996	1.222636738379277
MICROPHTHALMIA WITH LIMB ANOMALIES	0.036036000000000006	1.2223038915569928
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.035932563	1.2187954153767568
CHROMOSOME 17Q12 DELETION SYNDROME	0.03592785	1.2186355552857115
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.035920563	1.2183883877738408
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.035884189999999996	1.2171546531904351
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.035770528999999995	1.2132993894925146
VESTIBULOPATHY, FAMILIAL	0.035714300000000004	1.2113921599021509
MALARIA	0.035714300000000004	1.2113921599021509
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.035714300000000004	1.2113921599021509
YOUNG-ONSET PARKINSON DISEASE	0.035714300000000004	1.2113921599021509
CHARCOT-MARIE-TOOTH DISEASE TYPE 1A	0.035714300000000004	1.2113921599021509
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.035714300000000004	1.2113921599021509
SPINOCEREBELLAR ATAXIA TYPE 1	0.035714300000000004	1.2113921599021509
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.03543121	1.2017900395596912
ALPERS-HUTTENLOCHER SYNDROME	0.035365604	1.1995647518166155
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.03529794	1.1972696588396392
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.035256380000000004	1.1958599865748731
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.035256380000000004	1.1958599865748731
ALPHA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R3	0.035256380000000004	1.1958599865748731
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.035256380000000004	1.1958599865748731
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.035256380000000004	1.1958599865748731
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.035229109999999994	1.194935016347246
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.035161549	1.1926434170238618
NEMALINE MYOPATHY 2; NEM2	0.034993869999999996	1.1869559185714145
COSTELLO SYNDROME	0.03496462	1.1859637887893069
MARSHALL-SMITH SYNDROME; MRSHSS	0.03485368	1.1822008186003474
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.03461771400000001	1.17419709565454
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.0344828	1.169620952152888
MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	0.0344828	1.169620952152888
MYOCLONUS, FAMILIAL CORTICAL; FCM	0.0344828	1.169620952152888
SPINOCEREBELLAR ATAXIA TYPE 37	0.0344828	1.169620952152888
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.0344828	1.169620952152888
HEREDITARY MYOPATHY WITH EARLY RESPIRATORY FAILURE	0.0344828	1.169620952152888
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.034446634	1.1683942387956325
SIALIDOSIS TYPE 1	0.034436739	1.1680586106180615
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.03443441	1.167979613344129
ZUNICH NEUROECTODERMAL SYNDROME	0.034283779	1.1628703654395578
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.03422274	1.1607999856183584
SCHWARTZ-JAMPEL SYNDROME	0.03415131	1.1583771538120002
LEUKOENCEPHALOPATHY-PALMOPLANTAR KERATODERMA SYNDROME	0.033974330000000004	1.1523741750483265
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.03394403	1.151346430350963
FETAL HYDANTOIN SYNDROME	0.033922884	1.1506291798766912
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.033878854	1.1491357277636582
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.033878854	1.1491357277636582
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.033874719000000005	1.148995472835487
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.033874719000000005	1.148995472835487
KOOLEN-DE VRIES SYNDROME	0.033874243	1.1489793274072377
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.033828774	1.1474370659008217
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.03379519	1.1462979313161274
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.033624523	1.1405090829905542
TRISOMY 12P	0.033553314	1.1380937472758832
H SYNDROME	0.033518240000000005	1.1369040734304936
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.033353173	1.1313051713196143
GRISCELLI SYNDROME TYPE 1	0.033345072999999996	1.1310304276876457
%155050 MAXILLONASAL DYSPLASIA, BINDER TYPE;;BINDER SYNDROME	0.0333333	1.1306310996902185
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.03326377	1.1282727139209885
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.033249464	1.1277874691803789
DERMOCHONDROCORNEAL DYSTROPHY	0.0331536	1.12453586133655
PEHO-LIKE SYNDROME; PEHOL	0.033016444	1.119883671511087
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.033002519	1.1194113498968696
TRISOMY 4P	0.032996029999999996	1.1191912497205925
FRYNS MICROPHTHALMIA SYNDROME	0.032996029999999996	1.1191912497205925
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.03292872	1.1169081640579026
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.032920050000000006	1.1166140866147958
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.03290601	1.1161378643193838
FOUNTAIN SYNDROME	0.032889259000000004	1.1155696877046801
MUCOLIPIDOSIS TYPE II	0.03284823	1.114178026411343
CHILDHOOD APRAXIA OF SPEECH	0.0328042	1.11268457429831
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.032803653999999995	1.1126660545423772
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.032803653999999995	1.1126660545423772
OXOGLUTARIC ACIDURIA	0.032803653999999995	1.1126660545423772
LEIGH SYNDROME	0.032799519	1.112525799614206
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.112525799614206
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.032799519	1.112525799614206
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.032799519	1.112525799614206
SANDHOFF DISEASE	0.032799519	1.112525799614206
TUBEROUS SCLEROSIS-1	0.032799519	1.112525799614206
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.112525799614206
MENINGIOMA	0.03270391	1.1092828411069389
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.032655939999999994	1.1076557482642817
PITT-HOPKINS-LIKE SYNDROME	0.032651229000000004	1.1074959560111706
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.032522234000000004	1.1031205788746572
15Q24 MICRODELETION SYNDROME	0.032521943	1.1031107084552862
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.032520634	1.1030663085276016
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.032337370000000004	1.0968501829758674
ALLAN-HERNDON-DUDLEY SYNDROME	0.03228124	1.0949463113632274
DYSTONIA, JUVENILE-ONSET	0.0322581	1.0941614264689374
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0322581	1.0941614264689374
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.0322581	1.0941614264689374
DENT DISEASE	0.0322581	1.0941614264689374
CONGENITAL ANALBUMINEMIA	0.0322581	1.0941614264689374
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.0322581	1.0941614264689374
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.0322581	1.0941614264689374
ISOBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0322581	1.0941614264689374
MILD CANAVAN DISEASE	0.0322581	1.0941614264689374
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.0322581	1.0941614264689374
SECKEL SYNDROME 2; SCKL2	0.0322581	1.0941614264689374
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.0322581	1.0941614264689374
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.0322581	1.0941614264689374
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.0322581	1.0941614264689374
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.032220603	1.0928895669667253
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.032140369	1.0901681125756946
TONNE-KALSCHEUER SYNDROME; TOKAS	0.031972584000000005	1.0844770187127553
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.031949474	1.0836931513874726
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.031911	1.0823881530545898
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.031881509999999995	1.0813878827204233
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.031858759	1.0806161923042614
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.031762404	1.07734793024768
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.031525183	1.0693016389984
21Q22.11Q22.12 MICRODELETION SYNDROME	0.031407909	1.065323826073035
NARP SYNDROME	0.031389972999999995	1.064715455482543
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.031386759	1.0646064399228956
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.031368354	1.0639821613369231
COFFIN-LOWRY SYNDROME	0.031275709	1.0608397386475763
11Q22.2Q22.3 MICRODELETION SYNDROME	0.031248273	1.0599091378714425
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.03122715	1.0591926675334093
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.03118225	1.0576697059191653
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.030989753000000002	1.051140406545954
XQ28 (MECP2) DUPLICATION	0.030981663	1.0508660021036544
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.030848553999999997	1.0463510823372748
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.030844418999999998	1.0462108274091033
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.030844418999999998	1.0462108274091033
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.030824463000000003	1.045533940505454
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.030677729	1.0405568748149299
CALPAIN-3-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R1	0.030567110000000005	1.0368047926143489
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.030498773	1.0344868721726423
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.030447213	1.0327380102387795
RENPENNING SYNDROME 1; RENS1	0.030427489000000002	1.0320689925354531
LATHOSTEROLOSIS	0.030361082999999997	1.0298165696188493
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.030309788999999997	1.0280767301301845
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.030302999999999997	1.0278464542638346
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.030302999999999997	1.0278464542638346
MACHADO-JOSEPH DISEASE TYPE 3	0.030302999999999997	1.0278464542638346
MACHADO-JOSEPH DISEASE TYPE 2	0.030302999999999997	1.0278464542638346
MACHADO-JOSEPH DISEASE TYPE 1	0.030302999999999997	1.0278464542638346
CARIBBEAN PARKINSONISM	0.030302999999999997	1.0278464542638346
SPINOCEREBELLAR ATAXIA TYPE 26	0.030302999999999997	1.0278464542638346
AUTOSOMAL RECESSIVE ATAXIA DUE TO PEX10 DEFICIENCY	0.030302999999999997	1.0278464542638346
AXONAL POLYNEUROPATHY ASSOCIATED WITH IGG/IGM/IGA MONOCLONAL GAMMOPATHY	0.030302999999999997	1.0278464542638346
SPINOCEREBELLAR ATAXIA 18	0.030302999999999997	1.0278464542638346
POLYRADICULONEUROPATHY ASSOCIATED WITH IGG/IGA/IGM MONOCLONAL GAMMOPATHY WITHOUT KNOWN ANTIBODIES	0.030302999999999997	1.0278464542638346
FREEMAN-SHELDON SYNDROME	0.03028189	1.0271304248723716
EDINBURGH MALFORMATION SYNDROME	0.030130740000000003	1.0220035730239747
ROSSELLI-GULIENETTI SYNDROME	0.029957354	1.0161224990273738
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.029957354	1.0161224990273738
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.029930254000000003	1.0152032950241217
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.029914163	1.0146575049275781
MYOPATHY, DISTAL 3	0.0299107	1.0145400435451697
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029710972999999995	1.0077655100412013
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.029663389999999998	1.0061515438387385
EAR WAX, WET/DRY	0.0294118	0.9976178709539337
DARWINIAN TUBERCLE OF PINNA	0.0294118	0.9976178709539337
ALKAPTONURIA	0.0294118	0.9976178709539337
EAR ANTITRAGUS, TAG AT BASE OF	0.0294118	0.9976178709539337
OSSIFIED EAR CARTILAGES	0.0294118	0.9976178709539337
EXCHONDROSIS OF PINNA, POSTERIOR	0.0294118	0.9976178709539337
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.0294118	0.9976178709539337
EAR FOLDING	0.0294118	0.9976178709539337
EAR MALFORMATION	0.0294118	0.9976178709539337
BLAU SYNDROME	0.0294118	0.9976178709539337
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.0294118	0.9976178709539337
AREDYLD	0.0294118	0.9976178709539337
DARWINIAN POINT OF PINNA	0.0294118	0.9976178709539337
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0294118	0.9976178709539337
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.0294118	0.9976178709539337
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.0294118	0.9976178709539337
OSTEOMA OF MIDDLE EAR	0.0294118	0.9976178709539337
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.0294118	0.9976178709539337
ACROFACIAL DYSOSTOSIS, WEYERS TYPE	0.0294118	0.9976178709539337
EAR WITHOUT HELIX	0.0294118	0.9976178709539337
MUSICAL PERFECT PITCH	0.0294118	0.9976178709539337
HAIRY EARS, Y-LINKED	0.0294118	0.9976178709539337
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.029353104	0.9956269632722037
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.029301533	0.993877728229705
9Q33.3Q34.11 MICRODELETION SYNDROME	0.029202049	0.9905033337256629
ACROCALLOSAL SYNDROME; ACLS	0.029130188999999997	0.9880659167635336
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.029080913000000003	0.9863945257500928
SCHAAF-YANG SYNDROME; SHFYNG	0.028961273	0.9823364605490194
GABRIELE-DE VRIES SYNDROME	0.02882784	0.9778105510373608
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.02882719	0.9777885037088695
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.02880755	0.9771223351987636
SHUKLA-VERNON SYNDROME; SHUVER	0.028805623	0.9770569733495287
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	0.9708965088224929
DYSTONIA 28, CHILDHOOD-ONSET	0.028539494000000006	0.9680301526048244
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.028535359000000007	0.9678898976766529
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.028529854	0.967703173763815
CHROMOSOME 18Q DELETION SYNDROME	0.028519058999999996	0.9673370185160248
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.028400223000000002	0.9633062241643472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.028400223000000002	0.9633062241643472
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.028360993	0.9619755830924805
EPILEPSY, PYRIDOXINE-DEPENDENT	0.028341364	0.9613097876910106
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.028340654	0.9612857052245047
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.028323354000000002	0.9606989070969675
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.028323354000000002	0.9606989070969675
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.028323354000000002	0.9606989070969675
MENKES DISEASE	0.028319219000000003	0.960558652168796
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.028143519999999998	0.954599123601733
HENNEKAM SYNDROME	0.028131819000000002	0.9542022377699232
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.028063704000000002	0.9518918473388708
CAP MYOPATHY	0.027993940000000005	0.9495255245313843
DISTAL MONOSOMY 7Q36	0.027935149	0.9475313945477977
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	0.9421942790235274
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	0.9421942790235274
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.027777800000000002	0.9421942790235274
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	0.9421942790235274
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.027777800000000002	0.9421942790235274
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	0.9421942790235274
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	0.9421942790235274
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	0.9421942790235274
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	0.9421942790235274
NASAL BONES, ABSENCE OF	0.027777800000000002	0.9421942790235274
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	0.9421942790235274
CYANIDE, INABILITY TO SMELL	0.027777800000000002	0.9421942790235274
DWARFISM, LEVI TYPE	0.027777800000000002	0.9421942790235274
CLEFT CHIN	0.027777800000000002	0.9421942790235274
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	0.9421942790235274
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	0.9421942790235274
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	0.9421942790235274
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	0.9421942790235274
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	0.9421942790235274
OROFACIAL CLEFT 3	0.027777800000000002	0.9421942790235274
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	0.9421942790235274
DIMPLES, FACIAL	0.027777800000000002	0.9421942790235274
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	0.9421942790235274
GANGLIOCYTOMA	0.027777800000000002	0.9421942790235274
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	0.9421942790235274
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	0.9421942790235274
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	0.9421942790235274
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.027743873000000002	0.941043510233183
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.027593319999999998	0.9359369080080308
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	0.9352325467411845
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.027563409000000004	0.9349223577887956
DISTAL MONOSOMY 10Q	0.027543302999999998	0.9342403830401096
BRITTLE CORNEA SYNDROME	0.027257780000000002	0.924555737851159
MUCOPOLYSACCHARIDOSIS TYPE 4	0.027257780000000002	0.924555737851159
CEREBROFACIOTHORACIC DYSPLASIA	0.02724587	0.9241517629552647
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.027197913	0.9225251110591776
NIEMANN-PICK DISEASE TYPE B	0.0271205	0.9198993420737991
APNEA, OBSTRUCTIVE SLEEP	0.027027	0.9167279186677445
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	0.9167279186677445
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	0.9167279186677445
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.027026354000000002	0.9167060070151211
MELAS	0.02688837	0.9120257322850566
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.026885169	0.9119171576719787
INFANTILE SIALIC ACID STORAGE DISEASE	0.026712733	0.9060683066939421
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.026701364	0.9056826819591461
KEPPEN-LUBINSKY SYNDROME	0.026586138999999998	0.9017743689969789
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.026484563	0.898329016014162
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.026439254	0.8967921815424517
SECKEL SYNDROME 1; SCKL1	0.026411979	0.8958670417199901
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.026336443999999997	0.8933049725544681
HURLER SYNDROME	0.026319694	0.892736829858731
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.026186554000000004	0.8882208586043774
BETA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R4	0.02616939	0.8876386734563394
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.026167179	0.8875636786205022
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.026162674000000004	0.8874108736745743
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.026162440000000002	0.8874029366363173
AL KAISSI SYNDROME; ALKAS	0.026052392999999997	0.8836702560848083
COFS SYNDROME	0.026042469	0.8833336442571967
AYMÉ-GRIPP SYNDROME	0.026041254	0.8832924327124017
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.026019109999999998	0.8825413311091537
CRANIOFACIAL DYSSYNOSTOSIS	0.02601049	0.8822489496143924
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.025913600000000002	0.8789625409105143
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.025818759	0.8757456321698338
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.025776010000000002	0.8742956302534123
MIYOSHI MUSCULAR DYSTROPHY 1; MMD1	0.025641000000000004	0.8697162305309373
%187370 ARTHROGRYPOSIS, DISTAL, TYPE 10; DA10;;CONGENITAL PLANTAR CONTRACTURES;;TENDO CALCANEUS, SHORT	0.025641000000000004	0.8697162305309373
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.025641000000000004	0.8697162305309373
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.0256073	0.8685731613460812
VERVERI-BRADY SYNDROME; VERBRAS	0.02557473	0.8674684205938331
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.025553932999999997	0.8667630078390125
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.025513388999999997	0.8653877972446267
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.0254947	0.8647538856720519
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.02544385	0.8630291062046951
19P13.3 MICRODUPLICATION SYNDROME	0.025352613999999996	0.8599344753397239
FRANK-TER HAAR SYNDROME	0.02526559	0.8569827111633767
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.025247954000000003	0.8563845162629578
SPINOCEREBELLAR ATAXIA TYPE 40	0.02508944	0.8510078851422376
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.02497197	0.8470234240993583
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.02497197	0.8470234240993583
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.024954454	0.8464292994749686
NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE	0.024924	0.8453963312567014
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	0.024924	0.8453963312567014
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.024878619	0.8438570546193733
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.024875133999999997	0.843738847019693
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.024755060000000002	0.8396660609869812
2P15P16.1 MICRODELETION SYNDROME	0.024740553999999998	0.8391740324529893
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.02467052	0.8367985515244373
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.024621133999999996	0.8351234294246359
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.024563314000000003	0.8331622347579188
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.02455864	0.8330036975065829
RETT SYNDROME, CONGENITAL VARIANT	0.024555659	0.8329025850662253
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.024525190000000002	0.8318691080634546
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.0243656	0.8264559801343397
ASPARTYLGLUCOSAMINURIA; AGU	0.024350919000000002	0.8259580157811388
CLASSIC HOMOCYSTINURIA	0.024350919000000002	0.8259580157811388
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.0243372	0.8254926814741048
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.0242857	0.8237458546782567
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.0242857	0.8237458546782567
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.02425478	0.8226970802214095
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.024228372999999997	0.8218013820622257
TRISOMY 18P	0.024186850000000003	0.8203929647992356
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.024164763	0.8196437965771014
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.024151954	0.8192093285299555
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.023949163000000002	0.812330867311376
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.023925473	0.8115273269852858
OCULOCEREBRORENAL SYNDROME OF LOWE	0.023880869	0.8100144053852466
WEAVER SYNDROME	0.023855703	0.8091608006639979
MUCOPOLYSACCHARIDOSIS TYPE 6	0.0238095	0.8075936426358702
HURLER-SCHEIE SYNDROME	0.0238095	0.8075936426358702
SCIMITAR SYNDROME	0.0238095	0.8075936426358702
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.0238095	0.8075936426358702
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.023802843	0.8073678440731525
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.023799364	0.8072498399872738
OHDO SYNDROME	0.023742229000000004	0.8053118798128897
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.023667754	0.8027857647522917
CHROMOSOME 10Q26 DELETION SYNDROME	0.023580362999999997	0.7998215523150883
ADAMS-OLIVER SYNDROME	0.023392498999999997	0.7934493995155693
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.023326333	0.7912051171510239
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.02325381	0.7887452119138337
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.023242133	0.7883491401372296
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.023207859	0.7871866014653675
BARAITSER-WINTER SYNDROME 1; BRWS1	0.023201433	0.7869686381840059
COCKAYNE SYNDROME	0.023084249	0.7829938779656628
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.023059784000000003	0.7821640504402175
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.023053753	0.7819594851507852
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.02304886	0.7817935196456962
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.022948299000000002	0.7783825944142926
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.022904050000000002	0.7768817140475065
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.022811754	0.7737511290776111
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.022808528999999998	0.7736417404093273
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.022744554	0.7714717745012811
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.02271952	0.7706226470836643
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.02262717	0.7674902304895559
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.02261903	0.7672141300989112
DYSTONIA 12; DYT12	0.02261903	0.7672141300989112
BRANCHIOOTORENAL SYNDROME 1	0.02256055	0.7652305489140335
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.02253232	0.7642730164781735
JOUBERT SYNDROME 3; JBTS3	0.02252453	0.7640087877259472
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.763624621506728
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.02247053	0.7621771635128247
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.02247053	0.7621771635128247
BETA-UREIDOPROPIONASE DEFICIENCY	0.022456554	0.7617031120312951
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.022456554	0.7617031120312951
MYHRE SYNDROME	0.022435563	0.7609911189968941
GLASS SYNDROME	0.022430952999999997	0.7608347525594404
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.022396883	0.759679133356828
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.02231618	0.7569417709703167
RAPID-ONSET DYSTONIA-PARKINSONISM	0.022308269000000002	0.7566734380230943
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.022266242999999998	0.7552479595197482
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.0222662	0.7552465010041711
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.02226572	0.7552302199000545
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.022182923	0.7524218311968343
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.02216733	0.7518929327458117
SMITH-MAGENIS SYNDROME	0.022150543	0.7513235350482991
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.022134899	0.750792906729964
PEHO SYNDROME; PEHO	0.022063563	0.7483732633064957
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.022054003000000003	0.7480489979828393
FRANK-TER HAAR SYNDROME; FTHS	0.02203391	0.7473674641807231
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.021977984	0.7454705120373326
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.745119993433288
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.021958864	0.7448219813900198
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.02193308	0.7439474147472208
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.021911	0.7431984839578551
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.021873504000000002	0.74192665837461
ASPARTYLGLUCOSAMINURIA	0.021807449	0.7396861410153915
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.02177467	0.7385743111990594
MAN1B1-CDG	0.021700112999999997	0.7360454147831748
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.021643443	0.7341232269284036
NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX	0.0216279	0.7335960244257266
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.0216279	0.7335960244257266
9Q21.13 MICRODELETION SYNDROME	0.021596529	0.7325319525148032
PHOCOMELIA, SCHINZEL TYPE	0.021593479999999998	0.7324285335846956
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.02158374	0.7320981628469954
PELGER-HUET ANOMALY; PHA	0.021570044	0.7316336086762005
CARTILAGE-HAIR HYPOPLASIA	0.02156183	0.7313549982820045
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.02143243	0.7269658839638927
MICROPHTHALMIA, SYNDROMIC 1	0.021412859	0.7263020558625034
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.021386563	0.7254101227086468
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.021324523	0.7233057900015706
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.021318604	0.7231050236364323
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.7220128329019406
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.021283833	0.7219256272380159
JABERI-ELAHI SYNDROME; JABELS	0.021278913	0.7217587459208203
MYOPATHY, SPHEROID BODY	0.02124328	0.720550111372928
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.021225353000000002	0.7199420460531384
14Q22Q23 MICRODELETION SYNDROME	0.021223324000000002	0.7198732244692786
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.021100294	0.7157001739703813
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.021073984	0.7148077659509879
MENTAL RETARDATION, X-LINKED 104; MRX104	0.020988123	0.7118954495331564
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.020975422999999997	0.7114646786534035
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.02097441	0.711430318739924
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.020962254	0.71101799977817
16P11.2P12.2 MICRODELETION SYNDROME	0.020847004	0.7071088388418302
BEEMER LETHAL MALFORMATION SYNDROME	0.02083254	0.7066182349044486
MENTAL RETARDATION, X-LINKED 93	0.02082563	0.706383854843103
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.020822319	0.7062715491436649
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.020795098999999997	0.7053482748643836
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 3; SCAN3	0.02075321	0.7039274432595044
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.020740849999999998	0.7035082048285007
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7035082048285007
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7035082048285007
FETAL TRIMETHADIONE SYNDROME	0.020695374	0.7019657058893164
10Q22.3Q23.3 MICRODELETION SYNDROME	0.020652342999999997	0.7005061388242261
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.020641714000000002	0.7001456141249435
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.020641714000000002	0.7001456141249435
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.020598054	0.6986647120296671
TIBIAL APLASIA-ECTRODACTYLY SYNDROME	0.02056768	0.6976344573287526
FINNISH UPPER LIMB-ONSET DISTAL MYOPATHY	0.02055111	0.6970724200470594
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1G; CMT1G	0.02055111	0.6970724200470594
DISTAL MYOPATHY, WELANDER TYPE	0.02055111	0.6970724200470594
TIBIAL MUSCULAR DYSTROPHY	0.02055111	0.6970724200470594
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	0.02055111	0.6970724200470594
ADENYLOSUCCINASE DEFICIENCY	0.020519143	0.6959881324318578
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.020510204	0.6956849307866523
MEGAEPIPHYSEAL DWARFISM	0.02049922	0.6953123648541163
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.020402499999999997	0.6920317223746126
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.020397064	0.6918473388704917
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.02032355	0.689353819937094
ALPHA-DYSTROGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R16	0.020301649999999997	0.6886109945617721
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.020286989999999998	0.6881137425068763
CORNELIA DE LANGE SYNDROME	0.020254649	0.6870167691980505
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.02022581	0.6860385801113426
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.020179113999999998	0.6844547000325284
1P36 DELETION SYNDROME	0.020172443	0.6842284266042741
TURNPENNY-FRY SYNDROME; TPFS	0.020150404	0.6834808864925517
BRADDOCK SYNDROME	0.02014982	0.6834610778158764
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.0201355	0.6829753582097299
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.020122834	0.682545740574852
MOEBIUS SYNDROME; MBS	0.020120930000000002	0.682481158861856
SPINOCEREBELLAR ATAXIA 40; SCA40	0.01996123	0.6770642998463811
BAND HETEROTOPIA; BH	0.019954873	0.6768486769737364
SOTOS SYNDROME	0.019921083	0.6757025550818584
GABRIELE-DE VRIES SYNDROME; GADEVS	0.019902494	0.6750720354059745
MENTAL RETARDATION, BUENOS AIRES TYPE	0.01987247	0.6740536523434785
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.019837003	0.6728506483440931
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.019804814	0.6717588307182377
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.019793533000000002	0.6713761908525298
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.019793024	0.6713589260983726
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.019751594	0.6699536632993048
WRINKLY SKIN SYNDROME	0.019749724	0.6698902348311837
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.019749273	0.6698749373771076
MONOSOMY 18Q	0.019738843	0.6695211625522396
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.019735473	0.6694068556337539
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.019724959999999996	0.6690502655346324
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.01967596	0.6673882361560585
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.019614843	0.6653152106554401
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.0195983	0.6647540891858533
FRIAS SYNDROME	0.019592004	0.66454053537019
KUSKOKWIM SYNDROME	0.01957728	0.664041112501412
RAINE SYNDROME	0.019573004	0.6638960749989063
AASE-SMITH SYNDROME I	0.01956778	0.6637188823157701
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.019518279	0.6620398595347744
SUPRABULBAR PARESIS, CONGENITAL	0.019500019	0.6614204991990037
NANCE-HORAN SYNDROME	0.019444740000000002	0.659545492627204
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.019440183	0.6593909238949965
1Q41Q42 MICRODELETION SYNDROME	0.019423459	0.6588236630923991
WARSAW BREAKAGE SYNDROME; WABS	0.019418274	0.6586477932489725
LYMPHEDEMA, HEREDITARY, III	0.019418274	0.6586477932489725
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.01941391	0.6584997708773787
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.019409319	0.6583440489002963
HHHH SYNDROME	0.019409319	0.6583440489002963
COPPER DEFICIENCY, FAMILIAL BENIGN	0.019409319	0.6583440489002963
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.01936954	0.6569947863155965
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.019303004	0.6547379539332944
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.019224769	0.6520843035571161
SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT; SPG73	0.01921181	0.6516447476649336
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.01921181	0.6516447476649336
KUFOR-RAKEB SYNDROME	0.01921181	0.6516447476649336
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.01920604	0.6514490352258648
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.01920604	0.6514490352258648
PERMANENT NEONATAL DIABETES MELLITUS	0.019200004	0.651244300341598
TRANSIENT NEONATAL DIABETES MELLITUS	0.019200004	0.651244300341598
BOHRING-OPITZ SYNDROME	0.019180613	0.6505865776542525
DYSTONIA-APHONIA SYNDROME	0.019129043	0.6488373765307206
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.019110134	0.6481960027854258
SALT-AND-PEPPER SYNDROME	0.019082104	0.6472452541429475
RABSON-MENDENHALL SYNDROME	0.019046854000000002	0.6460496105593816
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.01904645	0.64603590729675
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.01904645	0.64603590729675
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 28	0.01897163	0.6434980901925682
SPINOCEREBELLAR ATAXIA 42	0.01897163	0.6434980901925682
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.018911083000000002	0.6414443985030884
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.01887272	0.6401431651755324
PFEIFFER-PALM-TELLER SYNDROME	0.01887272	0.6401431651755324
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.6399796757550279
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.6399796757550279
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.6399796757550279
KNUCKLE PADS	0.0188679	0.6399796757550279
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.6399796757550279
THROMBOCYTOPENIA 3	0.0188679	0.6399796757550279
TOE, MISSHAPEN	0.0188679	0.6399796757550279
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.6399796757550279
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.6399796757550279
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.6399796757550279
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.6399796757550279
RAYNAUD DISEASE	0.0188679	0.6399796757550279
TRACHEOBRONCHOMEGALY	0.0188679	0.6399796757550279
PUBIC BONE DYSPLASIA	0.0188679	0.6399796757550279
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.6399796757550279
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.6399796757550279
CARPAL DISPLACEMENT	0.0188679	0.6399796757550279
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.6399796757550279
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.6399796757550279
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.6399796757550279
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.6399796757550279
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.6399796757550279
LETTERER-SIWE DISEASE	0.0188679	0.6399796757550279
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.6399796757550279
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.6399796757550279
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.6399796757550279
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.6399796757550279
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.6399796757550279
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.6399796757550279
SPINAL ARACHNOIDITIS	0.0188679	0.6399796757550279
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.6399796757550279
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.6399796757550279
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.6399796757550279
MONOPHALANGY OF GREAT TOE	0.0188679	0.6399796757550279
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.6399796757550279
NEPHROSIALIDOSIS	0.0188679	0.6399796757550279
VAN DEN BOSCH SYNDROME	0.0188679	0.6399796757550279
VESICOURETERAL REFLUX 1	0.0188679	0.6399796757550279
48,XXYY SYNDROME	0.018847292999999998	0.6392807076039201
COHEN SYNDROME	0.018836309000000002	0.6389081416713844
SPINOCEREBELLAR ATAXIA TYPE 38	0.018826250000000003	0.63856695078324
FREE SIALIC ACID STORAGE DISEASE	0.018820953	0.6383872820155194
HSD10 DISEASE	0.018820953	0.6383872820155194
MIETENS SYNDROME	0.018639193999999998	0.6322222045089839
MARSHALL-SMITH SYNDROME	0.01863731	0.6321583011753262
GORLIN-CHAUDHRY-MOSS SYNDROME	0.018559199999999998	0.6295088906700116
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.018543413	0.6289734119394087
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6287406260695074
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.0185185	0.6281283887167879
MESOMELIC DWARFISM-CLEFT PALATE-CAMPTODACTYLY SYNDROME	0.0185185	0.6281283887167879
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.0185185	0.6281283887167879
HYPEREKPLEXIA 4; HKPX4	0.018479872999999997	0.6268182007819678
TRISOMY 17P	0.018479603999999997	0.6268090765798692
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.018467139	0.6263862766573403
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.018427214	0.6250320619034715
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.018415459000000002	0.6246333444474483
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.018400223	0.6241165550676125
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.018400223	0.6241165550676125
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.018400223	0.6241165550676125
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.01839085	0.6237986325907681
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.018385794	0.6236271382940728
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.018365529	0.6229397704296482
LATHOSTEROLOSIS	0.018353869000000002	0.6225442752754815
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2F	0.0183277	0.6216566498304222
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2S; CMT2S	0.0183277	0.6216566498304222
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.018279534	0.6200229088702509
CHOREOACANTHOCYTOSIS	0.018275399	0.6198826539420794
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.018275399	0.6198826539420794
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 66	0.01826711	0.6196014996253651
CRI-DU-CHAT SYNDROME	0.018263630000000003	0.6194834616205196
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.018259943	0.6193584023895236
SMITH-LEMLI-OPITZ SYNDROME	0.018245903	0.6188821800941117
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.018211173	0.6177041743733388
JOUBERT SYNDROME 14	0.018118824	0.6145717916981972
WIEDEMANN-STEINER SYNDROME; WDSTS	0.018115883	0.6144720360165159
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.018113994	0.6144079630880236
WIEACKER-WOLFF SYNDROME	0.018075373	0.613097978667005
ZLOTOGORA-OGUR SYNDROME	0.018032719	0.6116511990524398
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.01801618	0.6110902132587207
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.018008259	0.6108215411218292
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.017984014	0.6099991757691042
COFFIN-SIRIS SYNDROME 7; CSS7	0.017984014	0.6099991757691042
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.01797794	0.6097931519640949
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.01797794	0.6097931519640949
AUTOSOMAL RECESSIVE AXONAL CHARCOT-MARIE-TOOTH DISEASE DUE TO COPPER METABOLISM DEFECT	0.01797794	0.6097931519640949
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 15; MDDGC15	0.01794871	0.6088017005613251
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.017934049999999997	0.6083044485064292
ANTLEY-BIXLER SYNDROME	0.017934049999999997	0.6083044485064292
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.017921153999999998	0.607867029509162
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.017864729	0.6059531518012837
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.017864729	0.6059531518012837
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.017846503	0.6053349447103882
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.017843083	0.605218941843557
RIN2 SYNDROME	0.01783647	0.6049946357153834
MACS SYNDROME	0.01783647	0.6049946357153834
AL-RAQAD SYNDROME; ARS	0.017824614	0.6045924924437022
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.017784633	0.6032363782276866
ACRO-RENAL-OCULAR SYNDROME	0.017760319999999996	0.6024117063852116
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.017725613	0.6012344808006778
MOEBIUS SYNDROME	0.01766471	0.5991687139589777
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.017662629	0.5990981285888388
PELVIS-SHOULDER DYSPLASIA	0.017637229999999997	0.5982366207482999
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.017582533	0.5963813550152416
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.017578200000000002	0.5962343841316221
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.017551353	0.595323761626998
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.017529264	0.5945745255669301
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.017442104	0.5916181484110831
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.017395233000000003	0.5900283325130599
MEIER-GORLIN SYNDROME 3; MGORS3	0.017388169999999998	0.5897887628497767
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.017381784	0.5895721563270916
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.01738044	0.589526569235565
GAPO SYNDROME; GAPOS	0.017305239	0.5869758290049906
CEREBELLAR ATAXIA, CAYMAN TYPE	0.017301664	0.5868545686982886
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.017301664	0.5868545686982886
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.017297529	0.586714313770117
JUVENILE HUNTINGTON DISEASE	0.017297529	0.586714313770117
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.017263314000000002	0.5855537763173025
HYPERPROLINEMIA, TYPE I	0.017254172999999998	0.5852437230407811
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.01724419	0.5849051099941219
SPLIT-HAND/FOOT MALFORMATION WITH LONG BONE DEFICIENCY 1	0.0172414	0.584810476076444
269800 SENILE PLAQUE FORMATION	0.0172414	0.584810476076444
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.584810476076444
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.584810476076444
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.584810476076444
ALCOHOL DEPENDENCE	0.0172414	0.584810476076444
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.584810476076444
MOTION SICKNESS	0.0172414	0.584810476076444
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.584810476076444
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.584810476076444
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.584810476076444
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.584810476076444
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.584810476076444
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.584810476076444
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.584810476076444
TRANSSEXUALITY	0.0172414	0.584810476076444
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.584810476076444
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.584810476076444
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.584810476076444
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.584810476076444
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.584810476076444
PALMOMENTAL REFLEX	0.0172414	0.584810476076444
BARTSOCAS-PAPAS SYNDROME; BPS	0.0172414	0.584810476076444
JUMPING FRENCHMAN OF MAINE	0.0172414	0.584810476076444
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.584810476076444
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.584810476076444
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.584810476076444
CARDIAC ARRHYTHMIA	0.0172414	0.584810476076444
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.584810476076444
MOSAIC TRISOMY 15	0.0172414	0.584810476076444
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.584810476076444
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.0172414	0.584810476076444
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.584810476076444
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.584810476076444
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.584810476076444
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.584810476076444
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.584810476076444
CERVICAL RIB	0.0172414	0.584810476076444
MYOPATHY, CONGENITAL	0.0172414	0.584810476076444
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.584810476076444
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.584810476076444
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.584810476076444
DIASTEMATOMYELIA	0.0172414	0.584810476076444
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.584810476076444
SICKLE CELL ANEMIA	0.0172414	0.584810476076444
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.584810476076444
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.584810476076444
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.0172414	0.584810476076444
ERYTHERMALGIA, PRIMARY	0.0172414	0.584810476076444
RHEUMATOID ARTHRITIS	0.0172414	0.584810476076444
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.584810476076444
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.584810476076444
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.584810476076444
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.017168064	0.5823229947191562
SPASTIC PARAPLEGIA-OPTIC ATROPHY-NEUROPATHY SYNDROME	0.01712121	0.5807337554435703
FAMILIAL DYSKINESIA AND FACIAL MYOKYMIA	0.01712121	0.5807337554435703
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.01712121	0.5807337554435703
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.01712121	0.5807337554435703
SPINOCEREBELLAR ATAXIA TYPE 12	0.01710526	0.5801927479213611
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.017102273999999997	0.5800914658861687
MUCOPOLYSACCHARIDOSIS TYPE 2	0.017033853	0.577770696251242
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.016991792999999998	0.576344064503021
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.016973164	0.5757121880684607
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.016945979	0.5747901009530213
FACIOCARDIORENAL SYNDROME	0.016899169999999998	0.5732023880309464
BICD2-RELATED AUTOSOMAL DOMINANT CHILDHOOD-ONSET PROXIMAL SPINAL MUSCULAR ATROPHY	0.016894430000000002	0.5730416121277946
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.01689443	0.5730416121277946
NEMALINE MYOPATHY 4	0.01689443	0.5730416121277946
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.01689443	0.5730416121277946
MENTAL RETARDATION, X-LINKED 9	0.016866303	0.5720875733455261
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.016853483	0.5716527321897441
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.016839383	0.5711744747563178
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.016812793	0.5702725694261895
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.01675611	0.5683499406248486
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.01675611	0.5683499406248486
UROCANIC ACIDURIA	0.01675611	0.5683499406248486
COFFIN-LOWRY SYNDROME; CLS	0.016739519	0.5677871910448501
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.016732113	0.567535987175917
DESBUQUOIS DYSPLASIA 1	0.0167202	0.5671319105231222
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.016712754	0.5668793498955127
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.016712754	0.5668793498955127
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.016701364	0.5664930128624115
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.016701364	0.5664930128624115
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.01668494	0.565935927749887
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.01668354	0.5658884411962136
MARDEN-WALKER SYNDROME	0.016674553999999998	0.5655836453595632
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.016674553999999998	0.5655836453595632
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.016674553999999998	0.5655836453595632
LINEAR VERRUCOUS NEVUS SYNDROME	0.016670419	0.5654433904313917
OCULOCEREBROCUTANEOUS SYNDROME	0.016670419	0.5654433904313917
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 19	0.01663864	0.5643654795819691
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.016635843	0.5642706082315229
6Q TERMINAL DELETION SYNDROME	0.016631883	0.5641362891225605
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.01662251	0.5638183666457162
AU-KLINE SYNDROME; AUKS	0.016598324	0.5629980025120388
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.016597094	0.5629562821827399
SPINOCEREBELLAR ATAXIA TYPE 19/22	0.01655401	0.5614949174124035
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.01655401	0.5614949174124035
ZIMMERMANN-LABAND SYNDROME 1	0.016488298999999998	0.5592660681778019
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.0163957	0.556125205760933
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.016373874	0.5553848903891626
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.016364424	0.5550643561518661
HEART-HAND SYNDROME, SLOVENIAN TYPE	0.01633488	0.5540622541934868
WIEDEMANN-STEINER SYNDROME	0.016332479	0.5539808147539367
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.016320749000000002	0.5535829452720863
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.016316853	0.553450796977006
GAUCHER DISEASE	0.016301509999999998	0.5529303782677109
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.5529303782677109
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.016293334	0.5526530567942575
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.016250340000000002	0.5511947447309431
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.016233654	0.5506287728490882
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.016170554	0.5484884860370878
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.016166419	0.5483482311089164
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.016166419	0.5483482311089164
PENTALOGY OF CANTRELL	0.016128999999999998	0.5470790172861231
SEGMENTAL OUTGROWTH-LIPOMATOSIS-ARTERIOVENOUS MALFORMATION-EPIDERMAL NEVUS SYNDROME	0.016128999999999998	0.5470790172861231
DIGITOTALAR DYSMORPHISM	0.016128999999999998	0.5470790172861231
BARTSOCAS-PAPAS SYNDROME	0.016128999999999998	0.5470790172861231
MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	0.016128999999999998	0.5470790172861231
LAURIN-SANDROW SYNDROME	0.016128999999999998	0.5470790172861231
ACALVARIA	0.016128999999999998	0.5470790172861231
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.016128999999999998	0.5470790172861231
ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.016128999999999998	0.5470790172861231
TERMINAL TRANSVERSE LIMB DEFECT	0.016128999999999998	0.5470790172861231
MECKEL SYNDROME, TYPE 1; MKS1	0.016128999999999998	0.5470790172861231
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.016128999999999998	0.5470790172861231
MECKEL SYNDROME	0.016128999999999998	0.5470790172861231
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.016128999999999998	0.5470790172861231
GORDON SYNDROME	0.016128999999999998	0.5470790172861231
STUVE-WIEDEMANN SYNDROME	0.016128999999999998	0.5470790172861231
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.016109964	0.5464333358320307
CRANIOMETADIAPHYSEAL DYSPLASIA, WORMIAN BONE TYPE	0.01609075	0.5457816168018282
ROIFMAN-CHITAYAT SYNDROME	0.016042953999999998	0.5441604258594134
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.016031419999999998	0.5437692044950773
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.01603002	0.5437217179414037
CATEL-MANZKE SYNDROME; CATMANS	0.015999683	0.542692718242265
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.015846259	0.5374887346631153
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24	0.01576651	0.5347837309710357
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.015733334	0.5336584353248404
NEMALINE MYOPATHY 7; NEM7	0.015643380000000002	0.5306072885754476
6Q16 MICRODELETION SYNDROME	0.015642333999999997	0.53057180933606
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2	0.015625	0.5299838579636478
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B; CMT2B	0.015625	0.5299838579636478
MYOPATHY, DISTAL, WITH RIMMED VACUOLES	0.015625	0.5299838579636478
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 3; CMTX3	0.015625	0.5299838579636478
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.015625	0.5299838579636478
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1D; CMT1D	0.015625	0.5299838579636478
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2I	0.015625	0.5299838579636478
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2F; CMT2F	0.015625	0.5299838579636478
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2H; CMT2H	0.015625	0.5299838579636478
TIBIAL MUSCULAR DYSTROPHY, TARDIVE	0.015625	0.5299838579636478
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1	0.015625	0.5299838579636478
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.015625	0.5299838579636478
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE A; CMTDIA	0.015625	0.5299838579636478
GNE MYOPATHY	0.015625	0.5299838579636478
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.015625	0.5299838579636478
MYOPATHY, DISTAL, INFANTILE-ONSET	0.015625	0.5299838579636478
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.015625	0.5299838579636478
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2U; CMT2U	0.015625	0.5299838579636478
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.015625	0.5299838579636478
GIANT AXONAL NEUROPATHY, AUTOSOMAL DOMINANT	0.015625	0.5299838579636478
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2DD; CMT2DD	0.015625	0.5299838579636478
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B	0.015625	0.5299838579636478
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2W	0.015625	0.5299838579636478
CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE D; CMTRID	0.015625	0.5299838579636478
46,XY GONADAL DYSGENESIS-MOTOR AND SENSORY NEUROPATHY SYNDROME	0.015625	0.5299838579636478
WELANDER DISTAL MYOPATHY; WDM	0.015625	0.5299838579636478
HYPERMANGANESEMIA WITH DYSTONIA 1; HMNDYT1	0.015625	0.5299838579636478
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.01561356	0.5295958249822011
KEIPERT SYNDROME	0.015611580000000002	0.52952866542772
%611252 SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32	0.01556441	0.5279287077585907
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 31	0.01556441	0.5279287077585907
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 8	0.01556441	0.5279287077585907
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 12	0.01556441	0.5279287077585907
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 43	0.01556441	0.5279287077585907
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 37	0.01556441	0.5279287077585907
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 73	0.01556441	0.5279287077585907
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 60	0.01556441	0.5279287077585907
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 19	0.01556441	0.5279287077585907
SMITH-KINGSMORE SYNDROME; SKS	0.015548539	0.5273903798347672
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.015480022999999999	0.525066387897984
RING CHROMOSOME 14 SYNDROME	0.015476223999999998	0.5249375297426941
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.015470953999999999	0.5247587767870802
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.5247587767870802
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.015470953999999999	0.5247587767870802
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.015417573	0.522948148414475
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.015374479000000002	0.5214864444544695
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.015372673	0.5214251868002306
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.015364374	0.5211436932938472
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.01535388	0.520787747655097
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.01534392	0.5204499147446768
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.01524879	0.5172232034225596
HENNEKAM-BEEMER SYNDROME	0.015232619	0.5166746998086631
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.01513899	0.5134989008558773
COFFIN-SIRIS SYNDROME 1; CSS1	0.015102033	0.5122453575957966
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.015087123000000001	0.5117396257991733
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.01502789	0.5097305036322126
OROFACIODIGITAL SYNDROME TYPE 2	0.015016924	0.5093585482410812
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.015013642999999998	0.5092472601106505
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.014959674000000001	0.5074166873855025
ACROCRANIOFACIAL DYSOSTOSIS	0.014949890000000002	0.5070848242132583
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.014938604000000001	0.5067020147527156
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.014928303	0.506352615474579
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.01492611	0.506278231180146
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5062541487136402
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5062541487136402
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5062541487136402
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.014923059	0.5061747444121047
MODERATE MULTIMINICORE DISEASE WITH HAND INVOLVEMENT	0.0148978	0.5053179852269332
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.0148978	0.5053179852269332
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0148978	0.5053179852269332
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.014884783	0.50487646203467
SCARF SYNDROME	0.01488284	0.5048105574819645
LAMB-SHAFFER SYNDROME	0.014875134000000002	0.5045491779229586
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.014845379	0.5035399190625612
JOUBERT SYNDROME 2	0.014831254	0.5030608136549621
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.014831254	0.5030608136549621
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.014831254	0.5030608136549621
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.014831254	0.5030608136549621
DEXTROCARDIA	0.014831254	0.5030608136549621
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.014831254	0.5030608136549621
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.014831254	0.5030608136549621
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.014831254	0.5030608136549621
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.014831254	0.5030608136549621
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.01480813	0.5022764714641428
SAY-BARBER-MILLER SYNDROME	0.014802593999999999	0.5020886960633308
GAUCHER DISEASE, PERINATAL LETHAL	0.014789139	0.5016323163635612
DISTAL MONOSOMY 10P	0.01476133	0.5006890638127701
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.014688442999999999	0.4982168120716247
X SMALL RINGS	0.014683604	0.49805267819074883
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.014682933	0.4980299185639524
SMITH-FINEMAN-MYERS SYNDROME	0.014679989000000001	0.49793006112537036
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4H; CMT4H	0.01467102	0.4976258419111575
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.014671019999999998	0.49762584191115744
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.014666644	0.49747741251196076
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.014652278999999999	0.4969901665523033
3Q29 MICRODELETION SYNDROME	0.014591444	0.49492670620035334
NEONATAL ADRENOLEUKODYSTROPHY	0.014586369	0.4947545674432867
ACRODYSOSTOSIS	0.01457371	0.49432518724117713
KBG SYNDROME	0.014552433	0.49360349338224
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.014541569	0.4932349977257334
DISTAL ANOCTAMINOPATHY	0.01454149	0.4932323181273475
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.01454149	0.4932323181273475
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.014531803000000001	0.49290374509489354
ARGININEMIA	0.014531803000000001	0.49290374509489354
HURLER SYNDROME	0.014527794	0.49276776395655264
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.014525360000000001	0.4926852051910945
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.014523343000000001	0.4926167906348377
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.014477714	0.4910691020937162
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.01444966	0.49011753939603214
AMISH LETHAL MICROCEPHALY	0.01444966	0.49011753939603214
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.01444966	0.49011753939603214
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.014426779	0.4893414395141719
6Q25 MICRODELETION SYNDROME	0.014424493000000002	0.4892639007558165
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.014414460000000002	0.48892359176081174
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.014408900000000002	0.488735002304794
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.014386884	0.4879882423293106
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.0143777	0.48767673053721206
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.014366723000000001	0.48730440203744463
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.014346412999999999	0.4866155078195091
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.014311109	0.48541803261173005
ORAL SENSIBILITY, DISTURBANCE OF	0.0142857	0.48455618558152214
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C; CMTDIC	0.0142857	0.48455618558152214
INFANT BOTULISM	0.0142857	0.48455618558152214
236640 HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS	0.0142857	0.48455618558152214
WILSON DISEASE	0.0142857	0.48455618558152214
NEUROLEPTIC MALIGNANT SYNDROME	0.0142857	0.48455618558152214
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.0142857	0.48455618558152214
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	0.0142857	0.48455618558152214
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.0142857	0.48455618558152214
NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	0.0142857	0.48455618558152214
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC; HSAN1C	0.0142857	0.48455618558152214
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.0142857	0.48455618558152214
HYPOPHOSPHATASIA, ADULT	0.0142857	0.48455618558152214
EXOSTOSES, MULTIPLE, TYPE I	0.0142857	0.48455618558152214
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.0142857	0.48455618558152214
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.014268114	0.48395968662944866
KABUKI SYNDROME	0.014263029	0.48378720868271285
FOCAL DERMAL HYPOPLASIA; FDH	0.01425919	0.48365699376874666
MENTAL RETARDATION, X-LINKED 45	0.014257039999999999	0.4835840679898908
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.014244153999999998	0.4831469881822928
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.014222634	0.4824170520143966
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.01418537	0.48115309563147457
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.0141756	0.4808217073247671
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.014127204	0.47918016500220656
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.01410918	0.47856880954262654
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.01407476	0.47740131870159563
HALLERMANN-STREIFF SYNDROME; HSS	0.01405563	0.47675244886461354
CHST3-RELATED SKELETAL DYSPLASIA	0.014017499999999999	0.47545911865634766
FONTAINE PROGEROID SYNDROME; FPS	0.014015060000000001	0.4753763563770881
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.014007094000000001	0.47510615788668564
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.014007094000000001	0.47510615788668564
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.013989699	0.4745161374572918
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.013986249000000001	0.47439911702145354
ANGELMAN SYNDROME	0.013986249000000001	0.47439911702145354
NEUROCUTANEOUS MELANOCYTOSIS	0.013986249	0.4743991170214535
CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE	0.01398084	0.47421564932943905
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.01398084	0.47421564932943905
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.013964279	0.47365391731844797
CARNOSINASE DEFICIENCY	0.013932159999999999	0.4725644740202761
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.013916928999999998	0.4720478542352749
SPINOCEREBELLAR ATAXIA TYPE 21	0.013900140000000002	0.4714783886998285
GM1 GANGLIOSIDOSIS	0.013834389	0.46924818270655044
LISSENCEPHALY 8; LIS8	0.013789672999999999	0.46773146218221745
NATIVE AMERICAN MYOPATHY	0.013757239999999999	0.46663136832843605
15Q26 OVERGROWTH SYNDROME	0.013755380000000001	0.4665682790499841
MEIER-GORLIN SYNDROME 6; MGORS6	0.01375064	0.4664075031468322
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.4646423601088528
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.4646423601088528
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.013698599999999998	0.4646423601088528
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.4646423601088528
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.4646423601088528
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.013671173999999998	0.46371209852238804
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.013660819000000001	0.4633608676200385
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.013628593000000001	0.4622677949924074
HALL-RIGGS SYNDROME	0.013593969	0.4610933846821268
MENKES DISEASE	0.013586849	0.4608518816377299
MOSAIC TRISOMY 14	0.013579093	0.4605888061303785
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.013536794	0.45915406774906614
SPINOCEREBELLAR ATAXIA TYPE 13	0.013494233000000001	0.4577104425984237
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.013475493	0.4570748011585363
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.013468313	0.4568312629761249
SYRINGOMYELIA, ISOLATED	0.013461540000000001	0.4566015298132457
SPINOCEREBELLAR ATAXIA TYPE 8	0.013461540000000001	0.4566015298132457
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-SACCADIC INTRUSION SYNDROME	0.013461540000000001	0.4566015298132457
CHIARI MALFORMATION TYPE I	0.013461540000000001	0.4566015298132457
SPINOCEREBELLAR ATAXIA TYPE 43	0.013461540000000001	0.4566015298132457
SPINOCEREBELLAR ATAXIA TYPE 6	0.013461540000000001	0.4566015298132457
TRISOMY 9P	0.013448494	0.4561590229709421
OROFACIODIGITAL SYNDROME TYPE 6	0.013424083	0.45533102706970996
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.013413309	0.45496558412022514
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 59	0.013340999999999999	0.4525129375419536
SPASTIC PARAPLEGIA 33, AUTOSOMAL DOMINANT	0.013340999999999999	0.4525129375419536
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.013307183	0.45136589983796915
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.013307183	0.45136589983796915
INFANTILE LIVER FAILURE SYNDROME 1	0.013282073	0.45051419457886727
SECKEL SYNDROME 7; SCKL7	0.013267979	0.45003614065924236
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.013263409	0.44988113098046517
VOCAL CORD AND PHARYNGEAL DISTAL MYOPATHY	0.01325944	0.4497465066008006
ADULT-ONSET CERVICAL DYSTONIA, DYT23 TYPE	0.01325944	0.4497465066008006
KRABBE DISEASE	0.013253094	0.44953125683679185
GERMAN SYNDROME	0.013243814000000001	0.4492164888238701
ACROFACIAL DYSOSTOSIS, RODRÍGUEZ TYPE	0.013230180000000001	0.4487540376290236
KLEEFSTRA SYNDROME	0.013229808999999999	0.4487414536923
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.013167282999999998	0.4466206363673058
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.013122214	0.44509194244765377
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.013111733	0.44473643775547356
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.013051613	0.4426972294648639
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.013051613	0.4426972294648639
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.013029019999999999	0.44193089824547366
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.01299215	0.440680305935514
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.01299124	0.4406494396756262
PFEIFFER SYNDROME	0.01294239	0.4389924981420886
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.012909309	0.4378704247977498
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.012892023	0.4372841015357492
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.012863633999999999	0.4363211759841504
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.012844893	0.4356855006252962
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.01284347	0.4356372339353837
MONOSOMY 5P	0.012808420000000001	0.43444837414519977
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.01278575	0.4336794311653574
METACHROMATIC LEUKODYSTROPHY	0.012761629	0.4328612717645292
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.012761629	0.4328612717645292
FAMILIAL DYSAUTONOMIA	0.012761629	0.4328612717645292
PELIZAEUS-MERZBACHER DISEASE	0.012761629	0.4328612717645292
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.012761629	0.4328612717645292
GALACTOSE EPIMERASE DEFICIENCY	0.012740654	0.4321498214335988
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.012740654	0.4321498214335988
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.012740654	0.4321498214335988
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.012736519	0.43200956650542727
DILATED CARDIOMYOPATHY WITH ATAXIA	0.012736519	0.43200956650542727
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.012736519	0.43200956650542727
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.012736519	0.43200956650542727
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.012714873	0.43127535654770044
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.012714873	0.43127535654770044
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.012714393000000001	0.43125907544358394
GAUCHER DISEASE TYPE 3	0.01270754	0.43102662876335185
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.012690229	0.43043945752717855
KNIEST-LIKE DYSPLASIA, LETHAL	0.01268839	0.43037708054703167
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.012621729	0.42811600829386587
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.012609410000000001	0.4276981605405057
JOHNSON NEUROECTODERMAL SYNDROME	0.01258868	0.4269950203564681
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.012581272999999999	0.4267437825685681
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.01257666	0.42658731437421377
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.012570314	0.42637206461020505
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.012561603000000001	0.42607659648945484
MONOSOMY 22Q13.3	0.012540663	0.4253663333223663
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.012513914000000001	0.42445903487649944
DUCHENNE MUSCULAR DYSTROPHY	0.012513874	0.42445767811782303
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.012510194	0.42433285631959544
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.012506059	0.42419260139142395
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.01247786	0.42323612044353803
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.012459853000000002	0.4226253416063956
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.012453503000000001	0.4224099561665192
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.01244335	0.42206557689548524
PRIMARY DYSTONIA, DYT4 TYPE	0.01237685	0.41980996559599193
PAROXYSMAL TONIC UPGAZE, BENIGN CHILDHOOD, WITH ATAXIA	0.01235294	0.41899896309718165
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.012350604000000001	0.4189197283904807
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.01233253	0.41830667698255525
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.012323029	0.4179844128779464
NEMALINE MYOPATHY 11, AUTOSOMAL RECESSIVE; NEM11	0.012318079999999999	0.4178165479107104
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.012318079999999999	0.4178165479107104
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.012318079999999999	0.4178165479107104
GENITOPATELLAR SYNDROME; GTPTS	0.012310814	0.41757009269714473
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.012260704	0.415870413265301
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.01222021	0.41449689861926076
NEUROFERRITINOPATHY	0.01222021	0.41449689861926076
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.01222021	0.41449689861926076
CORTICOBASAL SYNDROME	0.01222021	0.41449689861926076
SPINOCEREBELLAR ATAXIA TYPE 17	0.01222021	0.41449689861926076
RHEUMATIC FEVER	0.01222021	0.41449689861926076
ADULT POLYGLUCOSAN BODY DISEASE	0.01222021	0.41449689861926076
ABETA AMYLOIDOSIS, IOWA TYPE	0.01222021	0.41449689861926076
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.012196593	0.4136958343777549
RAMOS-ARROYO SYNDROME	0.0121951	0.41364519336015876
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.0121951	0.41364519336015876
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0121951	0.41364519336015876
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0121951	0.41364519336015876
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.0121951	0.41364519336015876
JOUBERT SYNDROME 4	0.0121951	0.41364519336015876
POSTSYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.0121951	0.41364519336015876
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.0121951	0.41364519336015876
CLASSIC MULTIMINICORE MYOPATHY	0.0121951	0.41364519336015876
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.012176874	0.41302698626926304
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.012173454	0.412910983402432
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.012173454	0.412910983402432
MENTAL RETARDATION, X-LINKED 102	0.012169319	0.4127707284742605
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.012169319	0.4127707284742605
CEREBROFACIOARTICULAR SYNDROME	0.012163364	0.41256874102631336
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.012110869	0.4107881648583901
MELNICK-NEEDLES SYNDROME	0.01208815	0.4100175598491692
BARTH SYNDROME; BTHS	0.01208815	0.4100175598491692
CHROMOSOME 16Q22 DELETION SYNDROME	0.012078024000000001	0.40967409639024194
CHROMOSOME 9P DELETION SYNDROME	0.012078024000000001	0.40967409639024194
FUMARASE DEFICIENCY; FMRD	0.012039854	0.40837940942329964
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.012039854	0.40837940942329964
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.012039854	0.40837940942329964
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.012039854	0.40837940942329964
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012039854	0.40837940942329964
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.012039854	0.40837940942329964
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.012039854	0.40837940942329964
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.012039854	0.40837940942329964
PALLISTER-KILLIAN SYNDROME	0.011995109	0.4068617052489263
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.01196832	0.405953050044383
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.01196832	0.405953050044383
NEMALINE MYOPATHY 3; NEM3	0.01196832	0.405953050044383
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.01196832	0.405953050044383
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.01196832	0.405953050044383
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.01196832	0.405953050044383
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.01195033	0.405342847829678
COCKAYNE SYNDROME A; CSA	0.011926209	0.4045246884288498
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.01192077	0.40434020316782815
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.01192077	0.40434020316782815
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.011918434000000002	0.40426096846112713
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.011820593	0.4009423028197177
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.011773243	0.39933623973654464
BENT BONE DYSPLASIA SYNDROME; BBDS	0.01175792	0.3988164994065877
INFANTILE SYSTEMIC HYALINOSIS	0.01175792	0.3988164994065877
MOSAIC TRISOMY 1	0.011706200000000002	0.3970622104380195
8P23.1 MICRODELETION SYNDROME	0.011696313000000002	0.39672685361218357
CEDNIK SYNDROME	0.011684583	0.396328984130333
AYME-GRIPP SYNDROME; AYGRP	0.011679439	0.3961545049645496
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.01167338	0.395948989944044
SNEDDON SYNDROME	0.011666289	0.3957084705496875
PSEUDOACHONDROPLASIA	0.01166456	0.3956498246559006
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.01166456	0.3956498246559006
RAYNAUD-CLAES SYNDROME; MRXSRC	0.011663953000000001	0.3956292358429865
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.011649879	0.3951518603026998
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.011647403	0.3950678769406314
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.0116279	0.39440635532899204
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.0116279	0.39440635532899204
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.0116279	0.39440635532899204
VAN MALDERGEM SYNDROME 2; VMLDS2	0.01161781	0.3940641129528734
VAN MALDERGEM SYNDROME 1; VMLDS1	0.01161781	0.3940641129528734
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.01161701	0.39403697777934565
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.01161701	0.39403697777934565
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.01160355	0.3935804284847415
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.011567753	0.3923662312262759
SHPRINTZEN-GOLDBERG SYNDROME	0.01154303	0.391527652607368
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.011513790000000001	0.3905358620149292
PMM2-CDG	0.011510853	0.3904362420091154
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.011503673	0.390192703826704
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.011503673	0.390192703826704
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.011503673	0.390192703826704
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.011503673	0.390192703826704
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.011503673	0.390192703826704
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.011503673	0.390192703826704
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.011503673	0.390192703826704
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.011503673	0.390192703826704
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.011503673	0.390192703826704
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.011503673	0.390192703826704
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.011503673	0.390192703826704
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.011503673	0.390192703826704
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.011494299999999999	0.3898747813498596
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.3898747813498596
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.011494299999999999	0.3898747813498596
RING CHROMOSOME 22 SYNDROME	0.011430733000000002	0.3877186543803125
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.01142043	0.3873691872642421
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.011385199	0.3861741881410473
20Q11.2 MICRODELETION SYNDROME	0.011366664	0.3855455000893766
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.01128151	0.3826571643811502
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.011184764	0.37937564000850693
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.011184764	0.37937564000850693
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.011183854	0.37934477374861914
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.011179719	0.37920451882044764
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.011179719	0.37920451882044764
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.011179719	0.37920451882044764
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.01112487	0.377344097404419
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.011086973	0.3760586703154431
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.011086973	0.3760586703154431
COFFIN-SIRIS SYNDROME 2; CSS2	0.011072663	0.37557328989896566
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.011051623	0.37485963483518614
14Q24.1Q24.3 MICRODELETION SYNDROME	0.0110272	0.3740312319063511
HEART AND BRAIN MALFORMATION SYNDROME	0.010988123	0.3727057804364219
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.010959549999999998	0.37173661379491174
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.010958119	0.37168807575326407
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.010958119	0.37168807575326407
XYLOSIDASE DEFICIENCY	0.010958119	0.37168807575326407
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.010958119	0.37168807575326407
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.010958119	0.37168807575326407
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.010958119	0.37168807575326407
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.010958119	0.37168807575326407
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.010958119	0.37168807575326407
NEUROFIBROMATOSIS, TYPE I	0.010958119	0.37168807575326407
FETAL ALCOHOL SYNDROME	0.010948804000000001	0.37137212057650043
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.01086549	0.3685461957673879
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.010847729	0.36794376099610515
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.010839472999999999	0.36766372600529884
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.010828533000000001	0.3672926525073071
RECOMBINANT CHROMOSOME 8 SYNDROME	0.010795713	0.3661794320133316
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.010795713	0.3661794320133316
RECOMBINANT 8 SYNDROME	0.010795713	0.3661794320133316
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.010783629999999999	0.3657695891361619
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.010756224	0.3648400059290355
PROTEUS SYNDROME	0.010733620000000001	0.36407330160100926
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.01070843	0.3632188828245545
DYSTONIA 16	0.01068627	0.3624672385178362
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.01068627	0.3624672385178362
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.010686223000000002	0.36246564432639145
%608572 BURN-MCKEOWN SYNDROME	0.01067281	0.362010689223232
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.01067281	0.362010689223232
WOODHOUSE-SAKATI SYNDROME	0.01067281	0.362010689223232
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.010654803000000001	0.36139991038608954
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.01063921	0.36087101193506693
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.01063921	0.36087101193506693
AASE-SMITH SYNDROME	0.01063921	0.36087101193506693
HYDROLETHALUS SYNDROME 1	0.01063921	0.36087101193506693
SPASTIC PARAPLEGIA 42, AUTOSOMAL DOMINANT; SPG42	0.0106383	0.36084014567517914
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 13	0.0106383	0.36084014567517914
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 14	0.0106383	0.36084014567517914
SPASTIC PARAPLEGIA 38, AUTOSOMAL DOMINANT; SPG38	0.0106383	0.36084014567517914
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 17	0.0106383	0.36084014567517914
%611945 SPASTIC PARAPLEGIA 37, AUTOSOMAL DOMINANT; SPG37	0.0106383	0.36084014567517914
SPASTIC PARAPLEGIA-NEUROPATHY-POIKILODERMA SYNDROME	0.0106383	0.36084014567517914
%613364 SPASTIC PARAPLEGIA 41, AUTOSOMAL DOMINANT; SPG41	0.0106383	0.36084014567517914
PRIMARY LATERAL SCLEROSIS, ADULT	0.0106383	0.36084014567517914
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.0106383	0.36084014567517914
%300750 SPASTIC PARAPLEGIA 34, X-LINKED; SPG34	0.0106383	0.36084014567517914
SPASTIC PARAPLEGIA 36, AUTOSOMAL DOMINANT; SPG36	0.0106383	0.36084014567517914
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0106383	0.36084014567517914
EPISODIC ATAXIA, TYPE 1; EA1	0.0106383	0.36084014567517914
SPASTIC PARAPLEGIA 19, AUTOSOMAL DOMINANT	0.0106383	0.36084014567517914
SPASTIC PARAPLEGIA-PAGET DISEASE OF BONE SYNDROME	0.0106383	0.36084014567517914
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 42	0.0106383	0.36084014567517914
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.0106383	0.36084014567517914
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 38	0.0106383	0.36084014567517914
SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT	0.0106383	0.36084014567517914
SPASTIC PARAPLEGIA 14, AUTOSOMAL RECESSIVE	0.0106383	0.36084014567517914
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.0106383	0.36084014567517914
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 36	0.0106383	0.36084014567517914
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 41	0.0106383	0.36084014567517914
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 72	0.0106383	0.36084014567517914
PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ	0.0106383	0.36084014567517914
SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT	0.0106383	0.36084014567517914
SPASTIC PARAPLEGIA TYPE 7	0.0106383	0.36084014567517914
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.0106383	0.36084014567517914
SPASTIC PARAPLEGIA TYPE 2	0.0106383	0.36084014567517914
PRIMARY LATERAL SCLEROSIS	0.0106383	0.36084014567517914
CRANIOFRONTONASAL SYNDROME; CFNS	0.010637924	0.36082739214362114
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.01059269	0.35929310159442895
MONOSOMY 22	0.01055989	0.35818055947979166
POPOV-CHANG SYNDROME; POPCHAS	0.010545554	0.3576942971701746
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.010545554	0.3576942971701746
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.010545554	0.3576942971701746
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.010545554	0.3576942971701746
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.010531244	0.3572089167536972
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.010520119999999999	0.3568316021657939
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.01049053	0.3558279399349367
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.01049053	0.3558279399349367
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.010416700000000001	0.3533237026079955
DEAFNESS-HYPOGONADISM SYNDROME	0.010403250000000001	0.35286749250306043
MILROY DISEASE	0.010403250000000001	0.35286749250306043
HUNTINGTON DISEASE-LIKE 1	0.010342529	0.35080789891333813
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.010332819	0.3504785457446452
OTOPALATODIGITAL SYNDROME TYPE 2	0.010287114000000002	0.34892827936203863
2Q32Q33 MICRODELETION SYNDROME	0.010261633999999999	0.34806402408518006
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.010260353	0.3480205738885688
LIGNEOUS CONJUNCTIVITIS	0.010254294	0.3478150588680631
STURGE-WEBER SYNDROME	0.010250159	0.3476748039398916
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.010250159	0.3476748039398916
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.010220064000000001	0.34665401263074497
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 21	0.010183850000000001	0.3454256711630781
RIGID SPINE SYNDROME	0.010160934	0.34464838411737597
ZEBRA BODY MYOPATHY	0.010160934	0.34464838411737597
HYPOPHOSPHATASIA, CHILDHOOD	0.010156799	0.3445081291892044
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.010149533	0.3442616739756388
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.010138204	0.34387740599951905
ABLEPHARON MACROSTOMIA SYNDROME	0.010138204	0.34387740599951905
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.010134068999999999	0.34373715107134756
MECKEL SYNDROME, TYPE 10; MKS10	0.010109249	0.34289528231264954
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.010109249	0.34289528231264954
ACROOSTEOLYSIS DOMINANT TYPE	0.01009237	0.3423227640701811
FILIPPI SYNDROME	0.010064993000000001	0.341394164513095
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.01005432	0.34103214737926807
SPINOCEREBELLAR ATAXIA TYPE 35	0.01005432	0.34103214737926807
SPINOCEREBELLAR ATAXIA TYPE 27	0.01005432	0.34103214737926807
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.01005432	0.34103214737926807
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.010033372999999998	0.34032164677941107
TRISOMY 8Q	0.010023854	0.33999877213339796
WOLCOTT-RALLISON SYNDROME	0.010023138999999999	0.3399745200720575
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.010015543	0.3397168715994116
PRADER-WILLI-LIKE SYNDROME	0.010015543	0.3397168715994116
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.010015543	0.3397168715994116
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.010015543	0.3397168715994116
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.01	0.3391896690967346
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.01	0.3391896690967346
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.01	0.3391896690967346
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.01	0.3391896690967346
SPINOCEREBELLAR ATAXIA, X-LINKED 4	0.01	0.3391896690967346
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.01	0.3391896690967346
BETHLEM MYOPATHY 2; BTHLM2	0.01	0.3391896690967346
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.009998008999999999	0.3391221364336174
CONO-SPONDYLAR DYSPLASIA	0.009998008999999999	0.3391221364336174
KEIPERT SYNDROME; KPTS	0.00998569	0.33870428868025715
PELVISCAPULAR DYSPLASIA	0.00998569	0.33870428868025715
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.009975803	0.33836893185442124
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.009948163000000001	0.3374314116090379
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00991864	0.33643002194896354
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00991864	0.33643002194896354
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.009913469	0.3362546269710736
GLUTAMINE DEFICIENCY, CONGENITAL	0.009913469	0.3362546269710736
FRYNS SYNDROME	0.009913469	0.3362546269710736
TRISOMY 18-LIKE SYNDROME	0.009901150000000001	0.3358367792177134
SIMOSA CRANIOFACIAL SYNDROME	0.009901150000000001	0.3358367792177134
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.009901150000000001	0.3358367792177134
BRANCHIO-OCULO-FACIAL SYNDROME	0.009901150000000001	0.3358367792177134
BARBER-SAY SYNDROME	0.009901150000000001	0.3358367792177134
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.009891263	0.33550142239187747
MENTAL RETARDATION, X-LINKED 90	0.009858903	0.33440380462268043
HEREDITARY FOLATE MALABSORPTION	0.009858903	0.33440380462268043
INFANTILE REFSUM DISEASE	0.009858903	0.33440380462268043
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.009858903	0.33440380462268043
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.3325691616215031
BIOTINIDASE DEFICIENCY	0.009804814	0.3325691616215031
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.009804814	0.3325691616215031
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.009804814	0.3325691616215031
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.3324289066933315
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.3324289066933315
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.009799413	0.3323859652812239
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.009795044000000001	0.3322377733147956
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.009790909	0.33209751838662405
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.009790909	0.33209751838662405
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.009788573000000002	0.3320182836799231
2Q24 MICRODELETION SYNDROME	0.009753879	0.3308414990419588
LOWRY-MACLEAN SYNDROME	0.009753879	0.3308414990419588
JOUBERT SYNDROME WITH OCULAR DEFECT	0.009743583	0.33049226935865683
JOUBERT SYNDROME	0.009743583	0.33049226935865683
JOUBERT SYNDROME WITH RENAL DEFECT	0.009743583	0.33049226935865683
MAXILLOFACIAL DYSOSTOSIS	0.009741560000000002	0.33042365128859863
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.009741560000000002	0.33042365128859863
%300712 CRANIOFACIOSKELETAL SYNDROME	0.009718933999999999	0.32965620074330027
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.009716079999999998	0.32955939601174006
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.009716079999999998	0.32955939601174006
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.00970874	0.3293104307946231
DERMOCHONDROCORNEAL DYSTROPHY	0.00970874	0.3293104307946231
GINGIVAL FIBROMATOSIS-PROGRESSIVE DEAFNESS SYNDROME	0.00970874	0.3293104307946231
PERIODONTAL EHLERS-DANLOS SYNDROME	0.00970874	0.3293104307946231
HYPERTRICHOSIS LANUGINOSA CONGENITA	0.00970874	0.3293104307946231
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.00970874	0.3293104307946231
ACUTE PROMYELOCYTIC LEUKEMIA	0.00970874	0.3293104307946231
JUVENILE HYALINE FIBROMATOSIS	0.00970874	0.3293104307946231
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00970874	0.3293104307946231
FOCAL PALMOPLANTAR AND GINGIVAL KERATODERMA	0.00970874	0.3293104307946231
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00970874	0.3293104307946231
HEREDITARY GINGIVAL FIBROMATOSIS	0.00970874	0.3293104307946231
ENAMEL-RENAL SYNDROME	0.00970874	0.3293104307946231
HYALINE FIBROMATOSIS SYNDROME; HFS	0.00970874	0.3293104307946231
OTODENTAL SYNDROME	0.00970874	0.3293104307946231
HYPOPLASMINOGENEMIA	0.00970874	0.3293104307946231
204690 ENAMEL-RENAL SYNDROME; ERS;;AMELOGENESIS IMPERFECTA, HYPOPLASTIC, AND NEPHROCALCINOSIS;;AMELOGENESIS IMPERFECTA, TYPE IG; AI1G	0.00970874	0.3293104307946231
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00967451	0.32814938455730497
TREACHER-COLLINS SYNDROME	0.009634394000000001	0.32678869128075655
17Q24.2 MICRODELETION SYNDROME	0.009630259	0.326648436352585
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2CC; CMT2CC	0.00961538	0.326143756043936
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E	0.00961538	0.326143756043936
TRIM32-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R8	0.00961538	0.326143756043936
EPIPHYSEAL DYSPLASIA, MULTIPLE, 1	0.00961538	0.326143756043936
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.00961538	0.326143756043936
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.00961538	0.326143756043936
CAMURATI-ENGELMANN DISEASE	0.00961538	0.326143756043936
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.00961538	0.326143756043936
TYPICAL NEMALINE MYOPATHY	0.00961538	0.326143756043936
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.00961538	0.326143756043936
EPIPHYSEAL DYSPLASIA, MULTIPLE, 2; EDM2	0.00961538	0.326143756043936
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00961538	0.326143756043936
SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF	0.00961538	0.326143756043936
FILAMINOPATHY, AUTOSOMAL DOMINANT	0.00961538	0.326143756043936
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MATRILIN-3 TYPE	0.00961538	0.326143756043936
CZECH DYSPLASIA, METATARSAL TYPE	0.00961538	0.326143756043936
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, DI ROCCO TYPE; SEMDDR	0.00961538	0.326143756043936
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2H	0.00961538	0.326143756043936
CAMURATI-ENGELMANN DISEASE	0.00961538	0.326143756043936
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.00961538	0.326143756043936
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.00961538	0.326143756043936
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.00961538	0.326143756043936
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.009567830000000001	0.32453090916738103
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.009542349999999998	0.32366665389052246
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.009530794	0.3232746863089143
OGDEN SYNDROME; OGDNS	0.009530794	0.3232746863089143
GOLDBERG-SHPRINTZEN SYNDROME	0.009523574	0.3230297913678265
FAMILIAL VISCERAL MYOPATHY	0.00948183	0.3216138780131491
MENTAL RETARDATION, X-LINKED 106; MRX106	0.009474124	0.32135249845414315
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.009474124	0.32135249845414315
2Q23.1 MICRODELETION SYNDROME	0.009469989	0.3212122435259716
5Q14.3 MICRODELETION SYNDROME	0.009469989	0.3212122435259716
POSTENCEPHALITIC PARKINSONISM	0.009469989	0.3212122435259716
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.009469989	0.3212122435259716
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.009454179	0.3206759846591297
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.009442269000000001	0.32027200976323555
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.009420303	0.31952694573609763
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.009420303	0.31952694573609763
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.009420303	0.31952694573609763
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.009420303	0.31952694573609763
N-ACETYLASPARTATE DEFICIENCY; NACED	0.009420303	0.31952694573609763
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.009420303	0.31952694573609763
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00939519	0.31867513872009495
W SYNDROME	0.009392853999999999	0.31859590401339394
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.009349844	0.3171370492466089
FORSYTHE-WAKELING SYNDROME; FWS	0.009338114	0.31673917976475846
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.00933297	0.3165647005989751
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.00933297	0.3165647005989751
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00932914	0.31643479095571103
ABETAL34V AMYLOIDOSIS	0.009317484000000001	0.3160394314774119
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.009317484000000001	0.3160394314774119
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.009317484000000001	0.3160394314774119
2Q33.1 DELETION SYNDROME	0.009313349	0.31589917654924043
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.009313349	0.31589917654924043
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.009313349	0.31589917654924043
5Q35 MICRODUPLICATION SYNDROME	0.009313349	0.31589917654924043
L-2-HYDROXYGLUTARIC ACIDURIA	0.009313349	0.31589917654924043
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.009313349	0.31589917654924043
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.009313349	0.31589917654924043
ABETA AMYLOIDOSIS, DUTCH TYPE	0.009313349	0.31589917654924043
PINEOBLASTOMA	0.009313349	0.31589917654924043
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.009313349	0.31589917654924043
SCLERODERMA	0.009313349	0.31589917654924043
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00930341	0.31556205593712516
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.009301074	0.3154828212304241
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00925926	0.3140645335480631
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.3140645335480631
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.3140645335480631
GAUCHER DISEASE TYPE 2	0.00925926	0.3140645335480631
PAINE SYNDROME	0.00925926	0.3140645335480631
CARNOSINEMIA	0.00925926	0.3140645335480631
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.3140645335480631
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.3140645335480631
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.3140645335480631
HYDROXYLYSINURIA	0.00925926	0.3140645335480631
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.3140645335480631
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00923417	0.3132135066682994
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.009222149999999998	0.312805800686045
1Q44 MICRODELETION SYNDROME	0.009219123999999999	0.3127031618921764
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.009208153	0.3123310369062104
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.009198029	0.31198764128521683
CHROMOSOME 17P13.1 DELETION SYNDROME	0.009190254	0.31172392131749416
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.009108822999999999	0.3089618659230725
NON-DISTAL MONOSOMY 10Q	0.00909342	0.3084394120757628
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.00908884	0.30828406320731655
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00908884	0.30828406320731655
DUBOWITZ SYNDROME	0.00906044	0.30732076454708174
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00904871	0.3069228950652313
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.00904871	0.3069228950652313
MCDONOUGH SYNDROME	0.00904871	0.3069228950652313
CHARGE-LIKE SYNDROME, X-LINKED	0.00904871	0.3069228950652313
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00904871	0.3069228950652313
14Q11.2 MICRODELETION SYNDROME	0.00903873	0.3065843837754728
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.009037564	0.3065448342600561
CARPENTER SYNDROME	0.00902538	0.30613156556722865
DESANTO-SHINAWI SYNDROME	0.009023483	0.30606722128700103
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.009005223	0.30544786095123033
GENITOPATELLAR SYNDROME	0.008998003	0.30520296601014246
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.00892857	0.30284787038070315
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00892857	0.30284787038070315
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.008878884	0.3011625725908291
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.008878884	0.3011625725908291
PEROXISOME BIOGENESIS DISORDER 5B	0.008878884	0.3011625725908291
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.008878884	0.3011625725908291
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.008878884	0.3011625725908291
CEREBELLOPARENCHYMAL DISORDER II	0.008874749	0.3010223176626576
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.008874749	0.3010223176626576
INCONTINENTIA PIGMENTI	0.008808752999999999	0.2987838015224868
600736 VELOFACIOSKELETAL SYNDROME	0.00880429	0.2986324211731689
DERMOTRICHIC SYNDROME	0.008798549	0.2984376923841405
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.008798549	0.2984376923841405
NIJMEGEN BREAKAGE SYNDROME	0.00879256	0.29823455169131846
NANCE-HORAN SYNDROME	0.00879256	0.29823455169131846
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00879256	0.29823455169131846
BREATH-HOLDING SPELLS	0.00877193	0.2975348034039719
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.00877193	0.2975348034039719
INDOLENT SYSTEMIC MASTOCYTOSIS	0.00877193	0.2975348034039719
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00877193	0.2975348034039719
HISTIDINEMIA	0.00877193	0.2975348034039719
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00877193	0.2975348034039719
MONOAMINE OXIDASE A DEFICIENCY	0.00877193	0.2975348034039719
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00877193	0.2975348034039719
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00877193	0.2975348034039719
CAFFEY DISEASE	0.00877193	0.2975348034039719
MENTAL RETARDATION, X-LINKED 105; MRX105	0.00877193	0.2975348034039719
FAMILIAL PAROXYSMAL ATAXIA	0.00877193	0.2975348034039719
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.008759063000000001	0.29709836805674517
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00875552	0.2969781931569841
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00875552	0.2969781931569841
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.008712734	0.2955269362387869
SECKEL SYNDROME 9; SCKL9	0.008712734	0.2955269362387869
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.008708599000000001	0.2953866813106154
ALEXANDER DISEASE	0.008662599	0.2938264088327704
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.008662599	0.2938264088327704
MUSCLE-EYE-BRAIN DISEASE	0.008662599	0.2938264088327704
CADASIL	0.008662599	0.2938264088327704
PARTINGTON SYNDROME	0.008662599	0.2938264088327704
WEAVER SYNDROME	0.008637533999999999	0.29297622992717937
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00859108	0.2914005582383574
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.008588743999999999	0.2913213235316564
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.008584609	0.29118106860348497
RUBINSTEIN-TAYBI SYNDROME	0.008537163	0.2895717492994886
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.008494383	0.2881206958950927
WEBB-DATTANI SYNDROME; WEDAS	0.008494383	0.2881206958950927
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.008494383	0.2881206958950927
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.008494383	0.2881206958950927
OROFACIODIGITAL SYNDROME XIV; OFD14	0.008482064000000001	0.2877028481417325
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.008482064000000001	0.2877028481417325
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.008482064000000001	0.2877028481417325
BARAITSER-WINTER SYNDROME 2; BRWS2	0.008477929	0.28756259321356104
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.008477929	0.28756259321356104
LATERAL MENINGOCELE SYNDROME	0.00843149	0.2859874303092427
COFFIN-SIRIS SYNDROME 6; CSS6	0.008384044	0.2843781110052463
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.008376464	0.284121005236071
CORNELIA DE LANGE SYNDROME 3	0.008344483	0.2830362427553327
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00833611	0.282752239245398
SYDENHAM CHOREA	0.00833333	0.2826579445173891
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00833333	0.2826579445173891
MYXOPAPILLARY EPENDYMOMA	0.00833333	0.2826579445173891
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00833333	0.2826579445173891
HUNTINGTON DISEASE-LIKE 1	0.00833333	0.2826579445173891
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.00833333	0.2826579445173891
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.00833333	0.2826579445173891
DEAFNESS, X-LINKED 5; DFNX5	0.00833333	0.2826579445173891
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2T; CMT2T	0.00833333	0.2826579445173891
SPINOCEREBELLAR ATAXIA 41; SCA41	0.00833333	0.2826579445173891
KURU, SUSCEPTIBILITY TO	0.00833333	0.2826579445173891
ATAXIA-PANCYTOPENIA SYNDROME	0.00833333	0.2826579445173891
PLAGUE	0.00833333	0.2826579445173891
SPINAL MUSCULAR ATROPHY, DISTAL, X-LINKED 3	0.00833333	0.2826579445173891
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00833333	0.2826579445173891
DISTAL HEREDITARY MOTOR NEUROPATHY TYPE 5	0.00833333	0.2826579445173891
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.00833333	0.2826579445173891
NOONAN SYNDROME 6; NS6	0.008299504000000001	0.2815106015427026
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00826886	0.28047118872072246
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.008267163000000001	0.2804136282338768
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.008267163000000001	0.2804136282338768
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.008267163000000001	0.2804136282338768
HEREDITARY HYPEREKPLEXIA	0.008263198999999999	0.2802791734490468
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.008259943	0.28016873329278896
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.008259943	0.28016873329278896
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.008259943	0.28016873329278896
LATERAL MENINGOCELE SYNDROME	0.008255423999999999	0.28001545348132406
CAREY-FINEMAN-ZITER SYNDROME	0.00818825	0.2777369807981337
DISTAL TRISOMY 17Q	0.008182773	0.27755120661636945
AMYLOIDOSIS	0.00816718	0.2770223081653469
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.00816718	0.2770223081653469
PYRUVATE DEHYDROGENASE DEFICIENCY	0.008131213	0.27580234468250664
MESOMELIA-SYNOSTOSES SYNDROME	0.00812773	0.2756842049207603
SPASTIC PARAPLEGIA-FACIAL-CUTANEOUS LESIONS SYNDROME	0.00812118	0.27546203568750194
MUCOLIPIDOSIS TYPE IV	0.00812118	0.27546203568750194
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.008112813	0.2751782356913686
19P13.13 MICRODELETION SYNDROME	0.008107573000000002	0.27500050030476203
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.008059213999999999	0.27336021298397706
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.008037443	0.27262176315538655
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.008022569	0.2721172524415721
FEMORAL-FACIAL SYNDROME	0.00802185	0.27209286470436406
MEIER-GORLIN SYNDROME 1; MGORS1	0.00802185	0.27209286470436406
POTOCKI-SHAFFER SYNDROME	0.007991609	0.2710671212260486
OROFACIODIGITAL SYNDROME TYPE 1	0.007991608999999998	0.27106712122604854
OROFACIODIGITAL SYNDROME I; OFD1	0.007991608999999998	0.27106712122604854
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.007983523000000001	0.270792852459617
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.007983523000000001	0.270792852459617
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.007983523000000001	0.270792852459617
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.007983523000000001	0.270792852459617
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.007983523000000001	0.270792852459617
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.007983523000000001	0.270792852459617
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.007983523000000001	0.270792852459617
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.007983523000000001	0.270792852459617
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.007983523000000001	0.270792852459617
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.007983523000000001	0.270792852459617
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.007983523000000001	0.270792852459617
SALLA DISEASE	0.007983523000000001	0.270792852459617
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.007970539	0.2703524485932618
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.007952964	0.26975632274982425
300270 ADRENOMYODYSTROPHY	0.007952964	0.26975632274982425
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.007952964	0.26975632274982425
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.007948829	0.26961606782165276
BOWEN-CONRADI SYNDROME	0.007948829	0.26961606782165276
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.007948829	0.26961606782165276
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.007948829	0.26961606782165276
ADRENOMYODYSTROPHY	0.007948829	0.26961606782165276
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.007948829	0.26961606782165276
COG8-CDG	0.007948829	0.26961606782165276
DPM1-CDG	0.007948829	0.26961606782165276
CROME SYNDROME	0.007948829	0.26961606782165276
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.007948829	0.26961606782165276
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.007948829	0.26961606782165276
ADENYLOSUCCINATE LYASE DEFICIENCY	0.007948829	0.26961606782165276
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.007948829	0.26961606782165276
HEREDITARY METHEMOGLOBINEMIA	0.007948829	0.26961606782165276
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.007948829	0.26961606782165276
4Q21 MICRODELETION SYNDROME	0.007948829	0.26961606782165276
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.007948829	0.26961606782165276
LISSENCEPHALY 5; LIS5	0.007948829	0.26961606782165276
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.007948829	0.26961606782165276
CRANIAL NERVES, CONGENITAL PARESIS OF	0.00793651	0.2691982200682925
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.00793651	0.2691982200682925
BARBER-SAY SYNDROME; BBRSAY	0.00793651	0.2691982200682925
BRANCHIOOTIC SYNDROME 2	0.00793651	0.2691982200682925
EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIALABNORMALITIES	0.00793651	0.2691982200682925
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.00793651	0.2691982200682925
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00793651	0.2691982200682925
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.00793651	0.2691982200682925
184705 STEINFELD SYNDROME	0.00793651	0.2691982200682925
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00793651	0.2691982200682925
PILI TORTI-ONYCHODYSPLASIA SYNDROME	0.00793651	0.2691982200682925
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00793651	0.2691982200682925
POLYVALVULAR HEART DISEASE SYNDROME	0.00793651	0.2691982200682925
228940 FIBULOULNAR APLASIA OR HYPOPLASIA WITH RENAL ABNORMALITIES	0.00793651	0.2691982200682925
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 3	0.00793651	0.2691982200682925
NEU-LAXOVA SYNDROME 2; NLS2	0.00793651	0.2691982200682925
VAN BOGAERT-HOZAY SYNDROME	0.00793651	0.2691982200682925
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00793651	0.2691982200682925
WOLFRAM-LIKE SYNDROME	0.00793651	0.2691982200682925
FIBROCHONDROGENESIS 1; FBCG1	0.00793651	0.2691982200682925
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00793651	0.2691982200682925
KENNERKNECHT SYNDROME	0.00793651	0.2691982200682925
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.00793651	0.2691982200682925
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.00793651	0.2691982200682925
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00793651	0.2691982200682925
RESTRICTIVE DERMOPATHY, LETHAL	0.00793651	0.2691982200682925
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.007926622999999999	0.2688628632424565
POTOCKI-SHAFFER SYNDROME	0.007926622999999999	0.2688628632424565
CK SYNDROME	0.007926622999999999	0.2688628632424565
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.007909749	0.2682905145948228
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00786946	0.26692395333699886
OMODYSPLASIA 1; OMOD1	0.00786946	0.26692395333699886
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00786946	0.26692395333699886
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00786946	0.26692395333699886
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.00785773	0.2665260838551484
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00785773	0.2665260838551484
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.00785773	0.2665260838551484
LEPRECHAUNISM	0.00785773	0.2665260838551484
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.00783091	0.265616377162631
DYSTONIA, DOPA-RESPONSIVE; DRD	0.00783091	0.265616377162631
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.007829344	0.26556326006045045
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.007824603999999999	0.26540248415729856
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.007824603999999999	0.26540248415729856
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.007815084	0.2650795755923185
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.007815084	0.2650795755923185
DUANE RETRACTION SYNDROME	0.007803492999999999	0.26468642084686844
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.007721779999999999	0.2619148003037783
OSTEOGENESIS IMPERFECTA	0.007721779999999999	0.2619148003037783
BRITTLE CORNEA SYNDROME 2; BCS2	0.007721779999999999	0.2619148003037783
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.007721779999999999	0.2619148003037783
SCARF SYNDROME	0.00770987	0.2615108254078841
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.0076720899999999995	0.2602293668380366
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.007669754	0.26015013213133564
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.007669754	0.26015013213133564
TOLUENE EMBRYOPATHY	0.0076413539999999995	0.2591868334711009
FIBULAR HEMIMELIA	0.00762881	0.25876135395018596
CHARLIE M SYNDROME	0.00759805	0.25771800652804444
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.007587804	0.25737047279308795
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.007587804	0.25737047279308795
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.007587804	0.25737047279308795
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.007587804	0.25737047279308795
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.007587804	0.25737047279308795
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.2572302178649164
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.2572302178649164
FRIED SYNDROME	0.007578064000000001	0.2570401020553877
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.007567259	0.2566736076179286
THAUVIN-ROBINET-FAIVRE SYNDROME	0.007566153999999999	0.25663612715949347
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.007566153999999999	0.25663612715949347
POTOCKI-LUPSKI SYNDROME	0.0075649229999999994	0.25659437291122766
HYPERTRICHOSIS CUBITI	0.007558934	0.2563912322184056
DISTAL TRISOMY 15Q	0.007554799	0.2562509772902341
ERYTHROKERATODERMIA VARIABILIS	0.00751366	0.25485558491053706
OSTEOGLOSPHONIC DYSPLASIA	0.00751366	0.25485558491053706
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.00751366	0.25485558491053706
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.007496024	0.25425739001011805
SPINOCEREBELLAR ATAXIA 44; SCA44	0.007481150000000001	0.25375287929630364
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.007481150000000001	0.25375287929630364
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.007481150000000001	0.25375287929630364
SPINOCEREBELLAR ATAXIA 13	0.007481150000000001	0.25375287929630364
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.007481150000000001	0.25375287929630364
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.007481150000000001	0.25375287929630364
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.007481150000000001	0.25375287929630364
MULTIPLE METAPHYSEAL DYSPLASIA	0.0074621	0.2531067229766743
OROFACIODIGITAL SYNDROME XVI; OFD16	0.007442104000000001	0.2524284793143485
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.007442104000000001	0.2524284793143485
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.007442104000000001	0.2524284793143485
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.007442104000000001	0.2524284793143485
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.007442104000000001	0.2524284793143485
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.007442104000000001	0.2524284793143485
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.007437969000000001	0.252288224386177
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE SYNDROME	0.00742912	0.2519880754479933
FACIOCARDIORENAL SYNDROME	0.00742912	0.2519880754479933
TETRASOMY 18P	0.007426069	0.2518845886799519
2Q37 MICRODELETION SYNDROME	0.007409652999999999	0.25132777491916264
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00740741	0.25125169467638425
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.00740741	0.25125169467638425
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.00740741	0.25125169467638425
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00740741	0.25125169467638425
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00740741	0.25125169467638425
KID SYNDROME	0.00740741	0.25125169467638425
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.007406244	0.25121214516096757
1Q21.1 MICRODELETION SYNDROME	0.007385633	0.2505130413339923
TETRASOMY 5P	0.007385633	0.2505130413339923
FRONTOOCULAR SYNDROME	0.007385203999999999	0.25049849009718805
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.007385203999999999	0.25049849009718805
HADZISELIMOVIC SYNDROME	0.007385203999999999	0.25049849009718805
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.007325112999999999	0.24846026545661884
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.007305084	0.24778090246838502
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00728379	0.24705863198701042
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00728379	0.24705863198701042
INTERMEDIATE NEMALINE MYOPATHY	0.0072790500000000005	0.2468978560838586
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.0072790500000000005	0.2468978560838586
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.0072790500000000005	0.2468978560838586
NEUTRAL LIPID STORAGE MYOPATHY	0.0072790500000000005	0.2468978560838586
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 4	0.0072790500000000005	0.2468978560838586
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.0072790500000000005	0.2468978560838586
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.0072790500000000005	0.2468978560838586
ALAGILLE SYNDROME	0.00726953	0.24657494751887848
CENANI-LENZ SYNDROME	0.00726953	0.24657494751887848
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00726953	0.24657494751887848
CINCA SYNDROME	0.007267633999999999	0.24651063715761773
ABRUZZO-ERICKSON SYNDROME	0.0072647300000000005	0.2464121364777121
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.0072647300000000005	0.2464121364777121
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.007263499	0.24637038222944624
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.00725751	0.2461672415366242
RING CHROMOSOME 13 SYNDROME	0.0071801899999999995	0.24354462701516827
RING CHROMOSOME 6 SYNDROME	0.0071801899999999995	0.24354462701516827
STROMME SYNDROME; STROMS	0.00717297	0.24329973207408043
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.00717297	0.24329973207408043
WAARDENBURG-SHAH SYNDROME	0.00717297	0.24329973207408043
WAARDENBURG SYNDROME	0.00717297	0.24329973207408043
ADULT SYNDROME	0.00717297	0.24329973207408043
DONNAI-BARROW SYNDROME	0.007165523	0.24304713752750406
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.0071242	0.24164550405789564
PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA	0.0071242	0.24164550405789564
TREACHER COLLINS SYNDROME 3; TCS3	0.0071242	0.24164550405789564
TREACHER COLLINS SYNDROME 2; TCS2	0.0071242	0.24164550405789564
DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14	0.0071242	0.24164550405789564
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.0071242	0.24164550405789564
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.007095799999999999	0.24068220539766091
PTERYGIUM COLLI, ISOLATED	0.007095799999999999	0.24068220539766091
OROFACIAL CLEFT 15	0.007095799999999999	0.24068220539766091
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.23886584471964792
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.23886584471964792
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.23886584471964792
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.23886584471964792
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.23886584471964792
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.23886584471964792
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.23886584471964792
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.23886584471964792
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.23886584471964792
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.23886584471964792
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.23886584471964792
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.23886584471964792
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.23886584471964792
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.23886584471964792
17P11.2 MICRODUPLICATION SYNDROME	0.007023504	0.23822999976595918
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.007019368999999999	0.23808974483778764
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.007013809	0.2379011553817699
%106995 ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES;;COOKS SYNDROME	0.00701338	0.2378866041449656
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00701338	0.2378866041449656
BARDET-BIEDL SYNDROME	0.00701338	0.2378866041449656
SECKEL SYNDROME 5; SCKL5	0.00701338	0.2378866041449656
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00701338	0.2378866041449656
ACHONDROGENESIS TYPE 1B	0.006976199999999999	0.23662549695526394
ISOLATED CLEFT LIP	0.006976199999999999	0.23662549695526394
LOEYS-DIETZ SYNDROME 3; LDS3	0.006976199999999999	0.23662549695526394
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00697529	0.23659463069537617
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00695047	0.23575276193667807
MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	0.00689655	0.23392385124090853
SPASTIC PARAPLEGIA 57, AUTOSOMAL RECESSIVE; SPG57	0.00689655	0.23392385124090853
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00689655	0.23392385124090853
AUTOSOMAL DOMINANT LIMB-GIRDLE MUSCULAR DYSTROPHY TYPE 1A	0.00689655	0.23392385124090853
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 57	0.00689655	0.23392385124090853
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.00689655	0.23392385124090853
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.006888193000000001	0.2336403904344444
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.006884650000000001	0.2335202155346834
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.006876283	0.23323641553855012
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.006868233999999999	0.23296340177389416
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.006868233999999999	0.23296340177389416
ADAMS-OLIVER SYNDROME 5; AOS5	0.0068640989999999985	0.2328231468457226
LOEYS-DIETZ SYNDROME 5	0.006860689999999999	0.23270751708752757
MILLER-DIEKER SYNDROME	0.006845638999999999	0.23219700271657007
CEREBROOCULONASAL SYNDROME	0.006839649999999999	0.23199386202374805
BALLER-GEROLD SYNDROME	0.006839649999999999	0.23199386202374805
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.006783694	0.23009589231135036
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.006779558999999999	0.22995563738317884
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00673116	0.22831399330371757
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.00673116	0.22831399330371757
JOUBERT SYNDROME 24	0.006696534	0.22713951515550324
EHLERS-DANLOS SYNDROME, TYPE VI	0.006686959999999999	0.22681477496630997
COSTELLO SYNDROME; CSTLO	0.006684623999999999	0.22673554025960901
DISTAL MONOSOMY 6P	0.006684623999999999	0.22673554025960901
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.006668184000000001	0.226177912443614
15Q OVERGROWTH SYNDROME	0.006664049	0.2260376575154425
KABUKI SYNDROME 1	0.006635843000000001	0.22508093913478827
MICRO SYNDROME	0.006635843000000001	0.22508093913478827
2Q31.1 MICRODELETION SYNDROME	0.006572522999999999	0.22293319015006774
WALKER-WARBURG SYNDROME	0.0065514530000000005	0.22221851751728092
ADAMS-OLIVER SYNDROME 2; AOS2	0.0065514530000000005	0.22221851751728092
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.006487983	0.22006568068752394
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.006476253	0.21966781120567347
FANCONI ANEMIA	0.006450373999999999	0.21879002226101799
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.006450373999999999	0.21879002226101799
ICF SYNDROME	0.006450373999999999	0.21879002226101799
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.006450373999999999	0.21879002226101799
DISTAL MONOSOMY 3P	0.0064462389999999994	0.2186497673328465
KAGAMI-OGATA SYNDROME	0.006406123	0.21728907405629805
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.006406123	0.21728907405629805
WILSON-TURNER SYNDROME	0.006406123	0.21728907405629805
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.006406123	0.21728907405629805
PALLISTER-HALL SYNDROME	0.006406123	0.21728907405629805
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.006366759999999999	0.21595392176183256
BASAL CELL NEVUS SYNDROME	0.006366759999999999	0.21595392176183256
ELSAHY-WATERS SYNDROME; ESWS	0.006364424	0.2158746870551316
3C SYNDROME	0.006364424	0.2158746870551316
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.006342639000000001	0.21513576236100437
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.0062953029999999995	0.213530174143368
MEND SYNDROME; MEND	0.0062953029999999995	0.213530174143368
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.0062953029999999995	0.213530174143368
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.0062953029999999995	0.213530174143368
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.0062953029999999995	0.213530174143368
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.0062953029999999995	0.213530174143368
MEND SYNDROME	0.0062953029999999995	0.213530174143368
DISTAL 16P11.2 MICRODELETION SYNDROME	0.0062953029999999995	0.213530174143368
15Q14 MICRODELETION SYNDROME	0.0062953029999999995	0.213530174143368
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.00623814	0.21159126423791036
FRASER SYNDROME	0.00623814	0.21159126423791036
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00623814	0.21159126423791036
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.006215183	0.21081258651456503
PETTIGREW SYNDROME	0.006215183	0.21081258651456503
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.006215183	0.21081258651456503
XQ21 MICRODELETION SYNDROME	0.006215183	0.21081258651456503
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.006215183	0.21081258651456503
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.006178964	0.20958407545206356
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.006166573	0.20916378553308576
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00615098	0.20863488708206326
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.00615098	0.20863488708206326
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00615098	0.20863488708206326
MIRAGE SYNDROME; MIRAGE	0.006142613	0.20835108708593003
CHROMOSOME 18P DELETION SYNDROME	0.006094424	0.20671656598951976
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.0060902890000000005	0.20657631106134827
ARTERIAL TORTUOSITY SYNDROME	0.006078549999999999	0.20617813630879558
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.006013083	0.20395756330212003
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.006013083	0.20395756330212003
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.006013083	0.20395756330212003
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.006013083	0.20395756330212003
AICARDI-GOUTIÈRES SYNDROME	0.006013083	0.20395756330212003
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.006010034	0.2038541443720124
CHAR SYNDROME	0.006010034	0.2038541443720124
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.006010034	0.2038541443720124
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.006010034	0.2038541443720124
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.006010034	0.2038541443720124
BRESEK SYNDROME	0.006010034	0.2038541443720124
HARROD SYNDROME	0.006005899	0.20371388944384092
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.006005899	0.20371388944384092
16Q24.3 MICRODELETION SYNDROME	0.006005899	0.20371388944384092
FRAGILE X SYNDROME	0.006005899	0.20371388944384092
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.0059489	0.20178054224895642
OPITZ G/BBB SYNDROME	0.0059465640000000005	0.20170130754225546
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.0059465640000000005	0.20170130754225546
JOUBERT SYNDROME 10	0.0059465640000000005	0.20170130754225546
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00593717	0.201382672767106
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00593717	0.201382672767106
PROTEUS SYNDROME	0.005930699	0.20116318313223347
PROGEROID SYNDROME, PETTY TYPE	0.00590482	0.20028539418757801
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00590482	0.20028539418757801
RING CHROMOSOME 12 SYNDROME	0.005864704	0.1989247009110296
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.005864704	0.1989247009110296
MEIER-GORLIN SYNDROME 7	0.005864704	0.1989247009110296
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.005864704	0.1989247009110296
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.005864704	0.1989247009110296
EVEN-PLUS SYNDROME	0.005864704	0.1989247009110296
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.0058605689999999995	0.19878444598285805
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.0058605689999999995	0.19878444598285805
3-HYDROXYISOBUTYRIC ACIDURIA	0.0058605689999999995	0.19878444598285805
ADAMS-OLIVER SYNDROME 1; AOS1	0.005838853	0.1980478616974476
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.005818869999999999	0.19737005898169158
CRANIOFRONTONASAL DYSPLASIA	0.005818869999999999	0.19737005898169158
GENITOPALATOCARDIAC SYNDROME	0.005818869999999999	0.19737005898169158
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.00580122	0.19677138921573586
BEHR SYNDROME	0.00580122	0.19677138921573586
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00580122	0.19677138921573586
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2K	0.00580122	0.19677138921573586
DYSTONIA 16; DYT16	0.00580122	0.19677138921573586
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00580122	0.19677138921573586
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00580122	0.19677138921573586
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.00580122	0.19677138921573586
MAST SYNDROME	0.00580122	0.19677138921573586
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.0057611039999999995	0.1954106959391874
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.0057611039999999995	0.1954106959391874
ISOLATED GLYCEROL KINASE DEFICIENCY	0.005759873	0.19536894169092162
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.005759873	0.19536894169092162
CENTRAL BILATERAL MACROGYRIA	0.005759873	0.19536894169092162
SEVERE CANAVAN DISEASE	0.005759873	0.19536894169092162
CANAVAN DISEASE	0.005759873	0.19536894169092162
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.005759873	0.19536894169092162
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.005759873	0.19536894169092162
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.005759873	0.19536894169092162
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.005759873	0.19536894169092162
SCHIZENCEPHALY	0.005759873	0.19536894169092162
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.005759873	0.19536894169092162
VICI SYNDROME	0.0057598729999999996	0.19536894169092156
HARTNUP DISEASE	0.0057598729999999996	0.19536894169092156
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.0057598729999999996	0.19536894169092156
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.0057598729999999996	0.19536894169092156
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.0057598729999999996	0.19536894169092156
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.0057598729999999996	0.19536894169092156
TAY-SACHS DISEASE	0.0057598729999999996	0.19536894169092156
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.0057598729999999996	0.19536894169092156
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.0057598729999999996	0.19536894169092156
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.005756969	0.1952704410110159
12Q14 MICRODELETION SYNDROME	0.005753884	0.19516580099809958
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.005753884	0.19516580099809958
ALAZAMI-YUAN SYNDROME	0.005753884	0.19516580099809958
DISTAL TRISOMY 18Q	0.005753884	0.19516580099809958
OCULOFACIOCARDIODENTAL SYNDROME	0.005753884	0.19516580099809958
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.005753884	0.19516580099809958
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.005749749	0.19502554606992809
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.005673764	0.19244821336929652
MARINESCO-SJOGREN SYNDROME; MSS	0.005673764	0.19244821336929652
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.005673764	0.19244821336929652
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.005673764	0.19244821336929652
SPINOCEREBELLAR ATAXIA 5; SCA5	0.005673764	0.19244821336929652
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.005673764	0.19244821336929652
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.005669629000000001	0.19230795844112503
HUNTINGTON DISEASE; HD	0.005669629000000001	0.19230795844112503
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.005669629000000001	0.19230795844112503
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.005669629000000001	0.19230795844112503
INHERITED CREUTZFELDT-JAKOB DISEASE	0.005669629000000001	0.19230795844112503
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.005669629000000001	0.19230795844112503
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.005669629000000001	0.19230795844112503
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.005669629000000001	0.19230795844112503
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.005669629000000001	0.19230795844112503
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00564514	0.19147731686047403
FRONTONASAL DYSPLASIA 1; FND1	0.00564514	0.19147731686047403
GORLIN SYNDROME	0.00564514	0.19147731686047403
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00564514	0.19147731686047403
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00564514	0.19147731686047403
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.005601194	0.18998671394066152
SAUL-WILSON SYNDROME; SWILS	0.005601194	0.18998671394066152
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.005597059	0.18984645901249
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.00554887	0.18821193791607976
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00554887	0.18821193791607976
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.00554887	0.18821193791607976
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00554887	0.18821193791607976
SHORT SYNDROME	0.00554887	0.18821193791607976
LERI PLEONOSTEOSIS	0.00549746	0.18646816382725345
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00549746	0.18646816382725345
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00549746	0.18646816382725345
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.00548555	0.18606418893135923
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.005471664	0.18559319015685152
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.005471664	0.18559319015685152
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.005471664	0.18559319015685152
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.005471664	0.18559319015685152
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.005471664	0.18559319015685152
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.0054675290000000005	0.18545293522868003
SECONDARY SYRINGOMYELIA	0.0054675290000000005	0.18545293522868003
LIMB-MAMMARY SYNDROME	0.00546448	0.18534951629857244
SCHIZOPHRENIA 1; SCZD1	0.00546448	0.18534951629857244
WEAVER-WILLIAMS SYNDROME	0.00546448	0.18534951629857244
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00546448	0.18534951629857244
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00546448	0.18534951629857244
TRISOMY 5P	0.00546448	0.18534951629857244
CRANIOECTODERMAL DYSPLASIA 4	0.00546448	0.18534951629857244
THREE M SYNDROME 2; 3M2	0.00546448	0.18534951629857244
WOODHOUSE-SAKATI SYNDROME	0.00546448	0.18534951629857244
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00546448	0.18534951629857244
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00546448	0.18534951629857244
3M SYNDROME	0.00546448	0.18534951629857244
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.00546448	0.18534951629857244
HIDROTIC ECTODERMAL DYSPLASIA, HALAL TYPE	0.00546448	0.18534951629857244
WOOLLY HAIR, HYPOTRICHOSIS, EVERTED LOWER LIP, AND OUTSTANDING EARS	0.00546448	0.18534951629857244
RODRIGUES BLINDNESS	0.00546448	0.18534951629857244
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.00546448	0.18534951629857244
BLOOM SYNDROME	0.00546448	0.18534951629857244
BLOOM SYNDROME	0.00546448	0.18534951629857244
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.005420993	0.18387448218457142
49,XXXXY SYNDROME	0.005420993	0.18387448218457142
48,XXXY SYNDROME	0.005420993	0.18387448218457142
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.005420993	0.18387448218457142
8P11.2 DELETION SYNDROME	0.005420993	0.18387448218457142
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.00541292	0.18360065436470965
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00540101	0.18319667946881546
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.00540101	0.18319667946881546
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.00538928	0.18279880998696496
DISTAL MONOSOMY 19P13.3	0.005360472999999999	0.181821706307198
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.005360472999999999	0.181821706307198
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.005360472999999999	0.181821706307198
IMMUNODEFICIENCY 49; IMD49	0.005360472999999999	0.181821706307198
SIALIDOSIS TYPE 2	0.005360472999999999	0.181821706307198
DIGEORGE SYNDROME; DGS	0.005360472999999999	0.181821706307198
HEMIFACIAL MICROSOMIA	0.00531915	0.18042007283758957
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00531915	0.18042007283758957
VERLOOVE VANHORICK-BRUBAKK SYNDROME	0.00531915	0.18042007283758957
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00531915	0.18042007283758957
MICROTIA - EYE COLOBOMA - IMPERFORATION OF THE NASOLACRIMAL DUCT	0.00531915	0.18042007283758957
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00531915	0.18042007283758957
COXOAURICULAR SYNDROME	0.00531915	0.18042007283758957
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.00531915	0.18042007283758957
HAND-FOOT-GENITAL SYNDROME	0.00531915	0.18042007283758957
243440 ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME;;MICROTIA-AORTIC ARCH SYNDROME	0.00531915	0.18042007283758957
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.00531915	0.18042007283758957
CHANARIN-DORFMAN SYNDROME	0.00531915	0.18042007283758957
HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS	0.00531915	0.18042007283758957
DIABETIC EMBRYOPATHY	0.00531915	0.18042007283758957
MEIER-GORLIN SYNDROME 8; MGORS8	0.00531915	0.18042007283758957
MEIER-GORLIN SYNDROME 2; MGORS2	0.00531915	0.18042007283758957
ISOLATED ARRHINIA	0.00531915	0.18042007283758957
DISTAL MONOSOMY 17Q	0.00531915	0.18042007283758957
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00531915	0.18042007283758957
OCULOAURICULOFRONTONASAL SYNDROME	0.00531915	0.18042007283758957
GOLDENHAR SYNDROME	0.00531915	0.18042007283758957
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.00531915	0.18042007283758957
HEMIHYPERPLASIA-MULTIPLE LIPOMATOSIS SYNDROME	0.00531915	0.18042007283758957
TETRAAMELIA-MULTIPLE MALFORMATIONS SYNDROME	0.00531915	0.18042007283758957
MICROTIA-ANOTIA	0.00531915	0.18042007283758957
PARIETAL FORAMINA WITH CLEIDOCRANIAL DYSPLASIA	0.00531915	0.18042007283758957
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.00531915	0.18042007283758957
MICROTIA-EYE COLOBOMA-IMPERFORATION OF THE NASOLACRIMAL DUCT SYNDROME	0.00531915	0.18042007283758957
COXOAURICULAR SYNDROME	0.00531915	0.18042007283758957
OTOMANDIBULAR SYNDROME	0.00531915	0.18042007283758957
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.00531915	0.18042007283758957
MICROPHTHALMIA-MICROTIA-FETAL AKINESIA SYNDROME	0.00531915	0.18042007283758957
MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS	0.00531915	0.18042007283758957
ISOTRETINOIN SYNDROME	0.00531915	0.18042007283758957
DIAMOND-BLACKFAN ANEMIA 10	0.00531915	0.18042007283758957
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.005244963	0.17790372643946162
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.005218454	0.1770045685456531
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.005215549999999999	0.1769060678657474
ACHALASIA-MICROCEPHALY SYNDROME	0.005215549999999999	0.1769060678657474
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.005214319	0.17686431361748162
BANGSTAD SYNDROME	0.005214319	0.17686431361748162
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.005214319	0.17686431361748162
ANGELMAN SYNDROME (TYPE 2)	0.005214319	0.17686431361748162
MENTAL RETARDATION, X-LINKED 82	0.005214319	0.17686431361748162
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.005214319	0.17686431361748162
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.005214319	0.17686431361748162
AUTISM	0.005214319	0.17686431361748162
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.005214319	0.17686431361748162
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.005214319	0.17686431361748162
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.005214319	0.17686431361748162
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.005214319	0.17686431361748162
EPILEPSY, READING	0.005214319	0.17686431361748162
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.005214319	0.17686431361748162
XERODERMA PIGMENTOSUM	0.005214319	0.17686431361748162
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.005214319	0.17686431361748162
SYMMETRICAL THALAMIC CALCIFICATIONS	0.005214319	0.17686431361748162
CEREBROTENDINOUS XANTHOMATOSIS	0.005214319	0.17686431361748162
EPILEPSY, BENIGN OCCIPITAL	0.005214319	0.17686431361748162
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.005214319	0.17686431361748162
NODULAR NEURONAL HETEROTOPIA	0.005214319	0.17686431361748162
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.005214319	0.17686431361748162
PHAKOMATOSIS PIGMENTOVASCULARIS	0.005214319	0.17686431361748162
LINEAR NEVUS SEBACEUS SYNDROME	0.005214319	0.17686431361748162
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.005214319	0.17686431361748162
KRABBE DISEASE	0.005214319	0.17686431361748162
PRIMARY CUTIS VERTICIS GYRATA	0.005214319	0.17686431361748162
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.005214319	0.17686431361748162
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.005214319	0.17686431361748162
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.005214319	0.17686431361748162
ANGELMAN SYNDROME (TYPE 1)	0.005214319	0.17686431361748162
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.005214319	0.17686431361748162
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.005214319	0.17686431361748162
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00520833	0.17666117292465955
FRYNS-SMEETS-THIRY SYNDROME	0.00520833	0.17666117292465955
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00520833	0.17666117292465955
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00520833	0.17666117292465955
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00520833	0.17666117292465955
RUIJS-AALFS SYNDROME; RJALS	0.00520833	0.17666117292465955
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00520833	0.17666117292465955
MULTIPLE SYSTEM ATROPHY	0.00512821	0.17394358529585652
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.00512821	0.17394358529585652
SPINOCEREBELLAR ATAXIA TYPE 14	0.00512821	0.17394358529585652
CREUTZFELDT-JAKOB DISEASE; CJD	0.00512821	0.17394358529585652
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00512821	0.17394358529585652
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.00512821	0.17394358529585652
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00512821	0.17394358529585652
SPINOCEREBELLAR ATAXIA TYPE 23	0.00512821	0.17394358529585652
SPINOCEREBELLAR ATAXIA TYPE 25	0.00512821	0.17394358529585652
SPINOCEREBELLAR ATAXIA 31	0.00512821	0.17394358529585652
SPINOCEREBELLAR ATAXIA TYPE 28	0.00512821	0.17394358529585652
SPINOCEREBELLAR ATAXIA TYPE 20	0.00512821	0.17394358529585652
SPINOCEREBELLAR ATAXIA TYPE 15/16	0.00512821	0.17394358529585652
SPINOCEREBELLAR ATAXIA TYPE 18	0.00512821	0.17394358529585652
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.00512821	0.17394358529585652
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.00512821	0.17394358529585652
SPINOCEREBELLAR ATAXIA TYPE 2	0.00512821	0.17394358529585652
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.00512821	0.17394358529585652
SPINOCEREBELLAR ATAXIA 34; SCA34	0.00512821	0.17394358529585652
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.00512821	0.17394358529585652
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00512821	0.17394358529585652
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00512821	0.17394358529585652
DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	0.00512821	0.17394358529585652
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.00512821	0.17394358529585652
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.00512821	0.17394358529585652
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.00512821	0.17394358529585652
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00512821	0.17394358529585652
IMMUNODEFICIENCY BY DEFECTIVE EXPRESSION OF MHC CLASS II	0.00512821	0.17394358529585652
SPINOCEREBELLAR ATAXIA 26	0.00512821	0.17394358529585652
SPINOCEREBELLAR ATAXIA TYPE 31	0.00512821	0.17394358529585652
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00512821	0.17394358529585652
SPINOCEREBELLAR ATAXIA 20	0.00512821	0.17394358529585652
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00512821	0.17394358529585652
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.00512821	0.17394358529585652
SPINOCEREBELLAR ATAXIA 48; SCA48	0.00512821	0.17394358529585652
SUSAC SYNDROME	0.00512821	0.17394358529585652
CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS	0.00512821	0.17394358529585652
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.00512821	0.17394358529585652
SPINOCEREBELLAR ATAXIA 38; SCA38	0.00512821	0.17394358529585652
SPINOCEREBELLAR ATAXIA 14	0.00512821	0.17394358529585652
LARYNGEAL ABDUCTOR PARALYSIS WITH CEREBELLAR ATAXIA AND MOTOR NEUROPATHY	0.00512821	0.17394358529585652
SPINOCEREBELLAR ATAXIA 15	0.00512821	0.17394358529585652
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 39	0.00512821	0.17394358529585652
ARNOLD-CHIARI MALFORMATION TYPE I	0.00512821	0.17394358529585652
SPINOCEREBELLAR ATAXIA TYPE 41	0.00512821	0.17394358529585652
SPINOCEREBELLAR ATAXIA TYPE 30	0.00512821	0.17394358529585652
BOUCHER-NEUHAUSER SYNDROME	0.00512821	0.17394358529585652
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.00512821	0.17394358529585652
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.00512821	0.17394358529585652
SPINOCEREBELLAR ATAXIA 46; SCA46	0.00512821	0.17394358529585652
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00512821	0.17394358529585652
SPINOCEREBELLAR ATAXIA 45; SCA45	0.00512821	0.17394358529585652
SPINOCEREBELLAR ATAXIA 23; SCA23	0.00512821	0.17394358529585652
MYOTONIA PERMANENS	0.0050796	0.1722947843143773
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B1; CMT4B1	0.00505564	0.17148208586722152
CENTRAL CORE DISEASE	0.00505564	0.17148208586722152
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.00505564	0.17148208586722152
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.004943539	0.16767973575768022
MUENKE SYNDROME	0.004941203	0.16760050105097923
RUVALCABA SYNDROME	0.004941203	0.16760050105097923
POSTERIOR MENINGOCELE	0.00492611	0.16708856208341152
WILSON DISEASE	0.00492611	0.16708856208341152
IMMUNODEFICIENCY 9; IMD9	0.00492611	0.16708856208341152
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.00492611	0.16708856208341152
SPINAL MUSCULAR ATROPHY, JOKELA TYPE; SMAJ	0.00492611	0.16708856208341152
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.00492611	0.16708856208341152
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Q; CMT2Q	0.00492611	0.16708856208341152
CONGENITAL PATELLA DISLOCATION	0.00492611	0.16708856208341152
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A	0.00492611	0.16708856208341152
MT-ATP6-RELATED MITOCHONDRIAL SPASTIC PARAPLEGIA	0.00492611	0.16708856208341152
MYOPATHY, MYOFIBRILLAR, 9, WITH EARLY RESPIRATORY FAILURE; MFM9	0.00492611	0.16708856208341152
SPINOCEREBELLAR ATAXIA TYPE 36	0.00492611	0.16708856208341152
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.00492611	0.16708856208341152
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IIB; HMN2B	0.00492611	0.16708856208341152
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2G	0.00492611	0.16708856208341152
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.00492611	0.16708856208341152
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.00492611	0.16708856208341152
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2F	0.00492611	0.16708856208341152
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.00492611	0.16708856208341152
COASY PROTEIN-ASSOCIATED NEURODEGENERATION	0.00492611	0.16708856208341152
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.00492611	0.16708856208341152
POLYGLUCOSAN BODY MYOPATHY 2; PGBM2	0.00492611	0.16708856208341152
HEREDITARY MOTOR AND SENSORY NEUROPATHY V	0.00492611	0.16708856208341152
MYASTHENIC SYNDROME, CONGENITAL, 17; CMS17	0.00492611	0.16708856208341152
MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	0.00492611	0.16708856208341152
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00492611	0.16708856208341152
ALPHA-B CRYSTALLIN-RELATED LATE-ONSET MYOPATHY	0.00492611	0.16708856208341152
PRIMARY DYSTONIA, DYT2 TYPE	0.00492611	0.16708856208341152
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.00492611	0.16708856208341152
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00492611	0.16708856208341152
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.00492611	0.16708856208341152
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 74	0.00492611	0.16708856208341152
BIRK-LANDAU-PEREZ SYNDROME; BILAPES	0.00492611	0.16708856208341152
ADULT-ONSET NEMALINE MYOPATHY	0.00492611	0.16708856208341152
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 32	0.00492611	0.16708856208341152
NEURONOPATHY, DISTAL HEREDITARY MOTOR, TYPE IX; HMN9	0.00492611	0.16708856208341152
DIAPHANOSPONDYLODYSOSTOSIS	0.004879573999999999	0.16551010903930294
ROTHMUND-THOMSON SYNDROME	0.004879573999999999	0.16551010903930294
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.004879573999999999	0.16551010903930294
MARDEN-WALKER SYNDROME	0.004875439	0.16536985411113145
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.004875439	0.16536985411113145
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.004863134	0.16495248122330794
SPINOCEREBELLAR ATAXIA 47; SCA47	0.004858999	0.16481222629513645
COG5-CDG	0.004858999	0.16481222629513645
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.004856663000000001	0.16473299158843546
HELSMOORTEL-VAN DER AA SYNDROME	0.004856663000000001	0.16473299158843546
ZTTK SYNDROME; ZTTKS	0.004856663000000001	0.16473299158843546
3Q29 MICRODUPLICATION SYNDROME	0.004856663000000001	0.16473299158843546
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.004819054	0.1634573331619295
PERMANENT CONGENITAL HYPOTHYROIDISM	0.004819054	0.1634573331619295
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.004819054	0.1634573331619295
PRIMARY CONGENITAL HYPOTHYROIDISM	0.004819054	0.1634573331619295
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.004819054	0.1634573331619295
CONGENITAL HYPOTHYROIDISM	0.004819054	0.1634573331619295
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.004819054	0.1634573331619295
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.004819054	0.1634573331619295
FAMILIAL THYROID DYSHORMONOGENESIS	0.004819054	0.1634573331619295
THYROID ECTOPIA	0.004819054	0.1634573331619295
PERIPHERAL HYPOTHYROIDISM	0.004819054	0.1634573331619295
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.004819054	0.1634573331619295
THYROID HEMIAGENESIS	0.004819054	0.1634573331619295
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.004814918999999999	0.163317078233758
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.004814918999999999	0.163317078233758
MUCOPOLYSACCHARIDOSIS TYPE 3	0.004814918999999999	0.163317078233758
MUCOPOLYSACCHARIDOSIS, TYPE II	0.004814918999999999	0.163317078233758
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.004814918999999999	0.163317078233758
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.00475188	0.1611788604787391
LETHAL KNIEST-LIKE DYSPLASIA	0.00475188	0.1611788604787391
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.00475188	0.1611788604787391
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00475188	0.1611788604787391
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00475188	0.1611788604787391
ATELOSTEOGENESIS, TYPE I; AO1	0.00475188	0.1611788604787391
EPIPHYSEAL DYSPLASIA, MULTIPLE, 4	0.00475188	0.1611788604787391
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00475188	0.1611788604787391
MULTIPLE SYNOSTOSES SYNDROME 2	0.00475188	0.1611788604787391
ACROMESOMELIC DYSPLASIA, DEMIRHAN TYPE; AMDD	0.00475188	0.1611788604787391
ATELOSTEOGENESIS TYPE I	0.00475188	0.1611788604787391
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00475188	0.1611788604787391
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.004699409	0.15939909836602165
CONGENITAL HYDROCEPHALUS	0.004699409	0.15939909836602165
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.004699409	0.15939909836602165
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.004699409	0.15939909836602165
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.004682933	0.15884024946721786
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.004682933	0.15884024946721786
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.004682933	0.15884024946721786
C SYNDROME	0.004682933	0.15884024946721786
OCULOECTODERMAL SYNDROME; OES	0.004682933	0.15884024946721786
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.004682933	0.15884024946721786
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.004682933	0.15884024946721786
COFFIN-SIRIS SYNDROME	0.004682933	0.15884024946721786
SIALURIA	0.004682933	0.15884024946721786
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.0046729	0.1584999404722131
ELECTROENCEPHALOGRAPHIC PECULIARITY: 14 AND 6 PER SEC. POSITIVE SPIKEPHENOMENON	0.0046729	0.1584999404722131
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.0046729	0.1584999404722131
ARGININOSUCCINIC ACIDURIA	0.0046729	0.1584999404722131
BONNEMANN-MEINECKE-REICH SYNDROME	0.0046729	0.1584999404722131
ELECTROENCEPHALOGRAPHIC PATTERNS	0.0046729	0.1584999404722131
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.0046729	0.1584999404722131
ELECTROENCEPHALOGRAPHIC PECULIARITY: FRONTO-PRECENTRAL BETA WAVE GROUPS	0.0046729	0.1584999404722131
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.0046729	0.1584999404722131
ELECTROENCEPHALOGRAPHIC PECULIARITY: OCCIPITAL SLOW BETA WAVES	0.0046729	0.1584999404722131
SACCHAROPINURIA	0.0046729	0.1584999404722131
ISAAC SYNDROME	0.0046729	0.1584999404722131
DEAFNESS-VITILIGO-ACHALASIA SYNDROME	0.0046729	0.1584999404722131
SCHIZOPHRENIA	0.0046729	0.1584999404722131
KBG SYNDROME	0.0046712030000000005	0.15844237998536742
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.0046712030000000005	0.15844237998536742
11P15.4 MICRODUPLICATION SYNDROME	0.0046712030000000005	0.15844237998536742
SSR4-CDG	0.0046712030000000005	0.15844237998536742
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0046712030000000005	0.15844237998536742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.0046712030000000005	0.15844237998536742
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.0046712030000000005	0.15844237998536742
EMANUEL SYNDROME	0.0046712030000000005	0.15844237998536742
EMANUEL SYNDROME	0.0046712030000000005	0.15844237998536742
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.0046712030000000005	0.15844237998536742
HOLOPROSENCEPHALY 7	0.0046712030000000005	0.15844237998536742
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.0046712030000000005	0.15844237998536742
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.0046712030000000005	0.15844237998536742
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.0046712030000000005	0.15844237998536742
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.004671203	0.15844237998536737
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.004671203	0.15844237998536737
MENTAL RETARDATION, X-LINKED 101; MRX101	0.004671203	0.15844237998536737
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.004671203	0.15844237998536737
MACDERMOT-WINTER SYNDROME	0.004671203	0.15844237998536737
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.004671203	0.15844237998536737
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00466734	0.1583113510161953
FLOATING-HARBOR SYNDROME	0.004559374	0.1546492558348255
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.004555238999999999	0.15450900090665398
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.004535253	0.15383109643399728
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.004535253	0.15383109643399728
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.004535253	0.15383109643399728
L1 SYNDROME	0.004535253	0.15383109643399728
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.004535253	0.15383109643399728
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.004535253	0.15383109643399728
16P13.2 MICRODELETION SYNDROME	0.004535253	0.15383109643399728
FOIX-CHAVANY-MARIE SYNDROME	0.004535253	0.15383109643399728
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.004535253	0.15383109643399728
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.004535253	0.15383109643399728
NIEMANN-PICK DISEASE TYPE C	0.004535253	0.15383109643399728
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.004535253	0.15383109643399728
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.004529814	0.15364661117297557
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.004523343	0.15342712153810306
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.004523343	0.15342712153810306
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.004523343	0.15342712153810306
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.004523343	0.15342712153810306
15Q11Q13 MICRODUPLICATION SYNDROME	0.004523342999999999	0.15342712153810303
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.004523342999999999	0.15342712153810303
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00450775	0.15289822308708054
LARON SYNDROME	0.00440212	0.1493153626124117
ODONTOCHONDRODYSPLASIA; ODCD	0.00440212	0.1493153626124117
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00440212	0.1493153626124117
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00440212	0.1493153626124117
OCCIPITAL HORN SYNDROME	0.0043997839999999995	0.1492361279057107
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.004395649	0.1490958729775392
THANATOPHORIC DYSPLASIA	0.004395649	0.1490958729775392
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.004395649	0.1490958729775392
HYPERTELORISM AND TETRALOGY OF FALLOT	0.004334019999999999	0.14700548096586294
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.004334019999999999	0.14700548096586294
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.004334019999999999	0.14700548096586294
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.004334019999999999	0.14700548096586294
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00431758	0.1464478531498679
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.00431758	0.1464478531498679
HEREDITARY OROTIC ACIDURIA	0.004315244	0.14636861844316695
311450 PALLISTER W SYNDROME;;W SYNDROME	0.0043111090000000005	0.14622836351499546
GAPO SYNDROME	0.0042734999999999995	0.1449527050884895
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS WITH SEVERE OCULAR INVOLVEMENT	0.0042734999999999995	0.1449527050884895
MUCOPOLYSACCHARIDOSIS TYPE 7	0.0042734999999999995	0.1449527050884895
AUTOSOMAL DOMINANT CUTIS LAXA	0.0042734999999999995	0.1449527050884895
COOPER-JABS SYNDROME	0.0042734999999999995	0.1449527050884895
ACHONDROGENESIS TYPE 2	0.0042734999999999995	0.1449527050884895
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.0042734999999999995	0.1449527050884895
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.0042734999999999995	0.1449527050884895
FOCAL DERMAL HYPOPLASIA	0.0042734999999999995	0.1449527050884895
ACHONDROGENESIS TYPE 1A	0.0042734999999999995	0.1449527050884895
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	0.0042734999999999995	0.1449527050884895
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.0042734999999999995	0.1449527050884895
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.0042734999999999995	0.1449527050884895
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.0042734999999999995	0.1449527050884895
MUSCULAR HYPERTONIA, LETHAL	0.0042734999999999995	0.1449527050884895
FLOATING-HARBOR SYNDROME	0.0042734999999999995	0.1449527050884895
ACHONDROGENESIS	0.0042734999999999995	0.1449527050884895
X-LINKED EHLERS-DANLOS SYNDROME	0.0042734999999999995	0.1449527050884895
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	0.0042734999999999995	0.1449527050884895
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.0042734999999999995	0.1449527050884895
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.0042734999999999995	0.1449527050884895
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.0042734999999999995	0.1449527050884895
FETAL MINOXIDIL SYNDROME	0.0042734999999999995	0.1449527050884895
HURLER-SCHEIE SYNDROME	0.0042734999999999995	0.1449527050884895
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.0042734999999999995	0.1449527050884895
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.0042734999999999995	0.1449527050884895
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.0042734999999999995	0.1449527050884895
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.0042734999999999995	0.1449527050884895
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.0042734999999999995	0.1449527050884895
BLADDER EXSTROPHY	0.0042734999999999995	0.1449527050884895
HUNTER-MACDONALD SYNDROME	0.0042734999999999995	0.1449527050884895
CENTRAL CONGENITAL HYPOTHYROIDISM	0.0042734999999999995	0.1449527050884895
TETRASOMY X	0.004226054	0.14334338578449315
OROFACIODIGITAL SYNDROME VI	0.004226054	0.14334338578449315
BARATELA-SCOTT SYNDROME	0.004226054	0.14334338578449315
PHENOBARBITAL EMBRYOPATHY	0.004226054	0.14334338578449315
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.004221918999999999	0.14320313085632164
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00415799	0.14103472522075314
SOTOS SYNDROME 2	0.00415799	0.14103472522075314
JUVENILE POLYPOSIS OF INFANCY	0.00415799	0.14103472522075314
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.004141514000000001	0.14047587632194938
LIG4 SYNDROME	0.004141514000000001	0.14047587632194938
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.004141514000000001	0.14047587632194938
OCULOSKELETODENTAL SYNDROME; OCSKD	0.004141514000000001	0.14047587632194938
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.004141514000000001	0.14047587632194938
8Q12 MICRODUPLICATION SYNDROME	0.004141514	0.14047587632194936
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.004137379	0.14033562139377787
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.004137379	0.14033562139377787
ARTERIAL TORTUOSITY SYNDROME	0.004129784	0.1400780068400989
OPTIC ATROPHY 11; OPA11	0.004129784	0.1400780068400989
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.004129784	0.1400780068400989
HOLOPROSENCEPHALY 5; HPE5	0.004129784	0.1400780068400989
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.004129784	0.1400780068400989
MENTAL RETARDATION, X-LINKED 107; MRX107	0.004129784	0.1400780068400989
HYPOTONIA-CYSTINURIA SYNDROME	0.004129784	0.1400780068400989
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.004125649	0.13993775191192742
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.004125649	0.13993775191192742
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.004125649	0.13993775191192742
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.004125649	0.13993775191192742
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.004125649	0.13993775191192742
WARBURG MICRO SYNDROME 3; WARBM3	0.004125649	0.13993775191192742
FRAGILE X MENTAL RETARDATION SYNDROME	0.004125649	0.13993775191192742
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.0040138199999999995	0.1361446277613855
DAHLBERG-BORER-NEWCOMER SYNDROME	0.0040138199999999995	0.1361446277613855
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.0040138199999999995	0.1361446277613855
CARPENTER-WAZIRI SYNDROME	0.0040138199999999995	0.1361446277613855
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.0040138199999999995	0.1361446277613855
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.0040138199999999995	0.1361446277613855
SHORT SYNDROME	0.0040138199999999995	0.1361446277613855
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.0040138199999999995	0.1361446277613855
LÉRI-WEILL DYSCHONDROSTEOSIS	0.0040138199999999995	0.1361446277613855
OCULOMAXILLOFACIAL DYSOSTOSIS	0.0040138199999999995	0.1361446277613855
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.0040138199999999995	0.1361446277613855
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.003993834	0.13546672328872877
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.003993834	0.13546672328872877
SHWACHMAN-DIAMOND SYNDROME	0.003993834	0.13546672328872877
HYPERMANGANESEMIA WITH DYSTONIA 2	0.003993834	0.13546672328872877
HYDROCEPHALUS, NORMAL-PRESSURE	0.003993834	0.13546672328872877
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.003993834	0.13546672328872877
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.003993834	0.13546672328872877
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.003993834	0.13546672328872877
RIDDLE SYNDROME	0.003993834	0.13546672328872877
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.003993834	0.13546672328872877
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.003993834	0.13546672328872877
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.003993834	0.13546672328872877
BEHÇET DISEASE	0.003989699	0.13532646836055728
KALLMANN SYNDROME	0.003989699	0.13532646836055728
ALZHEIMER DISEASE 3; AD	0.003989699	0.13532646836055728
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.003989699	0.13532646836055728
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.003989699	0.13532646836055728
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.003989699	0.13532646836055728
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.003989699	0.13532646836055728
SUBEPENDYMOMA	0.003989699	0.13532646836055728
EPENDYMOMA	0.003989699	0.13532646836055728
ATAXIA-TELANGIECTASIA	0.003989699	0.13532646836055728
KUFOR-RAKEB SYNDROME	0.003989699	0.13532646836055728
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.003989699	0.13532646836055728
SPONTANEOUS PERIODIC HYPOTHERMIA	0.003989699	0.13532646836055728
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.003989699	0.13532646836055728
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.003989699	0.13532646836055728
CENTRONUCLEAR MYOPATHY	0.003989699	0.13532646836055728
X-LINKED CENTRONUCLEAR MYOPATHY	0.003989699	0.13532646836055728
DYSEQUILIBRIUM SYNDROME	0.003989699	0.13532646836055728
TENORIO SYNDROME; TNORS	0.003989699	0.13532646836055728
METACHROMATIC LEUKODYSTROPHY	0.003989699	0.13532646836055728
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.003989699	0.13532646836055728
CHOREOATHETOSIS, FAMILIAL INVERTED	0.003989699	0.13532646836055728
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.003989699	0.13532646836055728
FAMILIAL COLORECTAL CANCER TYPE X	0.003989699	0.13532646836055728
LYNCH SYNDROME	0.003989699	0.13532646836055728
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.00398426	0.13514198309953557
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00398426	0.13514198309953557
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.0039819239999999995	0.13506274839283455
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0039819239999999995	0.13506274839283455
CUTIS LAXA	0.0039819239999999995	0.13506274839283455
NOONAN SYNDROME 5; NS5	0.0039819239999999995	0.13506274839283455
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.0039819239999999995	0.13506274839283455
NOONAN SYNDROME 3; NS3	0.0039819239999999995	0.13506274839283455
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00385423	0.13073149983227075
FIBROCHONDROGENESIS	0.00385423	0.13073149983227075
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00385423	0.13073149983227075
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00385423	0.13073149983227075
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.0037896729999999995	0.1285417930854829
1Q21.1 MICRODUPLICATION SYNDROME	0.0037896729999999995	0.1285417930854829
DISTAL MONOSOMY 15Q	0.0037896729999999995	0.1285417930854829
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.0037896729999999995	0.1285417930854829
ACROMELIC FRONTONASAL DYSPLASIA	0.0037896729999999995	0.1285417930854829
HYPERTELORISM, TEEBI TYPE; TBHS	0.00376969	0.12786399036972693
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00376969	0.12786399036972693
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.00376969	0.12786399036972693
OTOPALATODIGITAL SYNDROME TYPE 1	0.00376969	0.12786399036972693
RING CHROMOSOME 1 SYNDROME	0.00376969	0.12786399036972693
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00376969	0.12786399036972693
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.00376969	0.12786399036972693
FRONTOMETAPHYSEAL DYSPLASIA	0.00376969	0.12786399036972693
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00376969	0.12786399036972693
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.0036804999999999997	0.12483875771105316
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.0036804999999999997	0.12483875771105316
OROFACIODIGITAL SYNDROME IV; OFD4	0.0036804999999999997	0.12483875771105316
JACOBSEN SYNDROME	0.0036804999999999997	0.12483875771105316
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.0036804999999999997	0.12483875771105316
SILLENCE SYNDROME	0.0036804999999999997	0.12483875771105316
TERMINAL OSSEOUS DYSPLASIA; TOD	0.0036804999999999997	0.12483875771105316
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.0036804999999999997	0.12483875771105316
CRANIOECTODERMAL DYSPLASIA	0.0036804999999999997	0.12483875771105316
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.0036804999999999997	0.12483875771105316
TORIELLO-LACASSIE-DROSTE SYNDROME	0.0036804999999999997	0.12483875771105316
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.0036804999999999997	0.12483875771105316
SUMMITT SYNDROME	0.0036804999999999997	0.12483875771105316
FRONTORHINY	0.0036804999999999997	0.12483875771105316
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.0036804999999999997	0.12483875771105316
VELO-FACIAL-SKELETAL SYNDROME	0.00359596	0.12197124824850937
3Q13 MICRODELETION SYNDROME	0.00359596	0.12197124824850937
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00359596	0.12197124824850937
FEINGOLD SYNDROME 1; FGLDS1	0.00359596	0.12197124824850937
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00359596	0.12197124824850937
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.00359596	0.12197124824850937
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00359596	0.12197124824850937
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00358423	0.1215733787666589
ATKIN-FLAITZ SYNDROME	0.00358423	0.1215733787666589
SAY SYNDROME	0.00358423	0.1215733787666589
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.00358423	0.1215733787666589
WARBURG MICRO SYNDROME 1	0.00358423	0.1215733787666589
%613576 ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 2; EDSS2	0.00358423	0.1215733787666589
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00358423	0.1215733787666589
DERMATOLEUKODYSTROPHY	0.00358423	0.1215733787666589
LAMBOTTE SYNDROME	0.00358423	0.1215733787666589
THAKKER-DONNAI SYNDROME	0.00358423	0.1215733787666589
NIJMEGEN BREAKAGE SYNDROME	0.00358423	0.1215733787666589
HOLZGREVE SYNDROME	0.00358423	0.1215733787666589
NAKAJO-NISHIMURA SYNDROME	0.00358423	0.1215733787666589
601095 HARROD SYNDROME	0.00358423	0.1215733787666589
MENTAL RETARDATION, X-LINKED, SYNDROMIC 11; MRXS11	0.00358423	0.1215733787666589
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00358423	0.1215733787666589
NEU-LAXOVA SYNDROME	0.00358423	0.1215733787666589
SOMATOMAMMOTROPINOMA	0.00358423	0.1215733787666589
DWARFISM, FAMILIAL, WITH MUSCLE SPASMS	0.00358423	0.1215733787666589
ALAGILLE SYNDROME 1; ALGS1	0.00358423	0.1215733787666589
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00358423	0.1215733787666589
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.00358423	0.1215733787666589
ACROMEGALY	0.00358423	0.1215733787666589
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00344828	0.11696209521528879
PSEUDOACHONDROPLASIA	0.00344828	0.11696209521528879
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00344828	0.11696209521528879
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00344828	0.11696209521528879
DOPA-RESPONSIVE DYSTONIA	0.00344828	0.11696209521528879
CLASSIC GALACTOSEMIA	0.00344828	0.11696209521528879
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00344828	0.11696209521528879
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.00344828	0.11696209521528879
POLYMYOSITIS	0.00344828	0.11696209521528879
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.00344828	0.11696209521528879
OSTEOCHONDRITIS DISSECANS	0.00344828	0.11696209521528879
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00344828	0.11696209521528879
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00344828	0.11696209521528879
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 5	0.00344828	0.11696209521528879
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.00344828	0.11696209521528879
DYSTONIA 23; DYT23	0.00344828	0.11696209521528879
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.00344828	0.11696209521528879
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 1	0.00344828	0.11696209521528879
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00344828	0.11696209521528879
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00344828	0.11696209521528879
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.00344828	0.11696209521528879
ATAXIA-OCULOMOTOR APRAXIA TYPE 1	0.00344828	0.11696209521528879
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00344828	0.11696209521528879
VON HIPPEL-LINDAU DISEASE	0.00344828	0.11696209521528879
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.00344828	0.11696209521528879
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.00344828	0.11696209521528879
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.00344828	0.11696209521528879
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00344828	0.11696209521528879
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00344828	0.11696209521528879
PELVIC DYSPLASIA-ARTHROGRYPOSIS OF LOWER LIMBS SYNDROME	0.00344828	0.11696209521528879
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.00344828	0.11696209521528879
EARLY-ONSET GENERALIZED LIMB-ONSET DYSTONIA	0.00344828	0.11696209521528879
SPONDYLOMETAPHYSEAL DYSPLASIA	0.00344828	0.11696209521528879
SPINOCEREBELLAR ATAXIA TYPE 4	0.00344828	0.11696209521528879
BENIGN HEREDITARY CHOREA	0.00344828	0.11696209521528879
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.00344828	0.11696209521528879
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.00344828	0.11696209521528879
GLYCOGEN STORAGE DISEASE DUE TO LAMP-2 DEFICIENCY	0.00344828	0.11696209521528879
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00344828	0.11696209521528879
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.00344828	0.11696209521528879
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00344828	0.11696209521528879
PALMOPLANTAR KERATODERMA-SPASTIC PARALYSIS SYNDROME	0.00344828	0.11696209521528879
POTASSIUM-AGGRAVATED MYOTONIA	0.00344828	0.11696209521528879
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00344828	0.11696209521528879
NEUROFIBROMATOSIS TYPE 2	0.00344828	0.11696209521528879
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.00344828	0.11696209521528879
ATAXIA WITH VITAMIN E DEFICIENCY	0.00344828	0.11696209521528879
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00344828	0.11696209521528879
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.00344828	0.11696209521528879
THORACOMELIC DYSPLASIA	0.00344828	0.11696209521528879
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.00344828	0.11696209521528879
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.00344828	0.11696209521528879
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.00344828	0.11696209521528879
CYSTINOSIS	0.00344828	0.11696209521528879
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.00344828	0.11696209521528879
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00344828	0.11696209521528879
HUNTINGTON DISEASE-LIKE 2	0.00344828	0.11696209521528879
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.00344828	0.11696209521528879
TRYPTOPHANURIA WITH DWARFISM	0.00344828	0.11696209521528879
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00344828	0.11696209521528879
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.00344828	0.11696209521528879
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00344828	0.11696209521528879
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.00344828	0.11696209521528879
SPINOCEREBELLAR ATAXIA TYPE 34	0.00344828	0.11696209521528879
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00344828	0.11696209521528879
224550 DYSTONIA WITH RINGBINDEN	0.00344828	0.11696209521528879
LATE-ONSET DISTAL MYOPATHY, MARKESBERY-GRIGGS TYPE	0.00344828	0.11696209521528879
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.00344828	0.11696209521528879
KENNEDY DISEASE	0.00344828	0.11696209521528879
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00344828	0.11696209521528879
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.00344828	0.11696209521528879
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.00344828	0.11696209521528879
AMYOTROPHIC LATERAL SCLEROSIS TYPE 4	0.00344828	0.11696209521528879
X-LINKED ADRENOLEUKODYSTROPHY	0.00344828	0.11696209521528879
AUTOSOMAL DOMINANT STRIATAL NEURODEGENERATION	0.00344828	0.11696209521528879
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00344828	0.11696209521528879
NONAKA MYOPATHY	0.00344828	0.11696209521528879
NEMALINE MYOPATHY 6	0.00344828	0.11696209521528879
MYOPATHY, DISTAL, 1; MPD1	0.00344828	0.11696209521528879
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00344828	0.11696209521528879
HYPERKALEMIC PERIODIC PARALYSIS	0.00344828	0.11696209521528879
MANGANESE POISONING	0.00344828	0.11696209521528879
HEREDITARY SPASTIC PARAPLEGIA	0.00344828	0.11696209521528879
MULTIPLE SYMMETRIC LIPOMATOSIS	0.00344828	0.11696209521528879
ACETAZOLAMIDE-RESPONSIVE MYOTONIA	0.00344828	0.11696209521528879
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00344828	0.11696209521528879
PSYCHOGENIC MOVEMENT DISORDERS	0.00344828	0.11696209521528879
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.00344828	0.11696209521528879
SPINOCEREBELLAR ATAXIA TYPE 5	0.00344828	0.11696209521528879
MASA SYNDROME	0.00344828	0.11696209521528879
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00344828	0.11696209521528879
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00344828	0.11696209521528879
ROUSSY-LÉVY SYNDROME	0.00344828	0.11696209521528879
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.00344828	0.11696209521528879
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.00344828	0.11696209521528879
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00344828	0.11696209521528879
SPONASTRIME DYSPLASIA	0.00344828	0.11696209521528879
MUTILATING HEREDITARY SENSORY NEUROPATHY WITH SPASTIC PARAPLEGIA	0.00344828	0.11696209521528879
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.00344828	0.11696209521528879
MYOTONIA FLUCTUANS	0.00344828	0.11696209521528879
RICHARDS-RUNDLE SYNDROME	0.00344828	0.11696209521528879
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00344828	0.11696209521528879
IDIOPATHIC JUVENILE OSTEOPOROSIS	0.00344828	0.11696209521528879
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.003439913	0.11667829521915556
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.003439913	0.11667829521915556
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.003439913	0.11667829521915556
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.003439913	0.11667829521915556
KETOADIPICACIDURIA	0.003439913	0.11667829521915556
VICI SYNDROME; VICIS	0.003439913	0.11667829521915556
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.003439913	0.11667829521915556
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.003439913	0.11667829521915556
PRADER-WILLI SYNDROME; PWS	0.003439913	0.11667829521915556
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.0034363700000000002	0.1165581203193946
NOONAN SYNDROME 8; NS8	0.0034363700000000002	0.1165581203193946
DIAMOND-BLACKFAN ANEMIA 1	0.0034363700000000002	0.1165581203193946
8Q21.11 MICRODELETION SYNDROME	0.0034363700000000002	0.1165581203193946
GMS SYNDROME	0.0034363700000000002	0.1165581203193946
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.0034363700000000002	0.1165581203193946
LEGIUS SYNDROME	0.0034363700000000002	0.1165581203193946
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.0034363700000000002	0.1165581203193946
ACRORENAL-MANDIBULAR SYNDROME	0.0034363700000000002	0.1165581203193946
NOONAN SYNDROME 4; NS4	0.0034363700000000002	0.1165581203193946
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.003248254	0.11017741994021446
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.003248254	0.11017741994021446
RAHMAN SYNDROME	0.003248254	0.11017741994021446
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.003248254	0.11017741994021446
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.003248254	0.11017741994021446
RICHARDS-RUNDLE SYNDROME; RRNS	0.003248254	0.11017741994021446
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.003248254	0.11017741994021446
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.003248254	0.11017741994021446
LARSEN-LIKE SYNDROME	0.003248254	0.11017741994021446
ATELOSTEOGENESIS TYPE III	0.003248254	0.11017741994021446
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.003248254	0.11017741994021446
MOSAIC TRISOMY 9	0.003248254	0.11017741994021446
ISOLATED SPINA BIFIDA	0.0032441189999999997	0.11003716501204294
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.0032441189999999997	0.11003716501204294
CYSTATHIONINURIA	0.0032441189999999997	0.11003716501204294
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.0032441189999999997	0.11003716501204294
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.0032441189999999997	0.11003716501204294
GRACILE BONE DYSPLASIA; GCLEB	0.003136153	0.10637506983067314
COWDEN SYNDROME	0.0031361529999999996	0.10637506983067313
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.0031361529999999996	0.10637506983067313
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.0031361529999999996	0.10637506983067313
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.0030516130000000003	0.10350756036812936
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.0030516130000000003	0.10350756036812936
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.0030516130000000003	0.10350756036812936
CHROMOSOME 1P35 DELETION SYNDROME	0.0030516130000000003	0.10350756036812936
BOHRING-OPITZ SYNDROME	0.0030516130000000003	0.10350756036812936
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.0030516130000000003	0.10350756036812936
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.0030516130000000003	0.10350756036812936
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.003051613	0.10350756036812934
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.003051613	0.10350756036812934
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.0028984939999999997	0.09831392207388706
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.0028984939999999997	0.09831392207388706
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.0028984939999999997	0.09831392207388706
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.0028984939999999997	0.09831392207388706
SPINOCEREBELLAR ATAXIA TYPE 7	0.0028984939999999997	0.09831392207388706
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.0028984939999999997	0.09831392207388706
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.0028984939999999997	0.09831392207388706
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.0028984939999999997	0.09831392207388706
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.0028984939999999997	0.09831392207388706
BETA-KETOTHIOLASE DEFICIENCY	0.002894359	0.09817366714571557
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.002894359	0.09817366714571557
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.002894359	0.09817366714571557
EPISODIC ATAXIA, TYPE 6	0.002894359	0.09817366714571557
LISSENCEPHALY 3; LIS3	0.002894359	0.09817366714571557
CYCLIC VOMITING SYNDROME	0.002894359	0.09817366714571557
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.002894359	0.09817366714571557
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.002894359	0.09817366714571557
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.002894359	0.09817366714571557
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.002894359	0.09817366714571557
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.002894359	0.09817366714571557
LISSENCEPHALY, X-LINKED, 1; LISX1	0.002894359	0.09817366714571557
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.002894359	0.09817366714571557
PRADER-WILLI SYNDROME	0.002894359	0.09817366714571557
CAMOS SYNDROME	0.002894359	0.09817366714571557
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.002894359	0.09817366714571557
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.002894359	0.09817366714571557
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.002894359	0.09817366714571557
47,XYY SYNDROME	0.002894359	0.09817366714571557
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.002894359	0.09817366714571557
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.0028920230000000005	0.09809443243901458
CHROMOSOME 16P13.3 DELETION SYNDROME	0.002892023	0.09809443243901457
611961 STEVENSON-CAREY SYNDROME	0.002892023	0.09809443243901457
GABA-TRANSAMINASE DEFICIENCY	0.002892023	0.09809443243901457
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.002892023	0.09809443243901457
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.002892023	0.09809443243901457
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.002892023	0.09809443243901457
MEVALONIC ACIDURIA	0.002892023	0.09809443243901457
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.002892023	0.09809443243901457
CHROMOSOME 19P13.13 DELETION SYNDROME	0.002892023	0.09809443243901457
LUSCAN-LUMISH SYNDROME; LLS	0.002892023	0.09809443243901457
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.002718293	0.09220169031779699
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.002718293	0.09220169031779699
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.002718293	0.09220169031779699
TEMPLE-BARAITSER SYNDROME; TMBTS	0.002718293	0.09220169031779699
TRISOMY X	0.002718293	0.09220169031779699
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.002718293	0.09220169031779699
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.002718293	0.09220169031779699
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.002718293	0.09220169031779699
19P13.12 MICRODELETION SYNDROME	0.002718293	0.09220169031779699
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0027182929999999997	0.09220169031779699
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.0027182929999999997	0.09220169031779699
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.0027182929999999997	0.09220169031779699
MENTAL RETARDATION, X-LINKED 91; MRX91	0.0027182929999999997	0.09220169031779699
XQ25 DUPLICATION SYNDROME	0.0027182929999999997	0.09220169031779699
DISTAL MONOSOMY 1Q	0.0027182929999999997	0.09220169031779699
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.0027026999999999997	0.09167279186677445
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.0027026999999999997	0.09167279186677445
BRUCK SYNDROME 2	0.0027026999999999997	0.09167279186677445
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.0027026999999999997	0.09167279186677445
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.0027026999999999997	0.09167279186677445
FAMILIAL CLUBFOOT DUE TO 17Q23.1Q23.2 MICRODUPLICATION	0.0027026999999999997	0.09167279186677445
258040 OEIS COMPLEX;;OMPHALOCELE-EXSTROPHY-IMPERFORATE ANUS-SPINAL DEFECTS	0.0027026999999999997	0.09167279186677445
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.0027026999999999997	0.09167279186677445
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.0027026999999999997	0.09167279186677445
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W; LGMD2W	0.0027026999999999997	0.09167279186677445
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.0027026999999999997	0.09167279186677445
PSEUDODIASTROPHIC DYSPLASIA	0.0027026999999999997	0.09167279186677445
BRUCK SYNDROME	0.0027026999999999997	0.09167279186677445
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.0027026999999999997	0.09167279186677445
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.0027026999999999997	0.09167279186677445
CRANE-HEISE SYNDROME	0.0027026999999999997	0.09167279186677445
CAMPOMELIC DYSPLASIA	0.0027026999999999997	0.09167279186677445
CAUDAL REGRESSION SEQUENCE	0.0027026999999999997	0.09167279186677445
INIENCEPHALY	0.0027026999999999997	0.09167279186677445
CLOACAL EXSTROPHY	0.0027026999999999997	0.09167279186677445
ATELOSTEOGENESIS, TYPE II	0.0027026999999999997	0.09167279186677445
MECKEL SYNDROME, TYPE 6; MKS6	0.0027026999999999997	0.09167279186677445
ULNAR HYPOPLASIA WITH MENTAL RETARDATION	0.0027026999999999997	0.09167279186677445
SCAPULOPERONEAL SYNDROME, NEUROGENIC, KAESER TYPE	0.0027026999999999997	0.09167279186677445
TIBIAL HEMIMELIA	0.0027026999999999997	0.09167279186677445
RENAL-HEPATIC-PANCREATIC DYSPLASIA 2; RHPD2	0.0027026999999999997	0.09167279186677445
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.0027026999999999997	0.09167279186677445
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	0.0027026999999999997	0.09167279186677445
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.0027026999999999997	0.09167279186677445
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.0027026999999999997	0.09167279186677445
RENAL AGENESIS	0.0027026999999999997	0.09167279186677445
PSEUDODIASTROPHIC DYSPLASIA	0.0027026999999999997	0.09167279186677445
ELLIS-VAN CREVELD SYNDROME	0.0027026999999999997	0.09167279186677445
LAMBERT SYNDROME	0.0027026999999999997	0.09167279186677445
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.0027026999999999997	0.09167279186677445
KYPHOMELIC DYSPLASIA	0.0027026999999999997	0.09167279186677445
CAMPOMELIC DYSPLASIA	0.0027026999999999997	0.09167279186677445
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.0027026999999999997	0.09167279186677445
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.0027026999999999997	0.09167279186677445
PRUNE BELLY SYNDROME	0.0027026999999999997	0.09167279186677445
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.0027026999999999997	0.09167279186677445
POLYMICROGYRIA, PERISYLVIAN, WITH CEREBELLAR HYPOPLASIA AND ARTHROGRYPOSIS; PMGYCHA	0.0027026999999999997	0.09167279186677445
ARTHROGRYPOSIS, DISTAL, TYPE 1B	0.0027026999999999997	0.09167279186677445
BRACHYDACTYLY TYPE A1	0.0027026999999999997	0.09167279186677445
CHROMOSOME 2Q31.1 DUPLICATION SYNDROME	0.0027026999999999997	0.09167279186677445
APROSENCEPHALY AND CEREBELLAR DYSGENESIS	0.0027026999999999997	0.09167279186677445
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.0027026999999999997	0.09167279186677445
TIBIA, ABSENCE OR HYPOPLASIA OF, WITH POLYDACTYLY, RETROCEREBELLAR ARACHNOID CYST, AND OTHER ANOMALIES	0.0027026999999999997	0.09167279186677445
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.0027026999999999997	0.09167279186677445
ULBRIGHT-HODES SYNDROME	0.0027026999999999997	0.09167279186677445
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.0027026999999999997	0.09167279186677445
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.0027026999999999997	0.09167279186677445
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0027026999999999997	0.09167279186677445
POPLITEAL PTERYGIUM SYNDROME	0.0027026999999999997	0.09167279186677445
STÜVE-WIEDEMANN SYNDROME	0.0027026999999999997	0.09167279186677445
NIEVERGELT SYNDROME	0.0027026999999999997	0.09167279186677445
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.0027026999999999997	0.09167279186677445
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.0027026999999999997	0.09167279186677445
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.0027026999999999997	0.09167279186677445
CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION	0.0027026999999999997	0.09167279186677445
ERYTHEMA OF ACRAL REGIONS	0.0027026999999999997	0.09167279186677445
LARYNGEAL ABDUCTOR PARALYSIS	0.0027026999999999997	0.09167279186677445
NAIL-PATELLA SYNDROME	0.0027026999999999997	0.09167279186677445
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.0027026999999999997	0.09167279186677445
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 4	0.0027026999999999997	0.09167279186677445
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B	0.0027026999999999997	0.09167279186677445
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.0025947339999999996	0.08801069668540464
TEMTAMY SYNDROME	0.0025947339999999996	0.08801069668540464
CHOPS SYNDROME; CHOPS	0.0025947339999999996	0.08801069668540464
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.0025947339999999996	0.08801069668540464
BARDET-BIEDL SYNDROME 17; BBS17	0.0025947339999999996	0.08801069668540464
BARDET-BIEDL SYNDROME 3; BBS3	0.0025947339999999996	0.08801069668540464
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.0025947339999999996	0.08801069668540464
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.0025947339999999996	0.08801069668540464
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.0025947339999999996	0.08801069668540464
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.0025947339999999996	0.08801069668540464
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.0025947339999999996	0.08801069668540464
MARINESCO-SJÖGREN SYNDROME	0.0025947339999999996	0.08801069668540464
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.0025947339999999996	0.08801069668540464
MCKUSICK-KAUFMAN SYNDROME	0.0025947339999999996	0.08801069668540464
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.002590599	0.08787044175723314
THANATOPHORIC DYSPLASIA TYPE 2	0.002590599	0.08787044175723314
CRANIOSYNOSTOSIS 2	0.002590599	0.08787044175723314
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.002590599	0.08787044175723314
THANATOPHORIC DYSPLASIA TYPE 1	0.002590599	0.08787044175723314
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.002590599	0.08787044175723314
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.0025101940000000003	0.08514318722286088
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.0025101940000000003	0.08514318722286088
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.0025101940000000003	0.08514318722286088
STEEL SYNDROME; STLS	0.0025101940000000003	0.08514318722286088
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.0025101940000000003	0.08514318722286088
ALAZAMI SYNDROME; ALAZS	0.0025101940000000003	0.08514318722286088
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.0025101940000000003	0.08514318722286088
SYNDROMIC DIARRHEA	0.0025101940000000003	0.08514318722286088
PENTASOMY X	0.0025101940000000003	0.08514318722286088
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.0025101940000000003	0.08514318722286088
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.0025101940000000003	0.08514318722286088
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0025101940000000003	0.08514318722286088
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.0025101940000000003	0.08514318722286088
FILIPPI SYNDROME; FLPIS	0.002506059	0.08500293229468936
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.002506059	0.08500293229468936
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.002506059	0.08500293229468936
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.002506059	0.08500293229468936
FAMILIAL BENIGN COPPER DEFICIENCY	0.002506059	0.08500293229468936
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.002506059	0.08500293229468936
ACROCARDIOFACIAL SYNDROME	0.002506059	0.08500293229468936
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.002506059	0.08500293229468936
MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT	0.00235294	0.07980929400044706
HYPERPARATHYROIDISM, TRANSIENT NEONATAL; HRPTTN	0.00235294	0.07980929400044706
MENTAL RETARDATION, X-LINKED 19	0.00235294	0.07980929400044706
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00235294	0.07980929400044706
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00235294	0.07980929400044706
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00235294	0.07980929400044706
SENGERS SYNDROME	0.00235294	0.07980929400044706
TEMPLE SYNDROME	0.00235294	0.07980929400044706
USHER SYNDROME, TYPE IF	0.00235294	0.07980929400044706
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 12; MDDGC12	0.00235294	0.07980929400044706
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00235294	0.07980929400044706
BETHLEM MYOPATHY 1	0.00235294	0.07980929400044706
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.00235294	0.07980929400044706
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.00235294	0.07980929400044706
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00235294	0.07980929400044706
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.00235294	0.07980929400044706
260150 PALANT CLEFT PALATE SYNDROME	0.00235294	0.07980929400044706
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00235294	0.07980929400044706
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00235294	0.07980929400044706
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.00235294	0.07980929400044706
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 8; MDDGC8	0.00235294	0.07980929400044706
GLYCOGEN STORAGE DISEASE IXA	0.00235294	0.07980929400044706
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00235294	0.07980929400044706
NEMALINE MYOPATHY 1; NEM1	0.00235294	0.07980929400044706
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00235294	0.07980929400044706
LESCH-NYHAN SYNDROME; LNS	0.00235294	0.07980929400044706
LARYNGEAL ABDUCTOR PARALYSIS-INTELLECTUAL DISABILITY SYNDROME	0.00235294	0.07980929400044706
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1F; CMT1F	0.00235294	0.07980929400044706
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.00235294	0.07980929400044706
OSTEOGENESIS IMPERFECTA, TYPE XVII; OI17	0.00235294	0.07980929400044706
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.00235294	0.07980929400044706
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00235294	0.07980929400044706
BRUNNER SYNDROME; BRNRS	0.00235294	0.07980929400044706
GILLESPIE SYNDROME; GLSP	0.00235294	0.07980929400044706
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.00235294	0.07980929400044706
NEUROPATHY, CONGENITAL HYPOMYELINATING, 1, AUTOSOMAL RECESSIVE; CHN1	0.00235294	0.07980929400044706
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.00235294	0.07980929400044706
MYOPATHY, CENTRONUCLEAR, 5	0.00235294	0.07980929400044706
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.00235294	0.07980929400044706
AMISH NEMALINE MYOPATHY	0.00235294	0.07980929400044706
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 29	0.00235294	0.07980929400044706
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.00235294	0.07980929400044706
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.00235294	0.07980929400044706
DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84	0.00235294	0.07980929400044706
%614990 USHER SYNDROME, TYPE IK; USH1K	0.00235294	0.07980929400044706
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.00235294	0.07980929400044706
CARDIAC-UROGENITAL SYNDROME; CUGS	0.00235294	0.07980929400044706
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.00235294	0.07980929400044706
SALIH MYOPATHY; SALMY	0.00235294	0.07980929400044706
MYASTHENIC SYNDROME, CONGENITAL, 13	0.00235294	0.07980929400044706
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00235294	0.07980929400044706
TEMPLE SYNDROME	0.00235294	0.07980929400044706
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00235294	0.07980929400044706
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00235294	0.07980929400044706
GLYCOGEN STORAGE DISEASE IXC	0.00235294	0.07980929400044706
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00235294	0.07980929400044706
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00235294	0.07980929400044706
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00235294	0.07980929400044706
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 23	0.00235294	0.07980929400044706
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.00235294	0.07980929400044706
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.00235294	0.07980929400044706
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.00235294	0.07980929400044706
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00235294	0.07980929400044706
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.00235294	0.07980929400044706
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00235294	0.07980929400044706
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00235294	0.07980929400044706
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.00235294	0.07980929400044706
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.00235294	0.07980929400044706
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.00235294	0.07980929400044706
SILVER-RUSSELL SYNDROME	0.00235294	0.07980929400044706
CHARCOT-MARIE-TOOTH DISEASE TYPE 1B	0.00235294	0.07980929400044706
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 9; MRT9	0.00235294	0.07980929400044706
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.00235294	0.07980929400044706
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.00235294	0.07980929400044706
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.00235294	0.07980929400044706
MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA	0.00235294	0.07980929400044706
X-LINKED SPASTIC PARAPLEGIA TYPE 16	0.00235294	0.07980929400044706
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.00235294	0.07980929400044706
MEVALONIC ACIDURIA; MEVA	0.002350604	0.07973005929374608
NOONAN SYNDROME 9; NS9	0.002350604	0.07973005929374608
NOONAN SYNDROME 2; NS2	0.002350604	0.07973005929374608
17P13.3 MICRODUPLICATION SYNDROME	0.002350604	0.07973005929374608
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.002350604	0.07973005929374608
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.002350604	0.07973005929374608
RITSCHER-SCHINZEL SYNDROME 1	0.002350604	0.07973005929374608
NOONAN SYNDROME 11; NS11	0.002350604	0.07973005929374608
CREE MENTAL RETARDATION SYNDROME	0.002350604	0.07973005929374608
COLE-CARPENTER SYNDROME	0.002350604	0.07973005929374608
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.002350604	0.07973005929374608
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.002350604	0.07973005929374608
CHROMOSOME 15Q25 DELETION SYNDROME	0.002350604	0.07973005929374608
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.0023464690000000003	0.07958980436557457
CLARK-BARAITSER SYNDROME	0.0023464690000000003	0.07958980436557457
AUTISM, SUSCEPTIBILITY TO, 18	0.0023464690000000003	0.07958980436557457
MALAN OVERGROWTH SYNDROME	0.0023464690000000003	0.07958980436557457
ATKIN-FLAITZ SYNDROME	0.0023464690000000003	0.07958980436557457
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.0023464690000000003	0.07958980436557457
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.0023464690000000003	0.07958980436557457
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.0023464690000000003	0.07958980436557457
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.0021768739999999996	0.07383731717252849
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.0021768739999999996	0.07383731717252849
DESBUQUOIS DYSPLASIA 2; DBQD2	0.0021768739999999996	0.07383731717252849
48,XYYY SYNDROME	0.0021768739999999996	0.07383731717252849
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.0021768739999999996	0.07383731717252849
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.0021768739999999996	0.07383731717252849
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.0021768739999999996	0.07383731717252849
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.0021768739999999996	0.07383731717252849
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0021768739999999996	0.07383731717252849
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.0021768739999999996	0.07383731717252849
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.0021768739999999996	0.07383731717252849
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0021768739999999996	0.07383731717252849
HARTSFIELD SYNDROME; HRTFDS	0.0021768739999999996	0.07383731717252849
KNOBLOCH SYNDROME	0.002172739	0.073697062244357
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.002172739	0.073697062244357
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.002172739	0.073697062244357
PROGRESSIVE OSSEOUS HETEROPLASIA	0.00204918	0.06950606861196465
CORNEODERMATOOSSEOUS SYNDROME	0.00204918	0.06950606861196465
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00204918	0.06950606861196465
BARDET-BIEDL SYNDROME 5; BBS5	0.00204918	0.06950606861196465
BARDET-BIEDL SYNDROME 4; BBS4	0.00204918	0.06950606861196465
CARDIOSPONDYLOCARPOFACIAL SYNDROME	0.00204918	0.06950606861196465
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.00204918	0.06950606861196465
MULTIPLE SYNOSTOSES SYNDROME 4; SYNS4	0.00204918	0.06950606861196465
604381 PATENT DUCTUS ARTERIOSUS AND BICUSPID AORTIC VALVE WITH HAND ANOMALIES	0.00204918	0.06950606861196465
MULTIPLE SYNOSTOSES SYNDROME	0.00204918	0.06950606861196465
ANAUXETIC DYSPLASIA 2; ANXD2	0.00204918	0.06950606861196465
272150 SUGARMAN BRACHYDACTYLY;;BRACHYDACTYLY WITH MAJOR PROXIMAL PHALANGEAL SHORTENING	0.00204918	0.06950606861196465
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.00204918	0.06950606861196465
OPSISMODYSPLASIA	0.00204918	0.06950606861196465
PYCNODYSOSTOSIS	0.00204918	0.06950606861196465
BRACHYDACTYLY, TYPE E2; BDE2	0.00204918	0.06950606861196465
SPONDYLOPERIPHERAL DYSPLASIA	0.00204918	0.06950606861196465
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00204918	0.06950606861196465
CHITAYAT SYNDROME	0.00204918	0.06950606861196465
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE	0.00204918	0.06950606861196465
BRACHYDACTYLY, LONG-THUMB TYPE	0.00204918	0.06950606861196465
SHORT-RIB THORACIC DYSPLASIA 4 WITH OR WITHOUT POLYDACTYLY; SRTD4	0.00204918	0.06950606861196465
FIBULAR APLASIA-COMPLEX BRACHYDACTYLY SYNDROME	0.00204918	0.06950606861196465
THIEMANN DISEASE, FAMILIAL FORM	0.00204918	0.06950606861196465
JEUNE SYNDROME	0.00204918	0.06950606861196465
FEINGOLD SYNDROME 2; FGLDS2	0.00204918	0.06950606861196465
SCHNECKENBECKEN DYSPLASIA	0.00204918	0.06950606861196465
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00204918	0.06950606861196465
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00204918	0.06950606861196465
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.00204918	0.06950606861196465
BRACHYDACTYLOUS DWARFISM, MSELENI TYPE	0.00204918	0.06950606861196465
SMITH-MAGENIS SYNDROME	0.00204918	0.06950606861196465
CRANIOECTODERMAL DYSPLASIA 3	0.00204918	0.06950606861196465
LARSEN SYNDROME	0.00204918	0.06950606861196465
2Q37 MONOSOMY	0.00204918	0.06950606861196465
WEILL-MARCHESANI SYNDROME	0.00204918	0.06950606861196465
SATOYOSHI SYNDROME	0.00204918	0.06950606861196465
TETRALOGY OF FALLOT	0.00204918	0.06950606861196465
RHIZOMELIC DYSPLASIA, PATTERSON-LOWRY TYPE	0.00204918	0.06950606861196465
PSEUDOHYPOPARATHYROIDISM, TYPE IB	0.00204918	0.06950606861196465
BARDET-BIEDL SYNDROME 18; BBS18	0.00204918	0.06950606861196465
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.00204918	0.06950606861196465
SHORT STATURE-ADVANCED BONE AGE-EARLY-ONSET OSTEOARTHRITIS SYNDROME	0.00204918	0.06950606861196465
CAMPTOBRACHYDACTYLY	0.00204918	0.06950606861196465
ECTRODACTYLY-POLYDACTYLY SYNDROME	0.00204918	0.06950606861196465
SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00204918	0.06950606861196465
LOWRY-WOOD SYNDROME	0.00204918	0.06950606861196465
GRANGE SYNDROME; GRNG	0.00204918	0.06950606861196465
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00204918	0.06950606861196465
PROXIMAL SYMPHALANGISM	0.00204918	0.06950606861196465
RHYNS SYNDROME; RHYNS	0.00204918	0.06950606861196465
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00204918	0.06950606861196465
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	0.00204918	0.06950606861196465
BRACHYDACTYLY-ECTRODACTYLY WITH FIBULAR APLASIA OR HYPOPLASIA	0.00204918	0.06950606861196465
ADAMS-OLIVER SYNDROME 6; AOS6	0.00204918	0.06950606861196465
HYPOCHONDROPLASIA	0.00204918	0.06950606861196465
HIRSCHSPRUNG DISEASE-TYPE D BRACHYDACTYLY SYNDROME	0.00204918	0.06950606861196465
%112440 BRACHYDACTYLY, COMBINED B AND E TYPES;;PITT-WILLIAMS BRACHYDACTYLY;;BRACHYDACTYLY, BALLARD TYPE	0.00204918	0.06950606861196465
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.00204918	0.06950606861196465
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00204918	0.06950606861196465
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00204918	0.06950606861196465
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.00204918	0.06950606861196465
X-LINKED SKELETAL DYSPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.00204918	0.06950606861196465
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00204918	0.06950606861196465
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.00204918	0.06950606861196465
%609052 SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4	0.00204918	0.06950606861196465
HAND-FOOT-GENITAL SYNDROME; HFG	0.00204918	0.06950606861196465
ROIFMAN SYNDROME	0.00204918	0.06950606861196465
FEINGOLD SYNDROME	0.00204918	0.06950606861196465
PREAXIAL DEFICIENCY, POSTAXIAL POLYDACTYLY, AND HYPOSPADIAS	0.00204918	0.06950606861196465
PERIPHERAL DYSOSTOSIS	0.00204918	0.06950606861196465
BRACHYDACTYLY-ARTERIAL HYPERTENSION SYNDROME	0.00204918	0.06950606861196465
DYSOSTOSIS, STANESCU TYPE	0.00204918	0.06950606861196465
ACROMICRIC DYSPLASIA	0.00204918	0.06950606861196465
SHORT-RIB THORACIC DYSPLASIA 17 WITH OR WITHOUT POLYDACTYLY; SRTD17	0.00204918	0.06950606861196465
BRACHYDACTYLY-ELBOW WRIST DYSPLASIA SYNDROME	0.00204918	0.06950606861196465
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00204918	0.06950606861196465
WEILL-MARCHESANI SYNDROME 3	0.00204918	0.06950606861196465
CLEIDOCRANIAL DYSPLASIA	0.00204918	0.06950606861196465
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00204918	0.06950606861196465
RHIZOMELIC SYNDROME, URBACH TYPE	0.00204918	0.06950606861196465
PYCNODYSOSTOSIS	0.00204918	0.06950606861196465
GREENBERG DYSPLASIA	0.00204918	0.06950606861196465
CAMPOMELIA, CUMMING TYPE	0.00204918	0.06950606861196465
CAMPTOBRACHYDACTYLY	0.00204918	0.06950606861196465
OSTEOCHONDRODYSPLASIA, BRACHYDACTYLY, AND OVERLAPPING MALFORMED DIGITS; OCBMD	0.00204918	0.06950606861196465
ACRODYSPLASIA SCOLIOSIS	0.00204918	0.06950606861196465
DYSOSTOSIS WITH BRACHYDACTYLY	0.00204918	0.06950606861196465
BRACHYDACTYLY-SYNDACTYLY SYNDROME	0.00204918	0.06950606861196465
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00204918	0.06950606861196465
EIKEN SYNDROME	0.00204918	0.06950606861196465
ACROMESOMELIC DYSPLASIA, GREBE TYPE	0.00204918	0.06950606861196465
METATROPIC DYSPLASIA	0.00204918	0.06950606861196465
ENG-STROM SYNDROME	0.00204918	0.06950606861196465
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.00204918	0.06950606861196465
DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE	0.00204918	0.06950606861196465
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED;;SEMD, X-LINKED; SEMDX	0.00204918	0.06950606861196465
HEART-HAND SYNDROME TYPE 3	0.00204918	0.06950606861196465
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00204918	0.06950606861196465
MULTIPLE EPIPHYSEAL DYSPLASIA	0.00204918	0.06950606861196465
HYPOCHONDROPLASIA	0.00204918	0.06950606861196465
ASPHYXIATING THORACIC DYSTROPHY 2; ATD2	0.00204918	0.06950606861196465
RADIO-RENAL SYNDROME	0.00204918	0.06950606861196465
EMERY-NELSON SYNDROME	0.00204918	0.06950606861196465
SPONDYLOMETAPHYSEAL DYSPLASIA, EAST AFRICAN TYPE	0.00204918	0.06950606861196465
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.00204918	0.06950606861196465
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00204918	0.06950606861196465
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2	0.00204918	0.06950606861196465
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, AGGRECAN TYPE; SEMDAG	0.00204918	0.06950606861196465
191482 UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, ANDBRACHYDACTYLY;;BORK SYNDROME	0.00204918	0.06950606861196465
TRIPHALANGEAL THUMBS WITH BRACHYECTRODACTYLY	0.00204918	0.06950606861196465
ISOLATED BRACHYCEPHALY	0.00204918	0.06950606861196465
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00204918	0.06950606861196465
COOKS SYNDROME	0.00204918	0.06950606861196465
THANATOPHORIC DYSPLASIA, TYPE II	0.00204918	0.06950606861196465
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00204918	0.06950606861196465
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00204918	0.06950606861196465
CORNEODERMATOOSSEOUS SYNDROME	0.00204918	0.06950606861196465
BANKI SYNDROME	0.00204918	0.06950606861196465
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.00204918	0.06950606861196465
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00204918	0.06950606861196465
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.00204918	0.06950606861196465
SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	0.00204918	0.06950606861196465
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00204918	0.06950606861196465
SYNDACTYLY, TYPE V	0.00204918	0.06950606861196465
FAMILIAL DIGITAL ARTHROPATHY-BRACHYDACTYLY	0.00204918	0.06950606861196465
TRICHO-RETINO-DENTO-DIGITAL SYNDROME	0.00204918	0.06950606861196465
SYMPHALANGISM, DISTAL	0.00204918	0.06950606861196465
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00204918	0.06950606861196465
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00196464	0.06663855914942086
MULIBREY NANISM	0.00196464	0.06663855914942086
ISOLATED TRIGONOCEPHALY	0.00196464	0.06663855914942086
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.00196464	0.06663855914942086
CRANIODIAPHYSEAL DYSPLASIA	0.00196464	0.06663855914942086
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.00196464	0.06663855914942086
MECKEL SYNDROME 12; MKS12	0.00196464	0.06663855914942086
RETINITIS PIGMENTOSA	0.00196464	0.06663855914942086
CRANIOMETAPHYSEAL DYSPLASIA	0.00196464	0.06663855914942086
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.00196464	0.06663855914942086
MARSHALL SYNDROME	0.00196464	0.06663855914942086
WAARDENBURG SYNDROME TYPE 1	0.00196464	0.06663855914942086
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00196464	0.06663855914942086
FRONTONASAL DYSPLASIA	0.00196464	0.06663855914942086
MEGALENCEPHALY	0.00196464	0.06663855914942086
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00196464	0.06663855914942086
DEAFNESS, X-LINKED 7; DFNX7	0.00196464	0.06663855914942086
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00196464	0.06663855914942086
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00196464	0.06663855914942086
FRONTONASAL DYSPLASIA 2; FND2	0.00196464	0.06663855914942086
PIEBALDISM	0.00196464	0.06663855914942086
ZECHI-CEIDE SYNDROME	0.00196464	0.06663855914942086
DILATED CARDIOMYOPATHY-HYPERGONADOTROPIC HYPOGONADISM SYNDROME	0.00196464	0.06663855914942086
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00196464	0.06663855914942086
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00196464	0.06663855914942086
ALAR CARTILAGES HYPOPLASIA-COLOBOMA-TELECANTHUS SYNDROME	0.00196464	0.06663855914942086
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.00196464	0.06663855914942086
BEEMER-ERTBRUGGEN SYNDROME	0.00196464	0.06663855914942086
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00196464	0.06663855914942086
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00196464	0.06663855914942086
MICROPHTHALMIA, SYNDROMIC 12	0.00196464	0.06663855914942086
DEAFNESS-CRANIOFACIAL SYNDROME	0.00196464	0.06663855914942086
BOOMERANG DYSPLASIA	0.00196464	0.06663855914942086
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00196464	0.06663855914942086
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.00196464	0.06663855914942086
AXENFELD-RIEGER SYNDROME	0.00196464	0.06663855914942086
WAARDENBURG SYNDROME, TYPE 1; WS1	0.00196464	0.06663855914942086
DIAMOND-BLACKFAN ANEMIA 8	0.00196464	0.06663855914942086
JUNG SYNDROME	0.00196464	0.06663855914942086
SCLEROSTEOSIS 1; SOST1	0.00196464	0.06663855914942086
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00196464	0.06663855914942086
DEAFNESS-CRANIOFACIAL SYNDROME	0.00196464	0.06663855914942086
OROFACIODIGITAL SYNDROME XV; OFD15	0.00196464	0.06663855914942086
NON-DISTAL TRISOMY 10Q	0.00180505	0.06122543122030608
HARTSFIELD SYNDROME	0.00180505	0.06122543122030608
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00180505	0.06122543122030608
MESOMELIA-SYNOSTOSES SYNDROME	0.00180505	0.06122543122030608
RESTRICTIVE DERMOPATHY	0.00180505	0.06122543122030608
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.00180505	0.06122543122030608
TRISOMY 1Q	0.00180505	0.06122543122030608
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.00180505	0.06122543122030608
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.00180505	0.06122543122030608
MEESTER-LOEYS SYNDROME; MRLS	0.00180505	0.06122543122030608
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.00180505	0.06122543122030608
ECTODERMAL DYSPLASIA 14, HAIR/TOOTH TYPE WITH OR WITHOUT HYPOHIDROSIS; ECTD14	0.00180505	0.06122543122030608
PROTEUS-LIKE SYNDROME	0.00180505	0.06122543122030608
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00180505	0.06122543122030608
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00180505	0.06122543122030608
JUVENILE POLYPOSIS SYNDROME	0.00180505	0.06122543122030608
MEMBRANOUS CRANIAL OSSIFICATION, DELAYED	0.00180505	0.06122543122030608
MARFAN SYNDROME; MFS	0.00180505	0.06122543122030608
RUVALCABA SYNDROME	0.00180505	0.06122543122030608
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00180505	0.06122543122030608
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.00180505	0.06122543122030608
APERT SYNDROME	0.00180505	0.06122543122030608
WAARDENBURG SYNDROME TYPE 3	0.00180505	0.06122543122030608
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00180505	0.06122543122030608
FRONTOMETAPHYSEAL DYSPLASIA	0.00180505	0.06122543122030608
2P15-16.1 MICRODELETION SYNDROME	0.00180505	0.06122543122030608
CAT-EYE SYNDROME (TYPE I)	0.00180505	0.06122543122030608
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.00180505	0.06122543122030608
CAT-EYE SYNDROME	0.00180505	0.06122543122030608
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.00180505	0.06122543122030608
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00180505	0.06122543122030608
THOMAS SYNDROME	0.00180505	0.06122543122030608
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00180505	0.06122543122030608
NOONAN SYNDROME 10; NS10	0.00180505	0.06122543122030608
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00180505	0.06122543122030608
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00180505	0.06122543122030608
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.00180505	0.06122543122030608
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00180505	0.06122543122030608
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00180505	0.06122543122030608
ACRO-RENAL-MANDIBULAR SYNDROME	0.00180505	0.06122543122030608
MARFAN SYNDROME	0.00180505	0.06122543122030608
CRANIOFACIAL-DEAFNESS-HAND SYNDROME	0.00180505	0.06122543122030608
PAI SYNDROME	0.00180505	0.06122543122030608
VENTRICULAR EXTRASYSTOLES WITH SYNCOPE, PERODACTYLY, AND ROBIN SEQUENCE	0.00180505	0.06122543122030608
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00180505	0.06122543122030608
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.00163132	0.055332689099088506
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00163132	0.055332689099088506
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00163132	0.055332689099088506
NASODIGITOACOUSTIC SYNDROME	0.00163132	0.055332689099088506
LICHTENSTEIN SYNDROME	0.00163132	0.055332689099088506
FETAL VALPROATE SYNDROME	0.00163132	0.055332689099088506
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00163132	0.055332689099088506
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.00163132	0.055332689099088506
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.00163132	0.055332689099088506
SCHOLTE SYNDROME; SHLTS	0.00163132	0.055332689099088506
RENAL AGENESIS, BILATERAL	0.00163132	0.055332689099088506
MONOSOMY X	0.00163132	0.055332689099088506
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00163132	0.055332689099088506
TURNER SYNDROME	0.00163132	0.055332689099088506
HYPOTONIA-CYSTINURIA SYNDROME	0.00163132	0.055332689099088506
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00163132	0.055332689099088506
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00163132	0.055332689099088506
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00163132	0.055332689099088506
EPICANTHUS	0.00163132	0.055332689099088506
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.00163132	0.055332689099088506
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00163132	0.055332689099088506
PENOSCROTAL TRANSPOSITION	0.00163132	0.055332689099088506
PFEIFFER-PALM-TELLER SYNDROME	0.00163132	0.055332689099088506
FOCAL FACIAL DERMAL DYSPLASIA 3, SETLEIS TYPE	0.00163132	0.055332689099088506
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00163132	0.055332689099088506
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.00163132	0.055332689099088506
PRIMARY PULMONARY HYPOPLASIA	0.00163132	0.055332689099088506
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00163132	0.055332689099088506
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00163132	0.055332689099088506
WHITE FORELOCK WITH MALFORMATIONS	0.00163132	0.055332689099088506
DUANE-RADIAL RAY SYNDROME; DRRS	0.00163132	0.055332689099088506
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00163132	0.055332689099088506
MOSAIC MONOSOMY X	0.00163132	0.055332689099088506
JUBERG-MARSIDI SYNDROME	0.00163132	0.055332689099088506
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00163132	0.055332689099088506
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.00163132	0.055332689099088506
BRITTLE CORNEA SYNDROME	0.00163132	0.055332689099088506
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.00163132	0.055332689099088506
CHROMOSOME 13Q14 DELETION SYNDROME	0.00163132	0.055332689099088506
STICKLER SYNDROME	0.00163132	0.055332689099088506
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00163132	0.055332689099088506
COFFIN-SIRIS SYNDROME 10; CSS10	0.00163132	0.055332689099088506
HYPOGLOSSIA-HYPODACTYLIA	0.00163132	0.055332689099088506
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00163132	0.055332689099088506
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00163132	0.055332689099088506
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00163132	0.055332689099088506
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.001086973	0.03686900121870849
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.001086973	0.03686900121870849
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.03686900121870849
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001086973	0.03686900121870849
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001086973	0.03686900121870849
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.001086973	0.03686900121870849
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001086973	0.03686900121870849
CLASSIC PHENYLKETONURIA	0.001086973	0.03686900121870849
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.001086973	0.03686900121870849
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001086973	0.03686900121870849
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.001086973	0.03686900121870849
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001086973	0.03686900121870849
17Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.03686900121870849
LEBER CONGENITAL AMAUROSIS	0.001086973	0.03686900121870849
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.03686900121870849
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001086973	0.03686900121870849
ALSTRÖM SYNDROME	0.001086973	0.03686900121870849
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.03686900121870849
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001086973	0.03686900121870849
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001086973	0.03686900121870849
HOLOPROSENCEPHALY 2; HPE2	0.001086973	0.03686900121870849
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.03686900121870849
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001086973	0.03686900121870849
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001086973	0.03686900121870849
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.001086973	0.03686900121870849
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.03686900121870849
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001086973	0.03686900121870849
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.03686900121870849
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001086973	0.03686900121870849
PYRUVATE CARBOXYLASE DEFICIENCY	0.001086973	0.03686900121870849
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.001086973	0.03686900121870849
NETHERTON SYNDROME	0.001086973	0.03686900121870849
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001086973	0.03686900121870849
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.001086973	0.03686900121870849
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001086973	0.03686900121870849
ALG3-CDG	0.001086973	0.03686900121870849
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001086973	0.03686900121870849
PFEIFFER SYNDROME TYPE 2	0.001086973	0.03686900121870849
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001086973	0.03686900121870849
CONGENITAL DISORDER OF GLYCOSYLATION	0.001086973	0.03686900121870849
ALG1-CDG	0.001086973	0.03686900121870849
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.001086973	0.03686900121870849
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.001086973	0.03686900121870849
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001086973	0.03686900121870849
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001086973	0.03686900121870849
GAUCHER DISEASE, TYPE II	0.001086973	0.03686900121870849
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.001086973	0.03686900121870849
MAPLE SYRUP URINE DISEASE	0.001086973	0.03686900121870849
METHYLMALONIC ACIDURIA, CBLA TYPE	0.001086973	0.03686900121870849
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001086973	0.03686900121870849
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001086973	0.03686900121870849
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001086973	0.03686900121870849
2P21 MICRODELETION SYNDROME	0.001086973	0.03686900121870849
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001086973	0.03686900121870849
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.001086973	0.03686900121870849
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001086973	0.03686900121870849
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.001086973	0.03686900121870849
FOLATE MALABSORPTION, HEREDITARY	0.001086973	0.03686900121870849
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.03686900121870849
JOUBERT SYNDROME 30; JBTS30	0.001086973	0.03686900121870849
COACH SYNDROME	0.001086973	0.03686900121870849
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001086973	0.03686900121870849
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001086973	0.03686900121870849
HARTNUP DISORDER	0.001086973	0.03686900121870849
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.03686900121870849
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.03686900121870849
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001086973	0.03686900121870849
HOLOPROSENCEPHALY 1; HPE1	0.001086973	0.03686900121870849
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001086973	0.03686900121870849
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.03686900121870849
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.03686900121870849
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.001086973	0.03686900121870849
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001086973	0.03686900121870849
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001086973	0.03686900121870849
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001086973	0.03686900121870849
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001086973	0.03686900121870849
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.001086973	0.03686900121870849
CRANIOPHARYNGIOMA	0.001086973	0.03686900121870849
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001086973	0.03686900121870849
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001086973	0.03686900121870849
MULTIPLE CARBOXYLASE DEFICIENCY	0.001086973	0.03686900121870849
CHÉDIAK-HIGASHI SYNDROME	0.001086973	0.03686900121870849
ELEJALDE DISEASE	0.001086973	0.03686900121870849
MULTIPLE SULFATASE DEFICIENCY	0.001086973	0.03686900121870849
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.001086973	0.03686900121870849
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001086973	0.03686900121870849
LEIGH SYNDROME; LS	0.001086973	0.03686900121870849
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.03686900121870849
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.001086973	0.03686900121870849
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001086973	0.03686900121870849
ARGININOSUCCINIC ACIDURIA	0.001086973	0.03686900121870849
WYBURN-MASON SYNDROME	0.001086973	0.03686900121870849
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.001086973	0.03686900121870849
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.03686900121870849
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.03686900121870849
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001086973	0.03686900121870849
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001086973	0.03686900121870849
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001086973	0.03686900121870849
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001086973	0.03686900121870849
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.03686900121870849
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001086973	0.03686900121870849
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.03686900121870849
KLEEFSTRA SYNDROME 2; KLEFS2	0.001086973	0.03686900121870849
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.001086973	0.03686900121870849
SHASHI-PENA SYNDROME; SHAPNS	0.001086973	0.03686900121870849
CITRULLINEMIA, CLASSIC	0.001086973	0.03686900121870849
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001086973	0.03686900121870849
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001086973	0.03686900121870849
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.03686900121870849
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001086973	0.03686900121870849
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.03686900121870849
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001086973	0.03686900121870849
PROPIONIC ACIDEMIA	0.001086973	0.03686900121870849
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.001086973	0.03686900121870849
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001086973	0.03686900121870849
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.03686900121870849
AICARDI-GOUTIERES SYNDROME 7	0.001086973	0.03686900121870849
PHACE ASSOCIATION	0.001086973	0.03686900121870849
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.03686900121870849
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.001086973	0.03686900121870849
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.001086973	0.03686900121870849
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.03686900121870849
LISSENCEPHALY 1; LIS1	0.001086973	0.03686900121870849
NIEMANN-PICK DISEASE, TYPE C2	0.001086973	0.03686900121870849
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.001086973	0.03686900121870849
CHROMOSOME 5Q12 DELETION SYNDROME	0.001086973	0.03686900121870849
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001086973	0.03686900121870849
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.001086973	0.03686900121870849
CONGENITAL TOXOPLASMOSIS	0.001086973	0.03686900121870849
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.001086973	0.03686900121870849
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001086973	0.03686900121870849
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001086973	0.03686900121870849
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001086973	0.03686900121870849
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.03686900121870849
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001086973	0.03686900121870849
DPAGT1-CDG	0.001086973	0.03686900121870849
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001086973	0.03686900121870849
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.001086973	0.03686900121870849
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001086973	0.03686900121870849
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.03686900121870849
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.03686900121870849
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001086973	0.03686900121870849
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001086973	0.03686900121870849
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.001086973	0.03686900121870849
GALACTOSEMIA	0.001086973	0.03686900121870849
FUCOSIDOSIS	0.001086973	0.03686900121870849
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001086973	0.03686900121870849
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001086973	0.03686900121870849
CHROMOSOME 2Q37 DELETION SYNDROME	0.001086973	0.03686900121870849
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001086973	0.03686900121870849
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001086973	0.03686900121870849
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001086973	0.03686900121870849
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.001086973	0.03686900121870849
HYDRANENCEPHALY	0.001086973	0.03686900121870849
TIMOTHY SYNDROME; TS	0.001086973	0.03686900121870849
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.03686900121870849
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.001086973	0.03686900121870849
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001086973	0.03686900121870849
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.03686900121870849
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.03686900121870849
ISOVALERIC ACIDEMIA	0.001086973	0.03686900121870849
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001086973	0.03686900121870849
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.001086973	0.03686900121870849
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.001086973	0.03686900121870849
NEPHROGENIC DIABETES INSIPIDUS	0.001086973	0.03686900121870849
SRD5A3-CDG	0.001086973	0.03686900121870849
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.001086973	0.03686900121870849
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.001086973	0.03686900121870849
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001086973	0.03686900121870849
SCHINDLER DISEASE, TYPE I	0.001086973	0.03686900121870849
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001086973	0.03686900121870849
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.03686900121870849
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001086973	0.03686900121870849
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.001086973	0.03686900121870849
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001086973	0.03686900121870849
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001086973	0.03686900121870849
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.03686900121870849
PONTINE TEGMENTAL CAP DYSPLASIA	0.001086973	0.03686900121870849
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001086973	0.03686900121870849
COFFIN-SIRIS SYNDROME 4; CSS4	0.001086973	0.03686900121870849
COFFIN-SIRIS SYNDROME 3; CSS3	0.001086973	0.03686900121870849
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.001086973	0.03686900121870849
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001086973	0.03686900121870849
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001086973	0.03686900121870849
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.001086973	0.03686900121870849
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.001086973	0.03686900121870849
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001086973	0.03686900121870849
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.001086973	0.03686900121870849
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.03686900121870849
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.03686900121870849
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.03686900121870849
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001086973	0.03686900121870849
LISSENCEPHALY 4	0.001086973	0.03686900121870849
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001086973	0.03686900121870849
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001086973	0.03686900121870849
17Q12 MICRODELETION SYNDROME	0.001086973	0.03686900121870849
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.001086973	0.03686900121870849
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001086973	0.03686900121870849
XP21 MICRODELETION SYNDROME	0.001086973	0.03686900121870849
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.001086973	0.03686900121870849
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.03686900121870849
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.03686900121870849
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.001086973	0.03686900121870849
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001086973	0.03686900121870849
RFT1-CDG	0.001086973	0.03686900121870849
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001086973	0.03686900121870849
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.03686900121870849
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001086973	0.03686900121870849
CITRULLINEMIA TYPE II	0.001086973	0.03686900121870849
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001086973	0.03686900121870849
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.001086973	0.03686900121870849
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.03686900121870849
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.001086973	0.03686900121870849
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.03686900121870849
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.001086973	0.03686900121870849
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.03686900121870849
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.03686900121870849
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.03686900121870849
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001086973	0.03686900121870849
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.001086973	0.03686900121870849
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001086973	0.03686900121870849
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001086973	0.03686900121870849
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.03686900121870849
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001086973	0.03686900121870849
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001086973	0.03686900121870849
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001086973	0.03686900121870849
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001086973	0.03686900121870849
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.03686900121870849
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.03686900121870849
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001086973	0.03686900121870849
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001086973	0.03686900121870849
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001086973	0.03686900121870849
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001086973	0.03686900121870849
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001086973	0.03686900121870849
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001086973	0.03686900121870849
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.03686900121870849
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.03686900121870849
GLYCEROL KINASE DEFICIENCY; GKD	0.001086973	0.03686900121870849
CHROMOSOME 16P13.2 DELETION SYNDROME	0.001086973	0.03686900121870849
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001086973	0.03686900121870849
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001086973	0.03686900121870849
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001086973	0.03686900121870849
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.001086973	0.03686900121870849
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001086973	0.03686900121870849
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.03686900121870849
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.03686900121870849
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001086973	0.03686900121870849
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.03686900121870849
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.001086973	0.03686900121870849
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001086973	0.03686900121870849
EAST SYNDROME	0.001086973	0.03686900121870849
ADULT-ONSET DYSTONIA-PARKINSONISM	0.001086973	0.03686900121870849
GRISCELLI SYNDROME	0.001086973	0.03686900121870849
STT3A-CDG	0.001086973	0.03686900121870849
STT3B-CDG	0.001086973	0.03686900121870849
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.03686900121870849
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.03686900121870849
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.03686900121870849
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001086973	0.03686900121870849
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.001086973	0.03686900121870849
COFFIN-SIRIS SYNDROME 5	0.001086973	0.03686900121870849
SULFOCYSTEINURIA	0.001086973	0.03686900121870849
KEUTEL SYNDROME	0.001086973	0.03686900121870849
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.03686900121870849
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001086973	0.03686900121870849
PELIZAEUS-MERZBACHER DISEASE	0.001086973	0.03686900121870849
OPTIC PATHWAY GLIOMA	0.001086973	0.03686900121870849
ALG6-CDG	0.000545554	0.018504628073439992
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.018504628073439992
NAVAJO NEUROHEPATOPATHY	0.000545554	0.018504628073439992
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.018504628073439992
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.018504628073439992
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.018504628073439992
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.018504628073439992
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.018504628073439992
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.018504628073439992
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000545554	0.018504628073439992
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.018504628073439992
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.018504628073439992
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.018504628073439992
NIEMANN-PICK DISEASE, TYPE A	0.000545554	0.018504628073439992
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.018504628073439992
CONGENITAL VARICELLA SYNDROME	0.000545554	0.018504628073439992
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.018504628073439992
JOUBERT SYNDROME 6	0.000545554	0.018504628073439992
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.018504628073439992
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.018504628073439992
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.018504628073439992
JOUBERT SYNDROME 7	0.000545554	0.018504628073439992
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.018504628073439992
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.018504628073439992
JOUBERT SYNDROME 27	0.000545554	0.018504628073439992
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.000545554	0.018504628073439992
JOUBERT SYNDROME 25	0.000545554	0.018504628073439992
8P23.1 DUPLICATION SYNDROME	0.000545554	0.018504628073439992
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.018504628073439992
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.000545554	0.018504628073439992
TYSHCHENKO SYNDROME	0.000545554	0.018504628073439992
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.018504628073439992
ATHYREOSIS	0.000545554	0.018504628073439992
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.018504628073439992
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000545554	0.018504628073439992
MUCOLIPIDOSIS IV; ML4	0.000545554	0.018504628073439992
REVESZ SYNDROME	0.000545554	0.018504628073439992
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.018504628073439992
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.018504628073439992
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.018504628073439992
HOLOPROSENCEPHALY 11	0.000545554	0.018504628073439992
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.018504628073439992
CRANIOSYNOSTOSIS 6; CRS6	0.000545554	0.018504628073439992
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.018504628073439992
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.000545554	0.018504628073439992
TRANSALDOLASE DEFICIENCY	0.000545554	0.018504628073439992
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.018504628073439992
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.018504628073439992
SENIOR-LOKEN SYNDROME 9	0.000545554	0.018504628073439992
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.018504628073439992
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.018504628073439992
JOUBERT SYNDROME 28	0.000545554	0.018504628073439992
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.018504628073439992
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.018504628073439992
NETHERTON SYNDROME; NETH	0.000545554	0.018504628073439992
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.018504628073439992
DYSKERATOSIS CONGENITA	0.000545554	0.018504628073439992
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000545554	0.018504628073439992
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.018504628073439992
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.018504628073439992
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000545554	0.018504628073439992
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.018504628073439992
JOUBERT SYNDROME 26	0.000545554	0.018504628073439992
PEROXISOME BIOGENESIS DISORDER 6B	0.000545554	0.018504628073439992
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.018504628073439992
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.018504628073439992
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.018504628073439992
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.018504628073439992
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.018504628073439992
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000545554	0.018504628073439992
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.018504628073439992
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.018504628073439992
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.018504628073439992
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.018504628073439992
HYDROXYKYNURENINURIA	0.000545554	0.018504628073439992
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.018504628073439992
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.018504628073439992
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.018504628073439992
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.018504628073439992
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.018504628073439992
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.018504628073439992
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.018504628073439992
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000545554	0.018504628073439992
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.018504628073439992
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.018504628073439992
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000545554	0.018504628073439992
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000545554	0.018504628073439992
JOUBERT SYNDROME 15	0.000545554	0.018504628073439992
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.018504628073439992
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.018504628073439992
ISOLATED COMPLEX I DEFICIENCY	0.000545554	0.018504628073439992
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000545554	0.018504628073439992
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.018504628073439992
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.018504628073439992
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.018504628073439992
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.018504628073439992
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.018504628073439992
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.018504628073439992
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.018504628073439992
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.018504628073439992
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.018504628073439992
OROTIC ACIDURIA	0.000545554	0.018504628073439992
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000545554	0.018504628073439992
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.018504628073439992
WOLMAN DISEASE	0.000545554	0.018504628073439992
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.018504628073439992
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.018504628073439992
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.018504628073439992
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.018504628073439992
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.018504628073439992
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.018504628073439992
JOUBERT SYNDROME 8	0.000545554	0.018504628073439992
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000545554	0.018504628073439992
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.018504628073439992
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.018504628073439992
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.018504628073439992
OROFACIODIGITAL SYNDROME TYPE 14	0.000545554	0.018504628073439992
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.018504628073439992
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.018504628073439992
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.018504628073439992
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.018504628073439992
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.018504628073439992
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000545554	0.018504628073439992
PELLAGRA-LIKE SYNDROME	0.000545554	0.018504628073439992
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.018504628073439992
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.018504628073439992
WAARDENBURG-SHAH SYNDROME	0.000545554	0.018504628073439992
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.018504628073439992
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.018504628073439992
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.018504628073439992
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.018504628073439992
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.018504628073439992
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.018504628073439992
FARBER DISEASE	0.000545554	0.018504628073439992
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.018504628073439992
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000545554	0.018504628073439992
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.018504628073439992
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.018504628073439992
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.018504628073439992
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.018504628073439992
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.018504628073439992
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.018504628073439992
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.000545554	0.018504628073439992
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.018504628073439992
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.018504628073439992
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.018504628073439992
HOYERAAL-HREIDARSSON SYNDROME	0.000545554	0.018504628073439992
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.018504628073439992
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.018504628073439992
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.018504628073439992
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.018504628073439992
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.018504628073439992
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.018504628073439992
BARDET-BIEDL SYNDROME 2	0.000545554	0.018504628073439992
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.018504628073439992
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.018504628073439992
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.018504628073439992
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.018504628073439992
CDAGS SYNDROME	0.000545554	0.018504628073439992
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.018504628073439992
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.018504628073439992
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.018504628073439992
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.018504628073439992
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000545554	0.018504628073439992
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.018504628073439992
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.018504628073439992
CURRY-JONES SYNDROME	0.000545554	0.018504628073439992
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.018504628073439992
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.018504628073439992
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.018504628073439992
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.018504628073439992
YUNIS-VARON SYNDROME	0.000545554	0.018504628073439992
LOWRY-MACLEAN SYNDROME	0.000545554	0.018504628073439992
PROPIONIC ACIDEMIA	0.000545554	0.018504628073439992
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000545554	0.018504628073439992
ISOLATED PLAGIOCEPHALY	0.000545554	0.018504628073439992
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.018504628073439992
EPIDERMAL NEVUS SYNDROME	0.000545554	0.018504628073439992
HYDROXYKYNURENINURIA	0.000545554	0.018504628073439992
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.018504628073439992
ARIMA SYNDROME	0.000545554	0.018504628073439992
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.018504628073439992
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.018504628073439992
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.018504628073439992
MECKEL SYNDROME 13; MKS13	0.000545554	0.018504628073439992
TRANSKETOLASE DEFICIENCY	0.000545554	0.018504628073439992
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.018504628073439992
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.018504628073439992
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.018504628073439992
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.018504628073439992
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.018504628073439992
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.018504628073439992
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.018504628073439992
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.018504628073439992
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.018504628073439992
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.018504628073439992
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000545554	0.018504628073439992
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.018504628073439992
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000545554	0.018504628073439992
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.000545554	0.018504628073439992
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.018504628073439992
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.018504628073439992
HYPERTRYPTOPHANEMIA; HYPTRP	0.000545554	0.018504628073439992
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.018504628073439992
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.018504628073439992
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.018504628073439992
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.018504628073439992
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000545554	0.018504628073439992
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.018504628073439992
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.018504628073439992
SENIOR-LOKEN SYNDROME	0.000545554	0.018504628073439992
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.018504628073439992
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.018504628073439992
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.018504628073439992
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.018504628073439992
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.000545554	0.018504628073439992
SECKEL SYNDROME 8; SCKL8	0.000545554	0.018504628073439992
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.018504628073439992
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.018504628073439992
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.018504628073439992
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.018504628073439992
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.018504628073439992
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.018504628073439992
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.018504628073439992
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.018504628073439992
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000545554	0.018504628073439992
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.018504628073439992
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.018504628073439992
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.018504628073439992
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.018504628073439992
SEPTOOPTIC DYSPLASIA	0.000545554	0.018504628073439992
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.018504628073439992
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.018504628073439992
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.018504628073439992
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000545554	0.018504628073439992
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.018504628073439992
JOUBERT SYNDROME 21	0.000545554	0.018504628073439992
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.018504628073439992
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.018504628073439992
USHER SYNDROME TYPE 1	0.000545554	0.018504628073439992
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.018504628073439992
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.018504628073439992
AUSTRALIA ANTIGEN	0.000545554	0.018504628073439992
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.018504628073439992
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.018504628073439992
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.018504628073439992
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.018504628073439992
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.018504628073439992
CURRARINO SYNDROME	0.000545554	0.018504628073439992
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.018504628073439992
THYROID HYPOPLASIA	0.000545554	0.018504628073439992
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.018504628073439992
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000545554	0.018504628073439992
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.018504628073439992
CULLER-JONES SYNDROME; CJS	0.000545554	0.018504628073439992
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.018504628073439992
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.018504628073439992
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.018504628073439992
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000545554	0.018504628073439992
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.018504628073439992
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.018504628073439992
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.018504628073439992
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.000545554	0.018504628073439992
LIG4 SYNDROME	0.000545554	0.018504628073439992
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.018504628073439992
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.018504628073439992
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.018504628073439992
MICROVILLUS INCLUSION DISEASE	0.000545554	0.018504628073439992
ALSTROM SYNDROME; ALMS	0.000545554	0.018504628073439992
SJÖGREN-LARSSON SYNDROME	0.000541419	0.018364373145268495
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.018364373145268495
ADDISON DISEASE	0.000541419	0.018364373145268495
FETAL GAUCHER DISEASE	0.000541419	0.018364373145268495
INSULINOMA	0.000541419	0.018364373145268495
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.018364373145268495
ACUTE ADRENAL INSUFFICIENCY	0.000541419	0.018364373145268495
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.018364373145268495
HADDAD SYNDROME	0.000541419	0.018364373145268495
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.000541419	0.018364373145268495
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.018364373145268495
PFEIFFER SYNDROME TYPE 3	0.000541419	0.018364373145268495
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.018364373145268495
LASSA FEVER	0.000541419	0.018364373145268495
NIPAH VIRUS DISEASE	0.000541419	0.018364373145268495
ENCEPHALITIS LETHARGICA	0.000541419	0.018364373145268495
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.018364373145268495
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.018364373145268495
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.018364373145268495
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.018364373145268495
TRIPLE A SYNDROME	0.000541419	0.018364373145268495
SYSTEMIC SCLEROSIS	0.000541419	0.018364373145268495
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.018364373145268495
SCRUB TYPHUS	0.000541419	0.018364373145268495
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.018364373145268495
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.018364373145268495
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.018364373145268495
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.018364373145268495
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.018364373145268495
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.018364373145268495
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.018364373145268495
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.018364373145268495
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.018364373145268495
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.018364373145268495
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.018364373145268495
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.018364373145268495
GURRIERI SYNDROME	0.000541419	0.018364373145268495
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.018364373145268495
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000541419	0.018364373145268495
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.018364373145268495
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.018364373145268495
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.018364373145268495
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.018364373145268495
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.018364373145268495
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.018364373145268495
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.018364373145268495
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.018364373145268495
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.018364373145268495
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.018364373145268495
LOWE OCULOCEREBRORENAL SYNDROME	0.000541419	0.018364373145268495
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.018364373145268495
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.018364373145268495
THREONINEMIA	0.000541419	0.018364373145268495
THYROCEREBRORETINAL SYNDROME	0.000541419	0.018364373145268495
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.018364373145268495
ADRENOLEUKODYSTROPHY	0.000541419	0.018364373145268495
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.018364373145268495
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.018364373145268495
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.018364373145268495
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.018364373145268495
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.018364373145268495
INCONTINENTIA PIGMENTI; IP	0.000541419	0.018364373145268495
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.018364373145268495
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.018364373145268495
IMMUNODEFICIENCY 47	0.000541419	0.018364373145268495
FABRY DISEASE	0.000541419	0.018364373145268495
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.018364373145268495
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.018364373145268495
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.018364373145268495
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.018364373145268495
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.018364373145268495
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.018364373145268495
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.018364373145268495
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.018364373145268495
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.018364373145268495
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.018364373145268495
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.018364373145268495
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.018364373145268495
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.018364373145268495
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.018364373145268495
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.018364373145268495
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.018364373145268495
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.018364373145268495
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.018364373145268495
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.018364373145268495
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.018364373145268495
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.018364373145268495
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.018364373145268495
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.018364373145268495
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000541419	0.018364373145268495
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000541419	0.018364373145268495
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.018364373145268495
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.000541419	0.018364373145268495
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.018364373145268495
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.018364373145268495
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.000541419	0.018364373145268495
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.018364373145268495
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.018364373145268495
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.000541419	0.018364373145268495
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.018364373145268495
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.000541419	0.018364373145268495
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.018364373145268495
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.018364373145268495
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.000541419	0.018364373145268495
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.018364373145268495
COWDEN SYNDROME 6; CWS6	0.000541419	0.018364373145268495
RETINITIS PIGMENTOSA 59; RP59	0.000541419	0.018364373145268495
PERRAULT SYNDROME 3	0.000541419	0.018364373145268495
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.018364373145268495
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.018364373145268495
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.018364373145268495
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.018364373145268495
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.018364373145268495
COWDEN SYNDROME 5; CWS5	0.000541419	0.018364373145268495
TAY-SACHS DISEASE; TSD	0.000541419	0.018364373145268495
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.018364373145268495
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.000541419	0.018364373145268495
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.018364373145268495
SNEDDON SYNDROME	0.000541419	0.018364373145268495
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.018364373145268495
STURGE-WEBER SYNDROME	0.000541419	0.018364373145268495
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.018364373145268495
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.018364373145268495
ALEXANDER DISEASE	0.000541419	0.018364373145268495
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.018364373145268495
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.018364373145268495
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.018364373145268495
PARIETAL FORAMINA	0.000541419	0.018364373145268495
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.018364373145268495
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.018364373145268495
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.018364373145268495
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000541419	0.018364373145268495
DIAMINOPENTANURIA	0.000541419	0.018364373145268495
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.018364373145268495
DYSOSTEOSCLEROSIS	0.000541419	0.018364373145268495
EPILEPSY-TELANGIECTASIA	0.000541419	0.018364373145268495
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.000541419	0.018364373145268495
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.018364373145268495
FOUNTAIN SYNDROME	0.000541419	0.018364373145268495
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.018364373145268495
1P36 MICRODELETION SYNDROME	0.000541419	0.018364373145268495
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.018364373145268495
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.018364373145268495
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.000541419	0.018364373145268495
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.018364373145268495
PAPILLORENAL SYNDROME	0.000541419	0.018364373145268495
CROUZON SYNDROME	0.000541419	0.018364373145268495
DARIER-WHITE DISEASE; DAR	0.000541419	0.018364373145268495
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.018364373145268495
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.018364373145268495
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.018364373145268495
FLYNN-AIRD SYNDROME	0.000541419	0.018364373145268495
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.018364373145268495
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.018364373145268495
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.018364373145268495
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.018364373145268495
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.018364373145268495
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.018364373145268495
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.018364373145268495
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.018364373145268495
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.018364373145268495
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.018364373145268495
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.018364373145268495
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.000541419	0.018364373145268495
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.018364373145268495
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.018364373145268495
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.018364373145268495
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.018364373145268495
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.000541419	0.018364373145268495
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.018364373145268495
NEURAMINIDASE DEFICIENCY	0.000541419	0.018364373145268495
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.018364373145268495
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.018364373145268495
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.018364373145268495
PHENYLKETONURIA	0.000541419	0.018364373145268495
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.018364373145268495
GITELMAN SYNDROME	0.000541419	0.018364373145268495
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.018364373145268495
RAMON SYNDROME	0.000541419	0.018364373145268495
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.018364373145268495
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.018364373145268495
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.018364373145268495
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.018364373145268495
HYPERPROLINEMIA, TYPE II	0.000541419	0.018364373145268495
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.018364373145268495
BERNARD-SOULIER SYNDROME	0.000541419	0.018364373145268495
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.018364373145268495
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.018364373145268495
HYPER-BETA-ALANINEMIA	0.000541419	0.018364373145268495
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.018364373145268495
HYPERLYSINEMIA, TYPE I	0.000541419	0.018364373145268495
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.018364373145268495
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.018364373145268495
MAPLE SYRUP URINE DISEASE; MSUD	0.000541419	0.018364373145268495
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.018364373145268495
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.018364373145268495
HYPOPHOSPHATASIA, INFANTILE	0.000541419	0.018364373145268495
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.018364373145268495
KAPUR-TORIELLO SYNDROME	0.000541419	0.018364373145268495
KIFAFA SEIZURE DISORDER	0.000541419	0.018364373145268495
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.018364373145268495
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000541419	0.018364373145268495
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.018364373145268495
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.000541419	0.018364373145268495
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.018364373145268495
WOLFRAM SYNDROME	0.000541419	0.018364373145268495
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.018364373145268495
TAKAYASU ARTERITIS	0.000541419	0.018364373145268495
MERCURY POISONING	0.000541419	0.018364373145268495
THYROCEREBRORENAL SYNDROME	0.000541419	0.018364373145268495
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.018364373145268495
VIRAL HEMORRHAGIC FEVER	0.000541419	0.018364373145268495
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.018364373145268495
WHIPPLE DISEASE	0.000541419	0.018364373145268495
WORSTER-DROUGHT SYNDROME	0.000541419	0.018364373145268495
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.018364373145268495
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.018364373145268495
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.018364373145268495
GALACTOSIALIDOSIS	0.000541419	0.018364373145268495
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.018364373145268495
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.018364373145268495
GLIOBLASTOMA	0.000541419	0.018364373145268495
ADIPOSIS DOLOROSA	0.000541419	0.018364373145268495
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.018364373145268495
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.018364373145268495
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.018364373145268495
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.018364373145268495
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.018364373145268495
TYROSINEMIA TYPE 2	0.000541419	0.018364373145268495
CONGENITAL RUBELLA SYNDROME	0.000541419	0.018364373145268495
CRONKHITE-CANADA SYNDROME	0.000541419	0.018364373145268495
PORENCEPHALY	0.000541419	0.018364373145268495
PROLACTINOMA	0.000541419	0.018364373145268495
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.018364373145268495
RAMON SYNDROME	0.000541419	0.018364373145268495
ISOLATED BILIARY ATRESIA	0.000541419	0.018364373145268495
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.018364373145268495
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.000541419	0.018364373145268495
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.018364373145268495
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.018364373145268495
NOCARDIOSIS	0.000541419	0.018364373145268495
LUJO HEMORRHAGIC FEVER	0.000541419	0.018364373145268495
EBOLA HEMORRHAGIC FEVER	0.000541419	0.018364373145268495
RIFT VALLEY FEVER	0.000541419	0.018364373145268495
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.018364373145268495
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.018364373145268495
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.018364373145268495
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.018364373145268495
MICROFORM HOLOPROSENCEPHALY	0.000541419	0.018364373145268495
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.018364373145268495
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.018364373145268495
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.018364373145268495
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.018364373145268495
EPISODIC ATAXIA TYPE 3	0.000541419	0.018364373145268495
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.018364373145268495
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.018364373145268495
HEREDITARY COPROPORPHYRIA	0.000541419	0.018364373145268495
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.018364373145268495
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.000541419	0.018364373145268495
FAMILIAL THROMBOCYTOSIS	0.000541419	0.018364373145268495
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.018364373145268495
MPDU1-CDG	0.000541419	0.018364373145268495
ALG2-CDG	0.000541419	0.018364373145268495
ALG9-CDG	0.000541419	0.018364373145268495
MOGS-CDG	0.000541419	0.018364373145268495
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.018364373145268495
PORPHYRIA VARIEGATA	0.000541419	0.018364373145268495
GRISCELLI SYNDROME TYPE 2	0.000541419	0.018364373145268495
PORPHYRIA	0.000541419	0.018364373145268495
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.018364373145268495
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.018364373145268495
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.000541419	0.018364373145268495
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.018364373145268495
HYPERPROLINEMIA TYPE 1	0.000541419	0.018364373145268495
HYPOPHOSPHATASIA	0.000541419	0.018364373145268495
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.018364373145268495
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.018364373145268495
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.018364373145268495
WHIM SYNDROME	0.000541419	0.018364373145268495
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.018364373145268495
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.018364373145268495
ONDINE SYNDROME	0.000541419	0.018364373145268495
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.018364373145268495
MICROPHTHALMIA, LENZ TYPE	0.000541419	0.018364373145268495
MYASTHENIA GRAVIS	0.000541419	0.018364373145268495
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.018364373145268495
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.018364373145268495
RECURRENT ACUTE PANCREATITIS	0.000541419	0.018364373145268495
NEVUS COMEDONICUS SYNDROME	0.000541419	0.018364373145268495
LHERMITTE-DUCLOS DISEASE	0.000541419	0.018364373145268495
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.018364373145268495
NASU-HAKOLA DISEASE	0.000541419	0.018364373145268495
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.018364373145268495
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.018364373145268495
ROMANO-WARD SYNDROME	0.000541419	0.018364373145268495
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.018364373145268495
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.018364373145268495
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.018364373145268495
BETA-MANNOSIDOSIS	0.000541419	0.018364373145268495
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.018364373145268495
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.018364373145268495
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.018364373145268495
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.018364373145268495
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.018364373145268495
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.018364373145268495
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.018364373145268495
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.018364373145268495
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.018364373145268495
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.018364373145268495
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.018364373145268495
CRISPONI SYNDROME	0.000541419	0.018364373145268495
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.018364373145268495
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.018364373145268495
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.018364373145268495
ROSAÏ-DORFMAN DISEASE	0.000541419	0.018364373145268495
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000541419	0.018364373145268495
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000541419	0.018364373145268495
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000541419	0.018364373145268495
PSEUDO-TORCH SYNDROME 2	0.000541419	0.018364373145268495
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.018364373145268495
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.000541419	0.018364373145268495
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.018364373145268495
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.000541419	0.018364373145268495
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.018364373145268495
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.018364373145268495
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.018364373145268495
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000541419	0.018364373145268495
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.018364373145268495
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.018364373145268495
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.018364373145268495
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.018364373145268495
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.018364373145268495
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000541419	0.018364373145268495
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.018364373145268495
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.018364373145268495
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.018364373145268495
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.018364373145268495
MICROSPORIDIOSIS	0.000541419	0.018364373145268495
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.000541419	0.018364373145268495
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.018364373145268495
SANJAD-SAKATI SYNDROME	0.000541419	0.018364373145268495
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.018364373145268495
CITRULLINEMIA TYPE I	0.000541419	0.018364373145268495
AICA-RIBOSIDURIA	0.000541419	0.018364373145268495
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.018364373145268495
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.018364373145268495
MOYAMOYA DISEASE	0.000541419	0.018364373145268495
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.018364373145268495
MOYNAHAN SYNDROME	0.000541419	0.018364373145268495
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.018364373145268495
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.018364373145268495
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.018364373145268495
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.018364373145268495
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.018364373145268495
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.018364373145268495
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.018364373145268495
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.018364373145268495
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.018364373145268495
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.018364373145268495
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.018364373145268495
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.018364373145268495
CENTRAL DIABETES INSIPIDUS	0.000541419	0.018364373145268495
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.018364373145268495
FRONTAL ENCEPHALOCELE	0.000541419	0.018364373145268495
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.018364373145268495
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.018364373145268495
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.018364373145268495
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.018364373145268495
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.000541419	0.018364373145268495
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.018364373145268495
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.018364373145268495
CRIGLER-NAJJAR SYNDROME	0.000541419	0.018364373145268495
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.000541419	0.018364373145268495
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.018364373145268495
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.018364373145268495
EPISODIC ATAXIA TYPE 6	0.000541419	0.018364373145268495
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.018364373145268495
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.018364373145268495
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.018364373145268495
